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Abstract
In skeletal muscle (SM), the microcirculation distributes blood flow to capillary networks to
meet local oxygen (O2 ) demand. Experiments using intravital video-microscopy (IVVM) have
quantified blood flow and O2 supply in capillary networks, and using an O2 exchange chamber
have measured local changes in blood flow believed due to O2 -dependent regulation. However,
IVVM is unable to simultaneously measure capillary O2 supply and SM O2 content, implying
the need for theoretical models to understand how flow regulation and SM oxygenation interact.
In this thesis, a novel blood-tissue O2 transport model using continuously distributed capillaries was developed to study SM O2 transport and flow regulation a↵ected by an O2 chamber.
The steady-state e↵ects of the chamber on capillary and SM O2 were quantified for ranges of
physiological and experimental parameters, and our simplified dynamic regulation model was
shown to support current understanding of the local O2 -dependent blood flow response in SM.
Keywords: model, microcirculation, capillaries, oxygen, endothelial, regulation,
control theory

Lay Abstract
The microcirculation is a component of the cardiovascular system encompassing the smallest
blood vessels in the body. Amongst these, capillaries though on a microscopic length scale, are
responsible for the large task of carrying oxygen from your arteries through blood and delivering oxygen to ensure the surrounding tissue can perform its metabolism. This metabolism,
in tissue such as skeletal muscle (SM), has been shown to have a large range depending on
the activity level needed. Experiments using a microscope technique called intra-vital video
microscopy (IVVM), are capable of analyzing SM microcirculation, while still attached to an
organism’s physiology. IVVM experiments have revealed SM microcirculation is capable of
changing its blood flow to match the metabolism demand of the surrounding SM at several
levels of activity. IVVM, is capable of measuring blood speed, and the oxygen concentration
within capillaries. However, IVVM is unable to measure how much oxygen leaves through
capillary walls, and into the surrounding tissues. Without a strong method to understand the
balance between tissue and capillary oxygen, explaining the phenomenon of how the microcirculation can vary its flow under a variety of activity levels is not possible. Thus, in the last
hundred years, mathematical models have been developed to relate capillary blood flow and
oxygen concentration that many techniques (including IVVM) can obtain, and return tissue
oxygen concentrations. As IVVM has become capable of simulating larger networks of SM
and capillaries, many of these models, are becoming impractical to use. Therefore, there is a
need for an oxygen transport model, which can calculate tissue oxygen levels at the length scale
of modern IVVM experiments, and also is capable of explaining regulation observations seen
in IVVM. In this thesis, a new oxygen transport model representing capillaries as a smooth distribution rather than traditionally used discrete cylinders, was developed to study SM oxygen
transport and blood flow regulation. E↵ects of oxygen chambers used in IVVM experiments to
stimulate muscle were simulated, and a second model to simulate microcirculatory regulation
reproduced trends seen in IVVM experiments. These models can be used to investigate SM
and its oxygen regulation further.
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Saturation Curve Linearization Constant given by = NHDCHb /(4↵T P50 ).
P01 , P02 Near & far layer inlet capillary PO2 (respectively) [mmHg]
T
Tissue thickness in [m]
Surface O2 chamber oxygenation in [mol/L]
Capillary volume fraction
Derived Parameters
v⇤1(B) Near-layer homogenizing velocity
P⇤(i)
Interface PO2 [mmHg]
⇤
⌘
Inlet Inter-layer PO2 [mmHg]
⇤
Inter-layer PO2 decrease [mmHg]
✏˜1 ✏˜12 Interface coupling coefficients
No-flux PO2 [mmHg]
P(i)
Microcirculatory O2 Parameters
PB(1) Capillary PO2 in first layer of microcirculatory O2 model [mmHg]
PB(2) Capillary PO2 in second layer of microcirculatory O2 model [mmHg]
”Near Layer” Layer in microcirculatory O2 model pertaining to 0  x < 200µm
”Far Layer” Layer in microcirculatory O2 model pertaining to 200  x  400µm
L
Length of skeletal muscle capillary segment along z-axis µm
xi

1
v1
v0

Capillary RBC velocity in microcirculatory O2 model. [µm/s]
Baseline RBC velocity in microcirculatory O2 model [µm/s].
Chamber O2 level supplied to skeletal muscle [mmHg]
O2
vcond Endothelial conduction speed [µm/s]
Control System Parameters
P(out) Di↵erence in capillary PO2 outlet between near and far layer [mmHg]
{ 1 , 2 , 3 , 4 } Linearization constants in baseline conditions and DMII
↵
Linearized P(out) o↵set, defined as ↵ = 1
2 O2 + vmin ( 3
4 O2 ) [mmHg]
⌘
Linearized P(out) negative gain defined as ⌘ = 3
[mmHg·s/µm]
4 O2
PO2 -to-signal gain [mmHg 1 ]
p
Signal-to-velocity gain [µm/s]
v
⌧⌃
PO2 -to-signal time constant [s]
⌧v
Signal-to-velocity time constant [s]
Decay constant [1/s]
v1
Steady-state velocity such that P(out) = 0
{F(s), G(s), H(s)} Generalized transfer functions (dimensionless)
Derived Parameters
{U1 , ˜⇢, ⌦P , ⌦A } Laplace transforms, L{} of {v1 , P(out) , ⌃P , and ⌃A }
⌧cond Conduction time-delay, ⌧cond = L/vcond [s]
v1,close Quasi Laplace-inversion function for v1 for small t-values
⌃A,close Quasi Laplace-inversion function for ⌃A for small t-values
tmax Time at which ⌃A,close attains its peak [s]
⌃A,close(max) Maximal ⌃A,close value [dimensionless]
˜ O2 ,(eq) Equilibrium chamber O2 value where ↵( ˜ O2 ,(eq) ) = ⌘( ˜ O2 ,(eq) )v0

Chapter 1
Introduction and Literature Assessment
1.1

Microvascular Blood Flow and O2 Transport in Skeletal
Muscle

The microcirculation defines the component of the cardiovascular system containing the smallest blood vessels in the body. These blood vessels though small in comparison to larger arterial
and venous vessels, thoroughly perfuse every organ and region of functional tissue within the
body. As a result of this direct contact with tissue, the microcirculation is responsible for several functions; among them, is the transport of blood through networks of microcirculatory
vessels. Blood, consisting of various populations of cells, contains red blood cells (RBCs),
which possess O2 -rich molecules of oxygenated hemoglobin (HbO2 ) bound to their surface.
Hemoglobin carried through blood to various tissues, allows the chief role of the microcirculation - transport of O2 to tissue - to occur. Through complex biochemical and physical processes, O2 bound to hemoglobin is released, and distributed to the tissues which the smallest
blood vessels in the microcirculation, referred to as capillaries, penetrate.1
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The transport of O2 to tissue through capillaries, allows the function of the heart pumping blood
through large blood vessels, to deliver O2 to every region of the body. The O2 is utilized within
biological cells to facilitate aerobic respiration; this allows the cells to generate energy used to
accomplish their function required by whichever tissue they comprise. When there is a lack
of blood flow through the microcirculation, or when the blood is insufficiently oxygenated,
there is a deficiency of O2 delivery to cells, in a state known as hypoxia. Hypoxia developing
in cells is typically accompanied by cellular dysfunction, as well as damage to the cell which
can persist even after O2 is re-supplied to the level required. The lack of proper blood flow
regulation resulting in a mismatch of O2 delivery from capillaries, and tissue O2 demand, also
termed ‘microvascular dysfunction’, has been shown present early in the pathophysiology of
both acute and chronic diseases. Insufficient capillary-tissue O2 delivery can also result from
extreme physiological conditions (ie. high physical activity) and from structural defects in the
microvasculature (capillary rarefaction).2

1.1.1

Skeletal muscle

Of particular interest, skeletal muscle tissue which comprises all muscle in the body not surrounding organs (smooth muscle), or part of the heart (cardiac tissue), has an interesting relationship with O2 delivery.3 Skeletal muscle is a highly organized tissue where the entire muscle
is bound by a layer of connective tissue referred to as the epimysium. The muscle within the
epimysium is divided into several sub-divisions termed ‘muscle fascicles’ bounded by connective tissue denoted perimysium. These fascicles contain several bundles of muscle fibers, which
are columnar arrangements of skeletal muscle cells, bounded by an internal connective tissue
layer, the endomysium. Muscle tissue is innervated by nerves that allow for tensile and contractile behavior. In addition, several levels of division of the microcirculation, ranging from
arterioles and venules to small capillaries, run throughout the muscle, with capillaries mainly
parallel to muscle fibers. This lends to a rectilinear arrangement of blood vessels delivering O2
to every region of the muscle.4
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Skeletal muscle cells, termed myocytes, are able to consume large quantities of O2 on
account of their function to perform contractions which require energy to facilitate sufficient
tension generated.4 As a result of their relatively large O2 requirement during contractions,
skeletal muscle is one of the first tissues to be a↵ected by a lack of properly distributed capillary O2 delivery. In various diseases including Diabetes Mellitus II, sepsis, and metabolic
syndrome, improperly distributed muscle O2 delivery can cause adverse consequences such as
muscle hypoxia, and eventually necrosis and gangrene, to form.5,6 Skeletal muscle can also
possess regionally varying O2 consumption rates, and varying geometric characteristics of
muscle fibers. Thus there is a variety of O2 delivery patterns required even at baseline conditions. Further, the wide range of O2 consumption rates in skeletal muscle make proper blood
flow regulation particularly important. Therefore, identifying, quantifying, and monitoring microvascular O2 delivery to skeletal mucle is essential to understand how blood flow and O2
supply is controlled, to ensure that the muscle tissue is functioning appropriately, and to ensure
that the muscle will not develop any adverse consequences.7

To begin to develop methods to quantify microvascular O2 delivery in skeletal muscle,
the complex biochemical and physical processes involved in the microcirculation convecting
blood, and delivering O2 to muscle tissue must be fully understood. Once the process is understood, explaining either how normoxic or hypoxic states arise can be possible. This explanation
however is only possible when regulatory pathways that the cardiovascular system uses to vary
microvascular O2 delivery, in order to accommodate for a plethora of physiological variablility, are also included. With a strong method of quantifying both how O2 bound to RBCs can
be transported to skeletal muscle, as well as how blood is regulated to ensure sufficient RBC
supply, O2 delivery can be predicted in tissue, and methods can be developed to monitor this
delivery rate.
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Microvascular experimental techniques

Within blood vessels, O2 transport is facilitated via the convection of blood containing HbO2
inside red blood cells. Oxygen is released from hemoglobin, at which point it exists as a
gas dissolved within the blood fluid.1,2,8 O2 concentration existing as a gas is quantified using Henry’s law dictating that a concentration of a gas within a medium can be described as
the product of the gas’ solubility, and the partial pressure it exerts on the surroundings. For
O2 , this partial pressure is denoted using PO2 , and is an important quantitative metric of O2
after it dissociates from Hb within capillaries, termed capillary PO2 , as well as once it is uptaken in muscle, termed tissue PO2 . Both are critical for understanding general muscle health
surrounding capillary networks.9,10 In general, research into quantifying blood flow and hemodynamics in microcirculatory networks, as well as quantifying capillary PO2 within skeletal
muscle, have produced successful experimental protocols. These have been developed over the
past decades and are based on di↵erent physical principles, but have each been validated in
their own respect. Quantifying tissue PO2 , though a more elusive metric, is an endeavor which
has been investigated experimentally and theoretically. This has produced a diverse number of
approaches, and is an ongoing area of research.
Blood Flow
Methods established in literature to assess microcirculatory vessel geometry, and well as hemodynamic parameters such as blood flow and capillary density are numerous. One of the pioneering experimental techniques to quantifying blood flow used ultrasound waves to detect
the local velocity of blood. Ultrasound techniques in the microcirculation have given rise to
laser-doppler methods of quantifying delay of ultrasound wave return, and inferring blood flow
speed from the delay. Nevertheless, ultrasound has been historically had difficulty with not
being able to attain sufficient resolution to discern microvascular blood flow.11 Another prominent method of quantifying blood flow at the microvascular level, is exemplified by intra-vital
video microscopy (IVVM), which was developed to elucidate structure-function relationships
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in specific microvascular networks,9 rather than in general regions of tissue.

IVVM consists of a microscopy system where a segment of rat skeletal muscle (usually
from a hindlimb muscle such as the extensor digitorum longus, or EDL) is able to be excised
from the rat under sedation, and prepared to view under a microscope while still attached to
the animal’s circulatory and nervous systems. In this method, one can observe in-vivo microcirculation of the rat, and quantify several parameters using time-dependent di↵erences per
collected frame, including but not limited to: RBC supply rate, RBC velocity, and hematocrit
levels.12 Often, to observe how the flow distribution in the microcirculation will alter with external stimuli, a muscle such as the EDL can be placed in proximity to an external O2 gas
chamber such that O2 di↵usion changes the local muscle PO2 , and changes to the aforementioned hemodynamic parameters can be quantified.13

Capillary PO2 Quantification
Most methods of capillary PO2 quantification rely on light absorption/reflection spectra at various wavelengths. By choosing appropriate wavelengths, various protocols can be implemented
with their own advantages.

One group of methods which are capable of capillary PO2 quantification relies on the
di↵erence in absorption spectra of hemoglobin in its oxygenated state (HbO2 ) compared to
its de-oxygenated state (Hb). Wavelengths chosen for this purpose are within the near-infrared
and red light regime, since shorter wavelengths do not penetrate well into tissue and underlying
vasculature. Conversely, longer wavelengths approaching the far-infrared regime are absorbed
in drastically higher proportions by non-vascular tissues and water. Wavelengths chosen for
this purpose are between 660nm in the red regime, and 940nm in the near-infrared regime.
Since these spectra can be measured extra-corporally, this non-invasive principle has enjoyed
widespread use through methods using near-infrared (NIR) light, and pulse-oximetry, which
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have been implemented in the clinic and academia as monitoring tools for arterial and capillary
PO2 .14 Near-infrared spectroscopy (or NIRS) has enjoyed widespread usage using mountable
rigs which can measure the absorbtion spectra from multiple spatial sources of light illuminating a surface. Using this technique, spatial fields of HbO2 concentrations, and subsequently
capillary O2 saturation (SO2 ) or PO2 can be reconstructed. While e↵ective at obtaining and
interpreting spectroscopy data over spatial fields, a downside which NIRS su↵ers from is its
spatial resolution. Light possessing a wavelength, is subject to several artifacts of interference,
that place an upper bound on the resolution which capillary PO2 can be obtained.15,16 Over the
span of its usage over the last two decades, while the NIRS’ resolution has vastly improved particularly in recent years,16 the method still remains non-ideal to produce oxygenation data at the
individual capillary level - the level which would be of use in quantifying capillary PO2 within
microcirculatory networks. Another example of where spectroscopy has been implemented
academically and clinically include commercial pulse oximetry tools which quantify capillary
PO2 most commonly from a fixable clip on the finger.17 Commonly reported disadvantages
include the lack of accuracy of pulse oximetry at low PO2 values lower than 70mmHg where
capillary networks can exhibit frequently, as well as the lack of spatial resolution which can be
found in the microcirculation.14 Consequentially, applications of pulse oximetry are typically
focused on homogenized arterial O2 data collection, without consideration of the underlying
capillary network geometry.

Another group of methods which are capable of capillary PO2 quantification are those
which seek to use di↵erences in light optical density between RBCs at two di↵erent wavelengths in IVVM settings which is collecting various hemodynamic parameters simultaneously.
In this method, two wavelengths are selected to track optical density. The first typically is an
isosbestic wavelength, meaning that the absoorbance of light of a sample is independent of any
chemical reaction (in this case, O2 dependent dissociation from Hb). The second wavelength
is selected to be one where its absorption spectrum is O2 -sensitive.18,19 When embedded in
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an IVVM setting, this method is termed dual-wavelength IVVM (D IVVM).20 By using an
IVVM experimental protocol, the optical density of the RBCs can be compared at an isosbestic wavelength (typically near 420nm) and an O2 dependent wavelength (roughly 436nm),
and RBC O2 saturations (SO2 ) can be obtained. This SO2 quantifies the average percentage of
O2 bound to hemoglobin on RBCs, and using the Hill Equation relating the O2 saturation to
the local capillary PO2 , this proxy measurement can be converted to the average intra-capillary
partial pressure of O2 .20 D IVVM is capable of resolving capillary PO2 to microscopic capillary network resolution,21–23 but also has disadvantages; the most prominent disadvantage is
its invasive nature, distinguishing it from pulse oximetry. Another limitation is that its wavelength pair is only sensitive to O2 bound to RBCs. Thus, if other gas/fluid spectra are desired
at di↵erent wavelengths, multi-wavelength imaging must be implemented, which can be costly
and difficult to integrate. Disadvantages being stated however, D IVVM is extremely useful as
a technique to probe O2 values with accuracy, which are typically localized to RBCs, and can
be coupled with blood flow measurements in IVVM as well to produce a complete picture of
microcirculatory hemodynamics.

Regardless of the method, both pulse oximetry and D IVVM are focused on capillary
dynamics. After O2 is dissociated from HbO2 , it then travels along the blood vessel as a dissolved gas with the convection of blood, and proceeds via di↵usion into the surrounding muscle
tissue.

Tissue PO2 Quantification
While both D IVVM and pulse oximetry are able to measure capillary PO2 , they are yet unable
to measure actual O2 entry into the surrounding tissue. This O2 in muscle (termed tissue PO2 )
may be a more accurate metric of microvascular O2 delivery. Studies have shown that tissue
PO2 is critical as a clinical indicator of the progression of several microcirculatory diseases
including sepsis and diabetes,24 and is likely reflective of overall muscle O2 -related health.
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Tissue PO2 on the other hand has been more elusive to measure in skeletal muscle. Techniques such as phosphorescence quenching, deposit chemiluminescent material in the muscle
region of interest; this material has the property where it radiates light proportional to O2 content in its vicinity through a chemical reaction. Similarly to spectroscopy, this light intensity
can be converted to a PO2 measurement, and therefore return tissue PO2 .25,26 While this method
can return a tissue PO2 measurement, studies which have documented interstitial PO2 , have also
demonstrated an underestimation of tissue PO2 using phosphorescence quenching, on account
of the chemiluminescent agents accumulating in the endomysial spaces, and thus not accurately quantifying whole-tissue PO2 ;27 rather, this technique is prone to computing endomysial
PO2 which will be lower on average than the tissue. This makes phosphorescence quenching
an indirect and potentially unreliable measure of skeletal muscle PO2 whether in a clinical or
academic setting. Therefore, on account of the lack of techniques of sufficient accuracy and
spatial resolution to assess skeletal muscle PO2 at the capillary level, theoretical modeling of
capillary-tissue O2 transport has been used to complement experimental techniques with the
aim of discovering additional regulatory mechanisms in healthy and diseased skeletal muscle
which may be PO2 -dependent.

Experimental Overview
To summarize, several methods including ultrasound, IVVM, NIRS, and phosphorescence
quenching have been proposed for monitoring bulk and network hemodynamic quantities that
reflect microvascular oxygenation. As was mentioned, with the goal of studying hemodynamics at the capillary-level ultrasound and NIRS have both su↵ered from an upper bound
on resolution. Thus, D IVVM which is capable of monitoring capillary SO2 and local blood
flow has been the gold standard for the quantification of microvascular hemodynamics and O2
supply. Despite all the benefits of D IVVM, tissue PO2 still remains elusive, and therefore
has often required complementation with mathematical modelling of the microcirculation to
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understand oxygen distribution from capillaries to the surrounding tissues, and for modelling
the e↵ect of regulation on this process.

1.1.3

Experimental motivation

Skeletal muscle O2 and capillary blood flow is a tightly regulated process in skeletal muscle.
Being one of the tissues which receives a large amount of blood flow, it has been seen that
under heavy exercise conditions, some 80% of cardiac output is received by skeletal muscle
in the body. Arterial blood vessels which the blood from the heart passes through to skeletal
muscle, are capable of largely variating their tone, or circumferential tension. Through the
vessels dilating, an increased flow rate of O2 -laden blood may be delivered in circumstances
of high activity. Similarly, contracting their vessel wall can decrease flow rate, and divert flow
from sufficiently oxygenated tissue to distribute it to other skeletal muscle regions which are
in higher metabolic need of blood flow. This dilation and contraction can depend on local
metabolic activity, sympathetic neural activation, and can even be a homeostatic response to
counter stretching of the vessel walls by blood volume (myogenic response). The regulatory
response is responsible for ensuring skeletal muscle is sufficiently supplied with O2 in a variety
of activity and states of disease, and often when disease causes tissue hypoxia, it is speculated
that a degradation of this regulatory system is responsible.28

With IVVM being able to quantify microcirculatory hemodynamics and capillary SO2
levels on the individual capillary muscle bundle level, it has been used in conjunction with
mathematical models to investigate this regulatory system. Several phenomena have been observed in IVVM studies analyzing hemodynamic response in the microcirculation. In IVVM
experiments, when muscle tissue is stimulated with externally applied O2 via a gas chamber,
the local tissue capillary networks were seen to modulate blood flow to recruit sufficient O2
delivery as per the local demands of skeletal muscle metabolism.13 Since capillaries have no
vascular smooth muscle and cannot actively change their diameters, microcirculatory adapta-
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tion at the capillary level, has led to the conclusion that the capillaries are capable of dynamic
signalling to upstream arterioles, to recruit blood flow via the alteration of arteriolar diameters
upstream from capillaries. Importantly, the changes in local capillary blood flow observed in
the O2 chamber experiments have been seen to be PO2 -dependent.21 Leading theories of how
upstream signalling beginning from capillaries occurs, is via sensing of O2 by cells on the inside of capillaries known as endothelia.29 Endothelia are thought to signal along the capillary
wall upstream to arterioles to change their diameter (and hence hydrodynamic resistance), resulting in a change of blood flow to a particular region in a signalling process referred to as
endothelial conduction30 (Fig.1.1).

Figure 1.1: Schematic of endothelial conduction where O2 in capillaries induces a release of
ATP that is received by endothelia, and creates a signal which propagates upstream to arterioles
that can alter their geometry and induce higher flow.31
While D IVVM is capable of elucidating the structure of capillary networks, monitoring capillary blood flow rate, and determining capillary SO2 , it still remains not feasible to calculate
tissue PO2 with high fidelity. Given the historical complementation of D IVVM with mathematical modelling, there is a need for mathematics to be able to generate accurate tissue PO2
measurements which agree with capillary SO2 and blood flow data from IVVM. Moreover,
with a good model for calculating tissue PO2 (often also providing a method to double-check
the validity of capillary SO2 data provided through IVVM), it still remains a challenge to
thoroughly explain regulatory phenomena such as endothelial conduction on a basis of IVVM
measurements and tissue PO2 alone. Therefore, there is a need to augment microcirculatory O2
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transport models with the capacity to account for parameter variations in IVVM data suspected
to be a result of microcirculatory regulation.

1.2

Microcirculatory O2 Modelling Approaches

To complement IVVM experiments which are able to obtain capillary blood flow and SO2 measurements, mathematical models may be developed to investigate how O2 might be transferred
from blood flow in microvessels to surrounding tissue. As a broad goal, several O2 transport
modelling approaches have been proposed over the past decades to accomplish the goal to
complement IVVM experiments. Modelling e↵orts founded around the established model of
O2 di↵usion from cylindrical blood vessels, termed the Krogh Model, were proposed. This pioneering model is known for posessing many drawbacks, since the Krogh Model assumes that
O2 transport is restricted to the e↵ect of individual blood vessels and is una↵ected by its neighbor vessels.32 In the context of exploring capillary networks where arrays of capillary segments
are side by side, this model is not very suitable. Thus, since the proposal of the Krogh Model,
several improvements have been suggested.

1.2.1

Previous discrete modelling approaches

Instead, more recent approaches in the past two decades have begun to use simplified finiteelement modelling to simulate di↵usion of O2 from cylindrical vessel segments with specified
O2 concentrations which were designed to simulate the O2 contribution of capillaries.33,34 This
approach has been termed the ’discrete approach’, owing the name to the discrete line nature of the capillary segments in the simulations. These capillary segments, or multi-segment
capillary arrays could be reconstructed from microscopy data obtained in IVVM experiments,
allowing for complementarity of this technique with IVVM.35 Using the discrete approach in
conjunction with IVVM data has provided experimentalists with insight into the physical basis
of observed gradients of capillary saturation in skeletal muscle, and the unique ability to cal-
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culate skeletal muscle tissue PO2 gradients. As IVVM modern research has advanced to the
stage of being able to construct expansive capillary networks with high degrees of freedom12
(Fig.1.2), describing PO2 transport in skeletal muscle using the discrete approach has become
inefficient due to the computational burden to account for the number and resolution of individual capillary segments. Furthermore, discrete approaches which have been used for capillary
networks which have sufficiently close spacing predict tissue PO2 distributions that are largely
smooth with the exception of PO2 aberrations in the periphery of the capillary segments.36

Figure 1.2: Microcirculatory extensive networks reconstructed from stitched IVVM fields of
view that are post-processed..12

1.2.2

Continuous-capillary modelling approaches

To provide a solution to model large capillary networks producing smooth tissue PO2 profiles
that do not exhibit much dependence on the networks specifics, an alternate approach regarding
capillaries not as discrete line elements, but as a general density field distributed in the muscle segment being considered has been proposed and termed the ’continuous approach’. The
continuous approach model, building on the work of Eric P. Salathe from the 1980s37 assumes
that O2 spreads to tissue from a di↵use field of capillaries occupying the same space as the
skeletal muscle tissue which is also represented as a locally homogeneous region. Continuous
approaches in the past two-decades have accounted for several sources of O2 in the microcirculation, but most continuous approaches have not considered how local blood flow within the
capillary space can a↵ect the O2 transport to surrounding skeletal muscle.38
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1.2.3

One-layer continuous-capillary O2 transport model

A recent continuous approach rectifying this inclusion of capillary blood flow is a new model
characterizing O2 transport in a homogeneous region of skeletal muscle and tissue. This model
is two-dimensional, and measures distance from an assumed source of O2 (ie. IVVM gas chamber) with x, while capillaries which are perpendicular to the x coordinate, has distance along
their length represented with z. The model represents capillaries as a continuously distributed
density field (x, z, t), equipped with a superimposed vector field vB (x, z, t) describing the flow
of blood at each point in the capillary density field (Fig.1.3). For simplicity, it is assume that
the blood flow is longitudinal along the capillaries which are perpendicular to the x coordinate,
such that vB = vB ẑ. It is also assumed that both vB and

are constant values in time and space,

such that there are equal density of capillaries and identical blood flow throughout the spatial
domain considered.

The model’s foundations lie on the principle of mass transport, and has influences from the
Krogh model by considering in oxygen di↵using from capillaries to tissue, where it is assume
that per unit volume, muscle is consuming oxygen through the parameter µ. The inclusion
of capillaries is by characterizing the O2 influence from blood which is convected along the
capillary containing oxygen. This O2 then di↵uses through the tissue wall through a mass
constant described as K. This model’s geometric parameters (thickness T and width L) are
informed from IVVM experimental fields of view. The model also that O2 is almost entirely
bound to hemoglobin in the capillaries, but is at a sufficiently high O2 level above the P50 of
the myoglobin dissociation curve (around 5mmHg) to assume all O2 in the skeletal muscle is
dissolved. This model termed the ’one-layer model’ has been validated against discrete approaches that factor blood flow, demonstrating that the one-layer model has higher efficiency
than equivalent discrete approaches, and accounts for blood flow to discrete-model accuracies
unlike previously proposed continuous approaches.39
The one-layer model possessing the ability to calculate tissue PO2 distributions efficiently,
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Figure 1.3: Illustration of one-layer model, with O2 exchange chamber (top) a↵ecting a skeletal
muscle segment with capillaries entering the muscle from the left, and being represented as a
di↵used cloud on the inside of the muscle segment. The segment’s O2 dynamics are governed
by: chamber PO2 [mmHg], inlet capillary PO2 P0 [mmHg], discharge hematocrit HD , capillary blood velocity vB [µm/s], tissue O2 consumption µ [mLO2 /mL/s], and capillary volume
fraction . The geometric parameters indicating the dimensions of the skeletal muscle segment
are also indicated: tissue segment length L (in the z direction), O2 permeable-membrane thickness ⌧ p (in the x direction), and tissue segment thickness T 40 (caption modified from Afas and
Goldman, 202240 ).
whilst also accounting for the e↵ect of capillary blood flow, presents an opportunity to study
the earlier described IVVM observations of microcirculatory adaptation to externally applied
O2 .

1.2.4

Past approaches to modelling microcirculatory regulation

Motivated by the IVVM observations of RBC flow distributions altering near to an externally
applied chamber O2 , there is evidence that regulatory mechanisms are playing a role in the
variations of blood flow and O2 supply. There has been much interest in coupling models for
blood flow and O2 supply with models to mimic regulatory mechanisms, with the goal of producing blood flow and O2 pressure responses similar to physiological responses. This would
produce models which are versatile in accounting for disruptions to regulatory systems, and
the resultant e↵ect on blood flow, but more importantly O2 supply.41
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As discussed in the experimental motivation, one hypothesis of how O2 supply and blood

flow is recruited to capillary networks is by the local sensing of capillary O2 and upstream communication to arterioles which can alter their diameters to recruit higher blood flow to a↵ect
O2 supply. Sensing and responding to capillary O2 content is part of the metabolic component
of microvascular regulation. Another aspect of the metabolic component is the direct e↵ect
of tissue metabolites (e.g., adenosine) on arteriolar diameter.42 There are also several other
recognized components that have been modeled, including the myogenic, shear-dependent,
sympathetic e↵ects on arterioles.29 Arterioles are capable of sensing intravascular pressure (or
lack thereof), and can alter smooth muscle wall tension and diameter to maintain baseline blood
flow, known as the myogenic e↵ect. A ’shear e↵ect’ has also been demonstrated where changes
in blood shear stress on the vascular endothelium enacts changes in vascular smooth muscle
tone and arteriolar diameter.29 In addition, nerves from the sympathetic nervous system act directly on arteriolar smooth muscle and can a↵ect their diameter and flow resistance.43 Lastly,
considering that blood can transport various gases (ie. CO2 , N2 ) and ions (ie. Ca2+ , K+ ), local
concentrations of these compounds can be detected biochemically.42 Then, vascular networks
can involve the peripheral nervous system to produce an increase of these compounds in the
blood which can a↵ect contractility, upstream conduction efficiency, and even cardiovascular
parameters including heart rate to produce an e↵ect at the microcirculatory level.42,44

E↵orts to represent these various processes have produced models with varying geometries; often, models seeking to account only for regulatory mechanisms which enact a change
at the arteriolar level, can represent changes in diameters and vascular tension using lumped
parameter modelling.45 Such models have their focus on larger vessels, and do not account for
the e↵ect of smaller vessels (such as capillaries), or account for them as a lumped parameter
element in their model schema. Models also di↵er based on the specific manner in which they
are modelling blood flow, and O2 transport. As earlier discussed, O2 transport can be represented using discrete models representing capillaries as discrete elements di↵using to their
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surroundings, whereas continuous models involving blood flow, and not as parameters have
been discussed. These di↵erences typically restrict which regulation and biophysical mechanisms can be examined e↵ectively. Discrete models only accounting for convection within
discrete vascular elements, and not for O2 di↵using spatially, will miss the biophysical component of the metabolic O2 e↵ect that involves di↵using O2 to adjacent modules.46 Conversely,
continuous models discussed earlier where O2 di↵usion is accounted for, but blood within capillaries is represented as having a constant PO2 value (not accounting for convection),38 mean
that blood flow cannot be a factor used as a target in a regulatory model.

The geometry description of O2 transport, and incorporation of blood flow, are frequently
chosen with the goal being to obtain a model with the simplest design possible, but care should
be given to the resulting limitations on the forms of regulation that can be studied.47 The opportunities a↵orded by the continuous distributed-capillary model, make it particularly suitable
for describing metabolic e↵ects induced by IVVM, since it accounts for the e↵ect of O2 di↵usion between adjacent capillary modules, as well as incorporates capillary O2 convection. At
the length scale of IVVM experiments, fields of view indicate that capillaries are the dominant
species of blood vessel in terms of O2 transport and O2 -dependent flow regulation. As such, it
is expected that the e↵ects of arterioles and larger vessels can be neglected in initial models,
aside from their assumed role in changing downstream blood flow as a result of signals sent
upstream from the capillary modules considered.

1.2.5

Multi-layer continuous capillary PO2 extensions

With the goal to develop a method of accounting for IVVM observations of RBC flow alterations under external chamber O2 stimuli, and establishing the suitability of the one-layer
model for such purpose, an extension to the one-layer model may be designed to model O2
transport through and across multiple capillary modules, assuming each is interacting with adjacent segments by di↵using O2 across their boundaries. The benefit of this approach is that
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individual segments (ie. capillary module/tissue units) can be modified, and their interaction
with adjacent segments can be investigated. To model RBC flow distributions altering near and
far relative to an O2 chamber, the simplest implementation to begin considering multi-segment
O2 transport is two layers of O2 transport, one near, and one far from the O2 chamber. This
would be done by applying the one-layer model to a segment of skeletal muscle near to an O2
chamber with flow able to variate dynamically, and also to a segment of skeletal muscle far
from the O2 chamber with unchanging flow. This near-layer blood flow can be investigated
to understand how its variations observed in IVVM may be connected to O2 transport when
perturbed by various chamber O2 levels. With a successful model of microcirculatory blood
flow adaptation in resting skeletal muscle subjected to externally applied O2 , consequences of
physiological variations in capillary density and other hemodynamic and metabolic parameters
in the model can be observed, and an initial model of endothelial conduction may be able to be
developed to understand microcirculatory mechanisms of O2 homeostasis.

1.3

Study aim, and thesis contents

The aim of this thesis is to develop a model of microcirculatory O2 transport de-novo, which includes O2 transport within and between capillary modules and can investigate and explain the
phenomenon of near-layer blood flow perturbations throughout skeletal muscle, in response to
externally applied chamber O2 observed in IVVM. In order to accomplish this aim, the model
which calculates O2 transport from blood to skeletal muscle tissue, and is capable of incorporating a simplified schematic of endothelial feedback will be developed over two related modules.
The development, and validation (qualitative and quantitative) of both of these modules will be
explored in respective studies which will explain several facets of these models including:
• The rationale behind the models (obtained from relevant physiology)
• The formulation of their respective governing equations (ODEs/PDEs)

1.3. Study aim, and thesis contents
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• The solution of each set of equations (whether numerical, analytic, or quasi-analytic)
• Quantitative calculations and visualizations produced by each model.
An overview of what each of these two models will target to accomplish in the subsequent
thesis is as follows:
1. Chapter 2: A two-layer continuously distributed capillary O2 transport model applied to blood flow regulation in resting skeletal muscle
• Goal: The first goal in order to develop a microcirculatory O2 transport model
which characterizes endothelial feedback amongst capillary segments, is to have a
reliable model capable of calculating O2 distributions within multi-layered coupled
segments of capillaries modules. As mentioned, a validated one-layer model has
been proposed which calculates capillary PO2 distributions and tissue PO2 profiles
with sufficient fidelity such that it agrees with boundary IVVM data and previously
published discrete models. It has been emphasized in several studies that mirocirculatory networks appear to be redudible to a fundamental unit referred to as a
capillary module.2,12 Adopting the perspective of a microcirculatory network which
can be subdivided into finite modules, it was emphasized that the one-layer model
could be extended to multiple capillary modules. Under this perspective, it is assumed capillary modules are communicating with eachother via O2 di↵usion. To
model the IVVM phenomenon of near-layer RBC velocity perturbations, extending
this model to two-coupled capillary modules is the minimum required, and so for
simplicity, a two-layered model will be targeted. Owing to the coupled layer nature of the model, and how capillary velocities will be able to be specified between
layers, the velocity will be fixed far from the O2 chamber as seen in IVVM experiments, and a hypothesis will be formed of how the near-layer may be a↵ected by
the O2 chamber.
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• Methods: To develop a two-layered continuous model of microcirculatory O2 transport, the one-layer model will be applied to two conjoined capillary-tissue modules,
both near and far to an external O2 chamber (as used in IVVM experiements). Owing to the versatility of the one-layer microcirculatory O2 transport model previously developed, each layer will possess its own tissue O2 consumption, capillary
RBC velocity fields, inlet capillary O2 saturation, and capillary volume fractions
(baselines obtained from IVVM data). Governing equations will be solved, and
analytic results will be obtained which are capable of visualizing tissue PO2 and
capillary PO2 profiles in a specified skeletal muscle domain. To investigate how
velocity in the near-layer may be a↵ected by the O2 chamber, the velocity will be
assume to vary to balance the O2 in both the near-layer and far-layer. Through this
method, the velocity which homogenizes O2 can be found at several chamber O2
levels.
• Expected Results: Tissue PO2 profiles will be visualized for a variety of tissue O2
consumption rates, and capillary volume fractions, to characterize how variations
in these bulk parameters which are typically provided by IVVM, can a↵ect O2
transport amongst both regions, near and far to the O2 chamber. This will be investigated for several di↵erent chamber O2 levels. Implementing the method described
to solve for the velocity which homogenize O2 in both layers, this homogenizing velocity will have profiles obtained against several chamber O2 levels, and variations
will be investigated to see how various hemodynamic parameters and an imbalance
of capillary RBC velocity a↵ects bulk tissue PO2 distributions in both layers for a
specified chamber O2 level.

2. Chapter 3: A simplified control-systems model of O2 -dependent blood flow regulation to capillary modules in skeletal muscle.
• Goal: With a continuous-capillary O2 transport model that can accurately calcu-
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late tissue PO2 distributions in two-layers of skeletal muscle adjacent to an O2 gas
chamber under a variety of near-layer RBC blood flow and chamber PO2 levels, this
chapter will focus on implementing an initial regulation model. As mentioned in
Fig.(1.1), the paradigm of microcirculatory regulation is that cells lining the inside
of capillaries are able to sense capillary PO2 levels, and provide feedback upstream
to recruit more blood flow. With the model in Chapter 2 that can relate microcirculatory O2 distributions in two coupled capillary modules, to the capillary blood
flow in each and the chamber O2 level, the method for obtaining the homogenizing
velocity which varies with chamber O2 could be obtained. With a relation between
the capillary blood flow and the chamber O2 , this can be incorporated as a component in a larger time-dependent endothelial feedback-based regulation model. If the
capillary blood flow in the far-layer is fixed, the capillary blood flow in the nearlayer could be targeted to vary with di↵erent chamber O2 levels to achieve a (target)
capillary PO2 . The process described by this model would simulate O2 -dependent
microcirculatory blood flow regulation and would be able to quantitatively explain
observed near-layer blood flow perturbations seen in IVVM experiments.
• Methods: The physiology of endothelial conduction will be examined through literature on endothelial feedback to know which parameters in the microcirculatory
O2 transport are relevant to the feedback process. Where new parameters indicated
from literature must be introduced, physiological considerations will dictate how to
integrate these parameters with the existing O2 transport model with the most simplicity. With an understanding of which variables are involved in endothelial conduction, control systems theory will be consulted to formulate a feedback circuit
which accurately captures feedback processes involved in endothelial conduction.
From this feedback-circuit, a set of coupled time-dependent ordinary di↵erential
equations (ODEs) will be developed. The O2 transport model that relates chamber
PO2 and blood flow at steady-state will be incorporated in the set of ODEs; Laplace
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analysis will be applied where analytic simplification of the ODE systems are possible, and a numerical solving scheme will be computationally implemented where
practical to do so. Results as time-dependent blood flow, PO2 , and signalling profiles will be obtained which are capable of characterizing the simplified endothelial
feedback process of interest in the capillary-tissue segment considered.
• Expected Results: Capillary RBC flow, endothelial signalling magnitude, and capillary PO2 time-dependent profiles will be obtained for a variety of capillary volume
fractions, and tissue O2 consumption rates, which can model baseline IVVM and
disease states. In this manner, a comparison of microcirculatory endothelial feedback in various microcirculatory conditions can be examined.
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blood flow regulation in resting skeletal
muscle
Reprinted with permission from (Afas & Goldman, J Theor Bio, 111058, 2022.)

Abstract
The microcirculation is the site of direct oxygen transfer from blood to tissue, and also of
oxygen delivery control via regulation of local blood flow. In addition, a number of diseases
including type II diabetes mellitus (DMII) and sepsis are known to produce microcirculatory
dysfunction in their early phases. Given the complexity of microvascular structure and physiology, and the difficulty of measuring tissue oxygenation at the micro-scale, mathematical
modelling has been necessary for understanding the physiology and pathophysiology of O2
transport in the microcirculation and for interpreting in vivo experiments. To advance this area,
31
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a model of blood-tissue O2 transport in skeletal muscle was recently developed which uses continuously distributed capillaries and includes O2 di↵usion, convection, and consumption. The
present work extends this model to two adjacent layers of skeletal muscle with di↵erent blood
flow rates and applies it to study steady-state O2 transport when flow regulation is stimulated
using an O2 exchange chamber. To generate a model which may be validated through in vivo
experiments, an overlying O2 permeable membrane is included. The model is solved using
traditional methods including separation of variables and Fourier decomposition, and to ensure
smooth profiles at the muscle-muscle and muscle-membrane interfaces matching conditions
are developed. The study presents qualitative verification for the model, using visualizations
of tissue PO2 distributions for varying capillary density (CD), and presents capillary velocity
response values in the near layer for varying chamber PO2 under the assumption that outlet
capillary O2 saturation is equalized between adjacent layers. These compensatory velocity
profiles, along with e↵ective ’no-flux’ chamber PO2 values, are presented for varying CD and
tissue O2 consumption values. Insights gained from the two-layer model provide guidance for
interpreting and planning future in-vivo experiments, and also provide motivation for further
development of the model to improve understanding of the interaction between O2 transport
and blood flow regulation.

2.1

Introduction

The principal function of the mammalian cardiovascular system is to deliver oxygen and other
substances such as glucose to all the body’s cells, and to remove products of cellular metabolism
such as carbon dioxide. The microcirculation, comprising vessels less than ⇡300microns in diameter, has several important functions, including determining blood flow distribution within
organs and tissues, and performing direct transport between blood and tissue. Arterioles (10200microns in diameter) are key in regulating microvascular hemodynamics due to their capacity to dilate or constrict (via vascular smooth muscle) and thereby alter their resistance and
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blood flow to downstream capillary beds. Capillaries (5-10 microns in diameter) comprise the
highest surface area of the circulatory system and are extremely well-suited to delivering O2
directly to surrounding tissue via di↵usion, but unlike arterioles do not generally possess the
vascular smooth muscle needed to actively alter their diameters.1
One of the main motivations for studying the physiology of the microcirculation is its
role in ensuring proper tissue O2 delivery, which depends on both capillary structure (mainly
density) and regulation of convective O2 delivery to capillary beds. In addition, many highly
prevalent diseases, such as type II diabetes (DMII), impair tissue O2 delivery via mechanisms
that alter both capillary density (or volume fraction)2,3 and microvascular flow regulation.4,5
The present modeling study focuses on capillary oxygen delivery under normal physiological conditions, with the goals of improving understanding of specific in vivo experiments and
laying a foundation for future experimental and modeling studies.

2.1.1

Experimental Motivation

As noted above, the microcirculation is the site of direct blood-tissue O2 transport, and also
a site of local blood flow regulation. Skeletal muscle, being highly regulated and possessing
a large range of metabolism and blood flow,6–9 has proven to be a very relevant and useful
tissue for intravital videomicroscopy (IVVM) studies.10 Microvascular blood flow regulation
has mostly been considered at the arteriolar level,11 due to the ability of arterioles to alter their
diameters and hence modulate blood flow magnitude and distribution. Mechanisms that have
been considered to act on arterioles include sympathetic innervation of vascular smooth muscle
(VSM), the myogenic response of VSM to pressure changes, fluid shear stress on the endothelium inducing dilation via VSM relaxation, and tissue metabolite production (e.g., adenosine)
causing dilation. There has also been interest in understanding how capillaries might regulate
their own blood flow and, more specifically, their O2 supply.12,13 The upstream conduction of
dilatory signals from capillaries to arterioles has been discussed and explored by a number of
experimentalists studying microcirculatory physiology,10,14–16 and has also been considered in
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computational modeling.1
For the present work, studies that have used O2 stimulation of capillaries near the surface
of an intact resting muscle to study blood flow regulation are of particular relevance. This
work was begun by Ellis and co-workers in the early 2000s, using an O2 exchange chamber
and a rat extensor digitorum longus (EDL) muscle preparation, and is ongoing.6–8,17–22 The
fundamental result, shown by Ellis et al. 201220 (see Figure 2) and more recently by Ghonaim
et al. 202121 (see Figures 1 and 3) and Sove et al. 202122 (see Figure 9) using resting rat
muscle, is that decreasing (increasing) the oxygen partial pressure at the muscle surface (from
baseline of ⇡35mmHg) results in a decrease (increase) in the oxyhemoglobin saturation of
erythrocytes flowing in near-surface capillaries, which is followed several seconds later by a
compensatory increase (decrease) in the erythrocyte supply rate in these capillaries (via velocity and/or hematocrit changes). Both step changes and sinusoidal oscillations of chamber PO2
have been considered, with PO2 in the 15-150mmHg range depending on the particular experimental protocol being followed. Importantly, the O2 changes imposed do not decrease muscle
PO2 enough to a↵ect aerobic metabolism or desaturate myoglobin, so that the mechanism for
flow changes is believed to be directly related to erythrocyte SO2 ,23 which tends to return to
baseline values following the local flow response.
Although experiments have shown a general consistency and local reproducibility in induced flow responses, heterogeneity has been observed across animals and spatially (for very
localized stimulation), and this has been attributed to several factors including local tissue properties such as capillary density and network structure, muscle fiber type and O2 consumption,
and proximity of arterioles and venules. Since the stimulation of the muscle has a complex
spatial and temporal nature, and since during IVVM experiments O2 content is only measured
in capillaries very close to the surface (< 100µm), this work has been complemented by computational modeling to estimate the extent and timing of the imposed tissue PO2 changes8,24
and their e↵ect on erythrocyte oxygenation as well as on O2 -dependent ATP release.25 The
mathematical model in,24 for example, was able to explain the measured magnitude and phase
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of O2 oscillations traveling into tissue when surface PO2 was oscillated sinusoidally but did not
induce a capillary flow response. The present study is a continuation of this modeling e↵ort,
and utilizes a novel distributed-capillary model which, unlike discrete-capillary models representing capillaries as discrete arrays reconstructed from IVVM experiments,26 allows explicit
mathematical solution of the governing steady-state oxygen transport equations.

2.1.2

One-Layer Continuous Capillary O2 Transport Model

IVVM techniques developed over the past several decades allow for capillary hemodynamic
(RBC velocity and hematocrit) and oxyhemoglobin saturation (SO2 ) measurements.20 In addition, phosphorescence quenching (see ”Tissue PO2 Quantification” in Sec.1.1.2) allows for
PO2 measurements in the plasma space inside capillaries and larger microvessels, and in the
interstitial space of tissue (ie. between muscle fibers).27–29 These tissue PO2 measurements
have been used to assess PO2 gradients near microvessels and to estimate O2 consumption in
resting and working muscle following imposed flow stoppages in the local microvasculature.
Although these phosphorescence quenching techniques have substantially improved the ability
to measure tissue PO2 at the microvascular level, as has been the case for several decades,30–34
mathematical modeling continues to be an important complement to experiment in understanding the detailed biophysics of blood-tissue O2 delivery and its regulation in the microcirculation.22,35
Recently, a continuous coupled partial di↵erential equation (PDE) model for a homogeneous section of skeletal muscle undergoing O2 transport with a continuous distribution of
capillaries was developed accounting for tissue O2 di↵usion, capillary O2 convection, tissue O2
consumption, and capillary-tissue O2 transfer.36 This model was developed in part to study the
IVVM protocol described above involving a controlled PO2 exposure of skeletal muscle using
a gas exchange chamber.7,8,21 To simulate the IVVM protocol, the model assumed a continuous
and homogeneous capillary distribution within a segment of skeletal muscle which was interacting by di↵usion with the O2 chamber. In order to focus on the di↵usive interaction between
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skeletal muscle and the O2 chamber, as well as on the e↵ect of the flow response (considered
uniform as a first approximation), this model follows25 and assumes all capillaries in a module are uniformly spaced, have concurrent flow, and receive the same convective O2 supply.
These simplifying assumptions are motivated by the structure of skeletal muscle, and could be
relaxed in the future to consider the detailed e↵ects of capillary network structure and function
on tissue oxygenation and flow responses during O2 chamber experiments.
In Afas et al.36 the continuous capillary model was validated against a discrete capillary model that has been used previously in several theoretical and experiment-based studies,26,33,34,37,38 including one on the e↵ect of the gas exchange chamber on resting rat EDL
muscle.25 Both models include a tissue O2 di↵usivity (DT ) based on experimental measurements39 and a capillary-tissue mass transfer coefficient (K, inverse of intravascular resistance)
based on calculations using discrete erythrocytes and known biophysical constants,40,41 which
are generally in agreement with similar published calculations.42 In the continuous model, the
local capillary-tissue PO2 di↵erence is determined by K, and nearby capillaries can e↵ectively
exchange O2 via di↵usion through the tissue compartment when external conditions (such as
PO2 imposed by gas exchange chamber) induce a di↵usive flux in a direction perpendicular to capillary flow. The schematic of the IVVM experiment being modeled is illustrated in
Fig.(2.1):
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Figure 2.1: Illustration of the IVVM system (with coordinate axes in top left), displaying an
oxygen exchange chamber (top) a↵ecting a skeletal muscle segment with capillaries running
into and out of the segment (left-to-right). The segment’s O2 dynamics are governed by: chamber PO2 [mmHg], inlet capillary PO2 P0 [mmHg], discharge hematocrit HD , capillary blood
velocity vB [µm/s], tissue O2 consumption µ [mLO2 /mL/s], and capillary volume fraction .
The geometric parameters indicating the dimensions of the skeletal muscle segment are also
indicated: tissue segment length L (in the z direction), O2 permeable-membrane thickness ⌧ p
(in the x direction), and tissue segment thickness T .

The O2 transport in the region indicated by the dotted black line in Fig.(2.1), was summarized
by PB and PT , which are the capillary and tissue PO2 fields respectively. It is assumed that
O2 was di↵using through tissue in the x direction, and convecting along the capillaries bound
to hemoglobin in the z direction. Assuming O2 mass conservation in both capillary and tissue
regions, and a transfer of O2 between capillary and tissue given by a linear ansatz, the PO2
fields were seen to obey the following governing equations:36
(

@2x PT

µ
2K
=
+
(PT
DT ↵T (1
)RDT

where the capillary volume fraction

2K
PB ) , @z PB =
(PT
s̃RvB

is given by

)
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(2.1)

= ⇡R2 (CD) assuming that CD is the cap-

illary density, and R is the capillary radius. The significance of the model is discussed further
in the Appendix. These equations were decoupled into a single PDE for the tissue PO2 by
⇣
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⇣
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⌘
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The above equations were considered subject to the appropriate boundary conditions specifying inlet capillary PO2 values on the left, and the chamber PO2 defined at the top of the
geometry. No flux boundary conditions are assumed at the bottom of the domain, which is an
approximation more easily justified in the two-layer model (see below) where the deeper layer
is mainly una↵ected by the O2 exchange chamber and should be nearly in equilibrium with the
capillary-perfused tissue above it. Since the model is two-dimensional it is considered homogeneous in the span-wise (y) direction, which models a nearly homogeneous capillary module
having minimal di↵usive interactions with the tissue (i.e., other modules) on either side. This
is a reasonable first-order approximation since O2 supply is provided normal to the surface of
the muscle, in the x direction. Therefore O2 flux momentum dictates that di↵usion in the y and
z directions will have a longer di↵usion time than di↵usion in the x direction. The z direction
will have O2 transport dominated by convection, which is why the y-axis is disregarded initially
for di↵usion. These boundary conditions are designed to model a single EDL capillary module
(or two vertically stacked modules, see below) when the O2 chamber is applied to either the
full muscle surface or a substantial portion of the surface, such that neighboring modules are
experiencing a similar O2 transport environment. Studies exploring localized stimulation (on
the order of a single module) would require revised boundary conditions as seen in Sove et
al.,22 or possibly the inclusion of neighboring modules in the y and z directions, similar to the
additional module in x considered below.
The IVVM protocol in Fig.(2.1) also illustrates a transparent O2 permeable-membrane
which acts as a bu↵er and facilitates di↵usion from the O2 chamber, to the skeletal muscle.
The O2 membrane’s inclusion is purely to mirror its physical inclusion in the IVVM experiments as a medium to allow O2 to travel between the O2 chamber and tissue. This O2 membrane
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was not included in the one-layer solution, but is not difficult to include in the model24 and will
be considered in the present study. This PDE system and relevant boundary conditions admit
analytic solutions which were used to create accurate and rapid steady-state PO2 profiles under
a variety of inlet PO2 and chamber PO2 values.
While there exist previous continuous-capillary approaches in literature, the inclusion of
capillary blood velocity denoted by vB in Eq.(2.1) is not shared amongst many approaches
used in microcirculatory O2 transport which consider exclusively tissue O2 di↵usion, tissue
O2 consumption, and a capillary-tissue transfer that relies on assuming capillaries supplying
a constant PO2 to the tissue.22,24 This coupling of capillary O2 convection in Eq.(2.1) is what
makes the recent coupled continuous capillary model a unique and well-suited approach to
study controlled PO2 exposure to skeletal muscle and the microcirculation, as well as the resultant O2 regulation which can be compared against IVVM parameters including capillary RBC
velocity, hemoglobin O2 saturation, and RBC supply rate.7,22–24,43
The IVVM protocol is useful for its ability to observe how oxygen spreads throughout
the segment of tissue from the face where PO2 is controlled by the chamber, and allows the
microcirculation to demonstrate a variety of regulatory mechanisms, which in turn a↵ects PO2
profiles throughout the tissue. The one-layer model returns tissue PO2 distributions, but is
restricted by the IVVM experiments since data is only obtained to a depth of approximately
100 microns. Extending the thickness of the one-layer model further than the depth of the
IVVM experiment is not an e↵ective solution, since in certain cases a thick single layer falsely
indicates hypoxia is occurring at greater depths.43 As mentioned above, IVVM experiments
demonstrate hemodynamic parameters in the skeletal muscle region near to the O2 chamber
undergo substantial variations in blood flow response to altered chamber PO2 21,24,43 to prevent
the development of hypoxia in deeper regions; models which ignore this only demonstrate
passive tissue O2 di↵usion which will predict hypoxia at deeper depths. Recent experimental studies have shown this phenomenon of near-layer hemodynamic parameter variations in
response to chamber PO2 levels, a↵ecting the microcirculation throughout several capillary
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networks which are interconnected.21 More importantly, this phenomenon is not explainable
by the one-layer microcirculatory O2 transport model, since hemodynamic parameters are assumed to be constant throughout the depth of the segment. The lack of flexibility in allowing
hemodynamics to vary with distance into the tissue means that the full behavior of skeletal
muscle microcirculatory regulation in various normal and pathophysiological states cannot be
faithfully simulated.

2.1.3

Two-Layer Continuous Capillary O2 Transport Model

To address the limitations of the one-layer model one could consider extending the model
to a more general multi-bundle of capillary modules. Such a multi-bundle would consist of
treating the skeletal muscle segment shown in Fig.(2.1) as one element of a larger network.
Any microcirculatory O2 transport model would then simulate blood flow and O2 dynamics in
a large macrostructure composed of several independent skeletal muscle segments, coupled at
their borders via di↵usion.
As a first step toward improving on the one-layer model, a 2x1 network is constructed. This
2x1 network models a two-layer segment of skeletal muscle with an O2 permeable-membrane
at a designated ”near” layer to allow bu↵ering between the tissue and O2 chamber; then a
”far” layer would lie adjacent to the near-layer, representing a microcirculatory segment far
from, and una↵ected by, an O2 chamber. Such a two-layer arrangement would allow for the O2
dynamics of a two-layer skeletal muscle segment to be modelled. As indicated above, if the
far-layer has its hemodynamic parameters fixed, and the near-layer parameters are allowed to
vary, then one may identify exactly how parameters in the near-layer would change in response
to chamber PO2 levels. The qualitative confirmation of experimentally observed regulatory
mechanisms in response to chamber PO2 levels will serve as a partial validation to consider a
greater number of capillary modules using this continuous approach.
Finally, with an analytic solution, investigation will be conducted into how various PO2
values at experimentally relevant locations depend on other biophysical parameters which were
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investigated in the one-layer model. One relevant location is the membrane-tissue interface. In
experimental methods, often the O2 membrane is unavoidable due to practical considerations.
However, when stimulating the tissue using the O2 chamber, it is important to know what
is occurring at the interface between the permeable-membrane and tissue. This O2 level is
often what the tissue is responding to, and is a combined e↵ect of the tissue dynamics and
the chamber PO2 . Another utility of the membrane-tissue interface PO2 is that an analytic
expression can be used to determine the sensitivity of PO2 at the membrane-tissue interface, to
other biophysical parameters in the near-layer and far-layer. Another parameter of interest is
the chamber PO2 at which there is zero steady-state flux through the membrane from the O2
chamber to the tissue. When inducing perturbations in the chamber, it is useful to know the
PO2 at which the membrane has minimal e↵ect on the tissue, similar to a no-flux boundary
condition which may be applied experimentally using an O2 -impermeable material.
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Theory & Methods

For brevity, much of the mathematical analysis and explicit mathematical methods used in the
development of the two-layer model are given in A.1-A.4.

2.2.1

Mathematical Formulation

The theory used to develop a two-layer model is similar to the method used to analyze the onelayer geometry and produce one-layer distributions, as per the schematic shown in Fig.(2.1).36
Summarized, the process of the one-layer model36 involved solving the resultant PDEs, imposing initial conditions, and obtaining visualizations. For a two-layer schematic, there will
be boundaries between the membrane and near-layer, as well as between the near-layer and
far-layer. In these regions, a matching algorithm must allow for separate parameters in each
region to dictate one unified PO2 profile along the entire model. To continue, the (x, z) coordinate system will be introduced as in the one-layer model,36 with x denoting the distance from
the O2 membrane-tissue interface and z denoting the distance from the capillary inlet. As per
this system, the two-layer geometry can be labelled as in Fig.(2.2):

Figure 2.2: Depiction of a two-layer geometry with a coordinate system super-imposed. Here,
x denotes the distance from the O2 chamber while z denotes the distance from the capillary
inlet.
Here, two tissue thicknesses are entertained: a near-layer of thickness T 1 , and a far-layer of
thickness T 2 . The geometry in Fig.(2.2) was analyzed, and PDEs were obtained as in Eq.(A.2)
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(See A.1). These were solved as per the boundary conditions specified (See A.2). In A.3,
analytic solutions to Eq.(A.2) were obtained as either a linear profile (for membrane/tissue
boundary) as in Eq.(A.10), or as a Fourier series (for boundary between tissue layers) as in
Eq.(A.15-A.16), and matching conditions were implemented as in A.4 by the implementation
of the epsilon matrix provided in Eq.(A.17).

2.2.2

Computational Code Implementation

In all calculations with the two-layer model, parameters as shown in Table(2.1) were utilized;
many are the same as in the one-layer model.19,36,37
Biophysical Parameter
Baseline tissue O2 consumption
Tissue O2 solubility
Tissue O2 di↵usivity
Baseline capillary blood velocity
Capillary radius
Baseline capillary volume fraction
Tissue length
Baseline Tissue thickness
Inlet capillary PO2
Discharge hematocrit
Hill coefficient
Hemoglobin P50
Mass-transfer coefficient
Hemoglobin binding capacity

Symbol
µ0
↵T
DT
v0
R
0

L
T0
{P01 , P02 }
HD
N
P50
K
CHb

Value
1.5(10) 4
3.89(10) 5
2.41(10) 5
3.573(10) 2
3(10) 4
0.03
5.00(10) 2
2.00(10) 2
47
0.2
2.7
37
1.573(10) 2
0.52

Units
mLO2 /mL/s
mLO2 /mL/mmHg
cm2 /s
cm/s
cm
none
cm
cm
[mmHg]
none
none
mmHg
cm/s
mL/mLO2

Table 2.1: Chart showing all hemodynamic and physical parameters utilized (CGS); CGS convention is utilized, except in applications where mmHg is required
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Chamber O2 levels considered here are within the bounds from 15-60mmHg. The lower bound
of chamber O2 of 15mmHg is equivalent to previous IVVM studies, and 60mmHg while within
the bounds of chamber O2 ’s imposed in IVVM studies was chosen to be similarly equidistant
as 15mmHg from literature EDL average O2 values of 35-40mmHg20–22,25

Impaired Capillary Density Conditions
For baseline conditions, both tissue segments were assumed to contain homogeneous capillary
density (CD), and so the capillary volume fraction was set to baseline in all layers of the model
{

1

=

2

=

0 }.

It was reported in clinical investigations of impaired microvascular health that

capillary density can decrease by up to 47%.44 Thus, to model a low CD state (due to either a
normal CD variation or possibly disease), since it was established that CD / , it was assumed
that the capillary volume fraction in both layers would be { = 0.53 0 } to model a 47% drop
in CD.

Determination of Suitable Near-Layer Thickness: O2 Penetration Depths
In Table(2.1), a baseline tissue thickness was chosen to be T 0 = 200µm agreeing with previous
one-layer studies.36,45 To validate that 200µm was suitable with a two-layer model, the extent
to which a chamber PO2 of 60mmHg would penetrate into a single layer of tissue PO2 was
investigated. The one-layer model36 was used to observe the x-depth (xpen ) when the di↵erence
between the tissue PO2 distribution PT (x, z) and the PO2 at x = 1 (P1 (z)) was 10% of the
di↵erence between the PO2 at the O2 permeable membrane P⇤(i) and P1 (z). As a constraint:
(

xpen 2 {x 2 R|0  x < 1} PT (xpen , z)

1 ⇤
P1 (z) =
P
10 (i)

P1 (z)

)

(2.3)

This was computed for baseline and low CD conditions, as well as varying tissue O2 consumption levels at several z points along the arteriovenous (AV) domain.
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Tissue and Capillary PO2 Convergence
The analytical solution for both tissue and capillary PO2 hinges on an infinite-term Fourier
series. Computationally, this series was truncated at a finite number of terms such that both
tissue and capillary PO2 did not vary more than 0.1mmHg each. This was tested by plotting
the tissue PO2 and capillary PO2 against the number of Fourier terms for an array of x and
z values. Both 15mmHg and 60mmHg O2 chamber levels, as well as velocity fluctuations in
the near-layer ranging from v1 = 0.5v0 , to v1 = 1.5v0 were considered, and using the results
from Sec.(2.2.2) it was assumed that T 2 = T 1 = T 0 . It should be pointed out that T 1 + T 2 =
2T 0 ⇡ 400µm; a larger far-layer (ie. T 2 > T 0 ) does not make a di↵erence in the solution as the
system’s solution does not depend on x far from the O2 chamber.
Tissue PO2 convergence was examined, and for a relevant range of parameters, utilizing
10 Fourier terms for tissue PO2 and 30 Fourier terms for capillary PO2 yielded appropriate
convergence to the desired threshold; proceeding forward, 10 and 30 Fourier terms were used
in tissue and capillary PO2 calculations, respectively. In general, both tissue PO2 and capillary
near the microcirculatory segment inlet (z = 10µm) did not exhibit variance with the number
of Fourier terms proceeding through the depth array. At low chamber O2 ( =15mmHg), both
tissue and capillary PO2 values were higher at the inlet than outlet, whereas for high chamber
O2 ( =60mmHg) the PO2 slightly downstream from the inlet had an intermediate PO2 value.
The e↵ect of near-layer velocity variations did not a↵ect neither tissue nor capillary PO2 values
near the inlet, but proportionally altered the outlet tissue PO2 . At the outlet, with increasing
distance from the O2 chamber (increasing x), tissue PO2 converged around 38mmHg, whereas
capillary PO2 converged around 39mmHg.
Tissue PO2 Segment Results with CD Variations
To obtain numerical results and visualizations of two-layer spatial distributions, parameters in
Table(2.1) were substituted into Eqs.(A.15-A.16), and a code was developed in Maple2020 to
generate skeletal muscle segments with geometrical parameters as shown in Table(2.1), and
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assuming T 2 = T 1 = T 0 as justified by the results from Sec.(2.2.2). The epsilon matrix from
Eq.(A.17) was also implemented, and was included implicitly in the PO2 distribution functions.
All functions, including the distributions and epsilon matrix depended on the number of Fourier
terms; to ensure distributions were accurate to a desired threshold (< 0.1mmHg), 10 Fourier
terms were utilized to visualize tissue PO2 utilizing the results from Sec.(2.2.2). In the segment
visualizations, a similar orientation was chosen as Fig.(2.2).
Tissue segment results were obtained assuming that both regions contained uniform tissue
O2 consumption {µ1 = µ2 = µ0 } and capillary velocity {v1 = v2 = v0 }. Segment visualizations
were generated for baseline conditions ( 0 ) and for low CD conditions (0.53 0 ), as well as for
=15mmHg and

=60mmHg. In addition to the tissue segment visualizations, a quantitative

line plot of the x-averaged tissue O2 distributions per near/far layer and per tissue/capillary
distribution, along the AV direction.

Tissue PO2 Segment Results with Decreased CD and Consumption
To investigate the e↵ect of a decrease in tissue O2 consumption on two-layer tissue O2 spatial distributions with low CD, a similar method to Sec.(2.2.2) was implemented but assuming
both regions had decreased CD (0.53 0 ) but also uniformly decreased tissue O2 consumption
(0.5µ0 ). Capillary RBC velocity (vB ) was assumed to be baseline {v1 = v2 = v0 }; where capillary velocity is mentioned, red blood cell (RBC) velocity is implied. Segment visualizations
and x-averaged quantitative line tissue PO2 distributions were generated for

=15mmHg.

Tissue-Membrane Interface PO2
To investigate the membrane-tissue interface PO2 , and its variation to various parameters near
to the membrane-tissue interface, analytical methods related to the coupling between layers
were used in A.5. Ultimately, Eq.(A.20) was obtained, and the interface PO2 (P⇤(i) ) was plotted
against

, and was varied against the near-layer velocity (adjacent to the membrane-tissue

interface) from 50% to 150% in 10% increments. Also, a plot was made against chamber PO2 ,
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with the membrane thickness varying from 50% to 150% in 10% increments.
No-Flux Chamber PO2
To investigate the

value at which there is no flux through the membrane, or when P⇤(i) =

,

Eq.(A.22) was used and plotted against both ⌧ p (from 0µm to 100µm), and also the border
between the near-layer and far-layer (T 1 , assuming T 1 + T 2 =constant). The NF border was
defined by assuming that the near-layer and far-layer thicknesses together (T 1 + T 2 ) comprised
400µm; thus, once the near-layer thickness (T 1 ) was defined, the far-layer thickness (T 2 ) was
the remainder out of 400µm. This was done for various near-layer and far-layer velocities
(50%-150%).
Determination of Capillary PO2 Homogenizing Velocity
To investigate how near-layer hemodynamic parameters might alter in order to homogenize
chamber PO2 levels, the far-layer velocity was fixed at baseline (v2 = v0 ), and tissue consumption was kept homogeneous at baseline {µ1 = µ2 = µ0 }. The average outlet capillary PO2 values
of both segments were defined by the following formulas. The near-layer outlet capillary PO2
was noted to be a function of its velocity v1 :
1
PB(out,1) (v1 ) =
T1

Z

T1

0

PB(1) |z=L (v1 )dx , PB(out,2)

1
=
T2

Z

T 1 +T 2

T1

PB(2) |z=L dx

(2.4)

The di↵erence between these outlet capillary PO2 ’s was implemented into Maple2020 by the
following equation:
PB(out) (v1 ) = PB(out,1) (v1 )
Denoting R(+) = {x 2 R|x

PB(out,2)

(2.5)

0}, the capillary PO2 homogenizing velocity was defined by

Eq.(2.5) as {v⇤1(B) 2 R(+) | P(out) (v1 ) = 0}, and was numerically found using a Newton’s method
to solve for when

P(out) = 0, for varying chamber PO2 ’s from

=15mmHg to 60mmHg

in increments of 5mmHg. This was obtained for baseline conditions ( 0 ), low CD conditions
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(0.53 0 ), and a simulated high CD condition by increasing CD by the same 47% it is decreased
in low CD condition(ie. 1.47 0 ). Here it was also assumed T 2 = T 1 = T 0 . To dismiss the
possibility of a reversed velocity, it was imposed that v1
which returned a v1 < 0, were simply set to v1 and the
and defined as the critical chamber PO2 (

(crit) )

0, and so any numerical solutions
at which v1 = 0 occurred was noted

.

Homogenized Tissue Segment PO2 Visualizations
Images similar to those described in Sec.(2.2.2) were created utilizing the capillary PO2 homogenizing near-layer velocity {v1 = v⇤1(B) , v2 = v0 }; likewise, it was assumed that T 2 = T 1 =
T 0 , for both

=15mmHg and 60mmHg. Similarly to Sec.(2.2.2), homogeneous consump-

tion was assumed {µ1 = µ2 = µ0 } and both baseline ( 0 ) and low CD conditions (0.53 0 ) are
considered.

O2 Consumption-Adjusted Profiles
Here, to characterize the e↵ect that local tissue O2 consumption has on the tissue’s critical
chamber PO2 (

(crit) ,

see ”Determination of Capillary PO2 Homogenizing Velocity” above),

compensatory profiles were obtained as in Sec.(2.2.2), assuming that tissue O2 consumption
was also µ = 0.53µ0 relative to baseline, in both layers. First it was hypothesized that

(crit) ,

would be increased in tissue with reduced O2 consumption (ie. µ1 = µ2 = 0.53µ0 ), and a
compensatory profile was obtained for the capillary PO2 homogenizing velocity with chamber
PO2 increasing in increments of 5mmHg. Next, the same was repeated assuming tissue with
an intermediate O2 consumption (ie. µ1 = µ2 = 0.73µ0 ). Profiles for the capillary PO2 homogenizing near-layer velocity were obtained, using chamber PO2 increments of 5mmHg; these
were combined with profiles from Sec.(2.2.2).
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Investigation

To investigate the critical chamber PO2 ,

(crit)

was computed and expressed relative to atmo-

spheric pressure (760mmHg) by forcing the homogenizing velocity to be zero (set as 10 4 v0
baseline velocity) and numerically solving for the chamber PO2 for varying ’s of 1% and 3%
(0.33

0

and

0,

since

0

= 0.03). In addition, consumption was varied to 50%, 100%, and

200% baseline tissue O2 consumption, and was plotted against varying near-layer thicknesses
(T 1 ) from 20% baseline thickness (40µm) to 110% baseline thickness (220µm). For reference,
the inlet PO2 as a percentage of the atmospheric PO2 (5% O2 ) was plotted also.
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Results

Here, graphical summaries of the tissue PO2 simulations as outlined in the methods section
were obtained.

2.3.1

Near-Layer Tissue O2 Penetration Depths

As outlined in Sec.(2.2.2), O2 penetration depths into the tissue were obtained at 60mmHg
chamber O2 , and results are shown below:

Figure 2.3: Tissue PO2 penetration depths [µm] for chamber O2 of 60mmHg, using the onelayer model computed at several arteriovenous (AV) positions. Line color indicates capillary
volume fraction ( ) variations while line thickness represents tissue O2 consumption (µ) variations.
As can be seen here for profiles oxygenated with 60mmHg chamber PO2 for several CD and µ
variations, since the maximal value between all profiles is the ”CD= 1%Vol, µ = 0.5µ0 ” profile
at 500µm AV distance, all are under the 120µm penetration depth mark. Thus, none of the
cases considered required more than ⇡ 100

120µm to decay to 10% of the di↵erence from

60mmHg to the P1 (z). Also, both CD and tissue O2 consumption increases in turn decreased
the depth to which chamber O2 penetrated into the tissue. Therefore using an approximate
(2⇥) safety factor, the IVVM-informed baseline tissue thickness of 200µm obtained from the
previous one-layer model36 was able to be assumed to be the thickness of both the near-layer
and far-layer in the two-layer model. This would ensure that the O2 chamber is not a↵ecting
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the far-layer in simulations, and that flow alterations modelled in the near-layer are purely due
to hemodynamic considerations in the near-layer. This value was used in all simulations per
layer as a baseline segment thickness.
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Tissue PO2 Segment Results with CD Variations

As outlined in Sec.(2.2.2), tissue PO2 segment visualizations were obtained for

= 15mmHg

as shown in Fig.(2.4).

(a) Baseline CD

(b) x-Averaged O2 along z (Fig.2.4a)

(c) Low CD

(d) x-Averaged O2 along z (Fig.2.4c)

Figure 2.4: Skeletal muscle segments exposed to an O2 chamber with an oxygenation level
of = 15mmHg. Baseline tissue O2 consumption and capillary blood velocity were utilized
{µ0 , v0 }. Panels(2.4a,2.4c) display baseline ( 0 ) and low (0.53 0 ) capillary volume fractions
respectively, while color-bars indicating tissue PO2 [mmHg] are on the same scale for both
panels. Panels(2.4b,2.4d) display both tissue and capillary PO2 per near/far layer segment
(averaged in the x-direction) along the AV coordinate z.
Observing Fig.(2.4), it can broadly be seen that moving along the capillary AV direction (increasing z), tissue O2 decreased, while moving away from the chamber O2 increased all PO2 .
Also it can be seen in Figs.(2.4a,2.4c) decreasing the CD from baseline to low CD (top-tobottom) exhibited a decrease in tissue PO2 . This is also reflected in the quantitative plots
in Figs.(2.4b,2.4d). In the x-averaged line plots, several trends from the 2D tissue segment

2.3. Results

53

visualization were quantified, including an approximate di↵erence of 2-3mmHg between the
capillary and tissue PO2 . In addition, what can be seen from the quantitative profiles is that at
15mmHg, the near layer attained a lower PO2 on average compared to the far-layer.
Tissue PO2 segment visualizations were obtained for

= 60mmHg seen in Fig.(2.5).

(a) Baseline CD, Baseline velocity

(b) x-Averaged O2 along z (Fig.2.5a)

(c) Low CD, Baseline velocity

(d) x-Averaged O2 along z (Fig.2.5c)

Figure 2.5: Skeletal muscle segments exposed to an O2 chamber with an oxygenation level
of = 60mmHg. Baseline tissue O2 consumption and capillary blood velocity were utilized
{µ0 , v0 }. Panels(2.5a,2.5c) display either baseline ( 0 ) and low (0.53 0 ) capillary volume fractions, while color-bars indicating tissue PO2 [mmHg] are homogenized among both panels.
Panels(2.5b,2.5d) display both tissue and capillary PO2 per near/far layer segment (averaged in
the x-direction) along the AV coordinate z.
Observing Fig.(2.5), it can broadly be seen that moving along the capillary AV direction (increasing z), tissue O2 decreased, and moving away from the chamber O2 also decreased all
PO2 . Also it can be seen in Figs.(2.5a,2.5c) decreasing the CD from baseline to low CD (topto-bottom) exhibited a decrease in tissue PO2 . This is also reflected in the quantitative plots
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in Figs.(2.5b,2.5d). In the x-averaged line plots, several trends from the 2D tissue segment
visualizations were quantified, including an approximate di↵erence of 2-3mmHg between the
capillary and tissue PO2 . In addition, what can be seen from the quantitative profiles is that at
60mmHg, the near layer attained a lower PO2 on average compared to the far-layer.

Tissue PO2 Segment Results with Decreased CD and Consumption
As outlined in Sec.(2.2.2), tissue PO2 segment visualizations were obtained for

= 15mmHg,

assuming both decreased CD and decreased µ as shown in Fig.(2.6)

(a) Low CD, Low µ

(b) x-Averaged O2 along z (Fig.2.6a)

Figure 2.6: Skeletal muscle segments exposed to an O2 chamber with an oxygenation level of
= 15mmHg. Both tissue O2 consumption and CD were assumed to be decreased. Panel(2.6a)
displays the two-layer tissue PO2 distribution at low (0.53 0 ) capillary volume fractions, and
Panel(2.6b) displays both tissue and capillary PO2 per near/far layer segment (averaged in the
x-direction) along the AV coordinate z. Colorbars here are homogenized with Fig.(2.4) where
was also set to 15mmHg
Observing the above figure, it can be seen with

= 15mmHg that when consumption is also

decreased 50% in response to a 47% decrease in CD, Fig.(2.6a) shows that the cyan contour
representing PT ⇡ 22mmHg which developed at the outlet in the decreased CD case (Fig.2.4c)
is restored to the green contour occupying the same region representing PT ⇡ 30mmHg at
baseline CD levels (Fig.2.4a). Interestingly, comparing the baseline CD & µ x-averaged line
plots quantitative plot in Fig.(2.4b) with the decreased CD profile (Fig.2.4d), and the above
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decreased CD & µ profile in Fig.(2.6b), decreasing the CD decreased the tissue and capillary
PO2 , while decreasing the consumption also raises the tissue and capillary PO2 to similar levels
to baseline CD and µ levels at the outlet.

2.3.3

Tissue-Membrane Interface PO2

As described in Sec.(2.2.2), interface PO2 was plotted against chamber PO2 , varying near-layer
velocity and membrane thickness. Results shown in Fig.(2.7):

(a) Interface PO2 for varying near-layer velocity

(b) Interface PO2 for varying membrane thickness

Figure 2.7: Tissue-membrane interface PO2 plotted against chamber PO2 from
2
[15, 60]mmHg as per Eq.(A.21). In Fig.(2.7a), variation in near-layer velocity was assessed
from 50% to 150% in 10% increments, while in Fig.(2.7b), variation in membrane thickness
was assessed from 50% to 150% in 10% increments.
In general, increasing the chamber PO2 increased the interface PO2 . As can be seen in Fig.(2.7a),
with decreasing near-layer velocity there was a decrease in the PO2 at the interface. Also in
Fig.(2.7b), we can see that decreasing the membrane thickness increased the gain in interface
PO2 per increase in chamber PO2 .

2.3.4

No-Flux Chamber PO2

As described in Sec.(2.2.2), no-flux PO2 was plotted against both membrane thickness in
Fig.(2.8a) and NF border in Fig.(2.8b). Results are shown below:
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(a) Plot against membrane thickness

(b) Plot against NF border

Figure 2.8: No-flux chamber PO2 plotted against both membrane thickness (Fig.2.8a), and the
NF border (Fig.2.8b) as per Eq.(A.22).
In Fig.(2.8a), it can be seen that the no-flux chamber PO2 did not vary with the membrane
thickness. The no-flux chamber PO2 was proportional to both the near-layer and far-layer
velocities, but as can be seen by the di↵erences in color profiles vs. the di↵erence in linestyle profiles within a color, the no-flux chamber PO2 had much more sensitivity to the nearlayer velocity. It can be seen in Fig.(2.8b) that similar trends held with the near and far layer
velocities, but there is also variation in the no-flux chamber PO2 against the NF border, which
approached an asymptote with increasing NF border.

2.3.5

Capillary PO2 Homogenizing Velocity in Baseline vs. Low CD States

As described in Sec.(2.2.2), the capillary PO2 homogenizing velocity values were obtained
as non-dimensional parameters v⇤1(B) /v0 , and were plotted against chamber PO2 values in the
interval

2 [15mmHg, 60mmHg] in increments of 5mmHg. For v⇤1(B) /v0 < 0, since v⇤1(B) /v0 2

R(+) , it was assumed that v⇤1(B) = 0. Data were collected for baseline vs. low capillary volume
fraction, and are summarized in Fig.(2.9):
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Figure 2.9: Capillary PO2 homogenizing velocity values obtained as a non-dimensional ratio to
baseline v⇤1(B) /v0 , plotted against chamber PO2 values in the interval 2 [15mmHg, 60mmHg]
with increments of 5mmHg. Results were computed for baseline ( 0 ) and low (0.53 0 ) capillary volume fraction.

Here, it can be seen that in general, for low chamber O2 levels, homogenizing velocity ratio
values > 1 were exhibited. This indicates at low chamber O2 values, capillary velocity in the
near-layer would increase to ensure capillary PO2 flowing out of the two-layer skeletal muscle segment is homogenized. Increasing the chamber O2 level

decreased the homogenizing

velocity, indicating that with a higher chamber O2 , a lower velocity than baseline would homogenize capillary PO2 outlets past 40mmHg, 37mmHg, and 25mmHg chamber O2 levels for
high, baseline, and low CD’s, respectively. For low/high CD states, there were lower/higher
values for the homogenizing velocity ratio at all chamber O2 values, indicating lower capillary
velocity would homogenize capillary PO2 outlets with lower CD’s, whereas high capillary velocities were required to homogenize high CD skeletal muscle.
It can also be observed that for lower CD values, beyond a specific chamber PO2 (roughly
50mmHg), the capillary velocity was calculated to be zero; this was defined as the critical
chamber PO2 (

(crit) ).

Beyond this chamber PO2 , the capillary PO2 is unable to be homog-

enized in both the near and far layer since homogenizing velocity ratios were restricted to
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positive values. In addition,

(crit)

was found to be roughly 70mmHg for baseline CD states,

and 75mmHg for high CD states.
Tissue PO2 distributions calculated assuming µ1 = µ2 = µ0 , are displayed below in
Fig.(2.10) assuming {v1 = v⇤1(B) , v2 = v0 } for both

(a)

= 15mmHg, Baseline CD
v⇤1(B) = 1.532v0

(c)

= 60mmHg, Baseline CD
v⇤1(B) = 0.348v0

= 15mmHg and

(b)

= 60mmHg:

= 15mmHg, low CD
v⇤1(B) = 1.199v0

(d)

= 60mmHg, low CD
v⇤1(B) = 0

Figure 2.10: Skeletal muscle segments exposed to an O2 chamber with oxygenation levels of
= 15 mmHg and 60mmHg. Baseline tissue O2 consumption was utilized (µ0 ), far-layer
velocities were fixed at v2 = v0 , and near-layer velocities were set to their respective capillary
PO2 homogenizing values v1 = v⇤1(B) . Both baseline ( 0 )and low (0.53 0 ) capillary volume
fractions are visualized.
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Here, it can be seen that panels (2.10a), (2.10b), (2.10c), and (2.10d) are homogenized versions of naive baseline velocity segments shown in panels (2.4a), (2.4c), (2.5a), and (2.5c),
respectively. For

= 15mmHg, a capillary velocity of 153% baseline will ensure capillary

PO2 outlets would be homogenized. Decreasing CD by 47% in low CD states indicated a
capillary velocity of 120% will homogenize capillary PO2 outlets. This is a decrease of 33%
in near-layer capillary velocity, accompanying the 47% decrease in CD. At

= 60mmHg, a

near-layer capillary velocity of 35% baseline would homogenize capillary outlets. As for low
CD, observing Fig.(2.9), there was no near-layer capillary velocity > 0 which homogenized
capillary outlets. While capillary velocity was concluded to be v1 = 0 in Fig.(2.10d), the skeletal muscle segment was not homogenized, and the far-layer capillary PO2 outlet was far lower
than the near-layer capillary PO2 outlet.
As described in Sec.(2.2.2), 0.53µ and 0.73µ tissue O2 consumption variations alongside
the 0.53CD variation were tested, and are presented in Fig.(2.11):

Figure 2.11: Capillary PO2 homogenizing velocity values obtained as a non-dimensional
ratio to baseline v⇤1(B) /v0 , plotted against chamber PO2 values in the interval
2
[15mmHg, 60mmHg] with increments of 5mmHg. Results were computed for baseline ( 0 )
and low (0.53 0 ) capillary volume fraction. Added are compensatory profiles assuming that
consumption of the tissue might decrease along with low CD states.
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Here, similar profiles to those in Fig.(2.9) were considered, at tissue O2 consumption values
p
of 0.53µ0 , and ( 0.53)µ0 , to model proportional, and root-proportional compensatory mechanisms in tissue O2 consumption. As can be seen, for all chamber O2 values > 50mmHg, lower
consumption values were associated with elevated homogenized velocity ratio values. However in the decreased CD case, all alternative consumption curves attained a homogenizing
velocity of zero at 50mmHg.

2.3.6

Critical Chamber PO2

As described in Sec.(2.2.2),

(crit)

was computed for several varying CD’s, tissue O2 consump-

tions, and near-layer thicknesses. Results are shown below:

Figure 2.12: Critical chamber PO2 values ( (crit) ) obtained as a percentage of atmospheric
pressure (760mmHg), plotted against near-layer thicknesses ranging from 30µm to 230µm.
Results were computed for varying capillary volume fractions (1% and 3%) indicated by color,
and varying consumption values (50%, 100%, and 200%) indicated by line thickness.
In Fig.(2.12), it can be seen that with increasing near-layer thickness (T 1 ) there was an increase
in

(crit) ,

while

decreases for a fixed near-layer thickness lowered

(crit) .

Finally, it can be

seen that for a fixed near-layer thickness, increased tissue O2 consumption lowered

(crit) .

In-

terestingly, it can also be seen that for a provided CD, there exists a near-layer thickness at
which

(crit)

which would be coincident with the inlet PO2 , is independent of the tissue O2

consumption.
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The result as was seen in Fig.(2.9) where
noting that for

=

0,

(crit)

= 70mmHg can be observed in this figure by

and for µ = µ0 , the critical chamber O2 at a thickness of T 1 = T 0

is approximately 10%⇡70mmHg. In addition, the result in Fig.(2.11) can also be noted since
crit

= 50mmHg⇡ 7%atm is between the red and blue profiles ( = 0.53 0 ) corresponding to

µ = µ0 and T 1 = T 0 .

2.4
2.4.1

Discussion
Comparison With Alternative Tissue PO2 Investigations

We note recent experiments using phosphorescence quenching46 that indicate a 17mmHg capillaryinterstitial PO2 di↵erence in resting rat spinotrapezius muscle which is much higher than the
⇡1mmHg local capillary-tissue PO2 di↵erence our transport model predicts, as well as similar
results obtained previously using cryospectrophotometric methods.47 However, our model is in
general agreement with phosphorescence measurements of tissue PO2 in the same resting muscle by Pittman and co-workers,48 who found a mean tissue PO2 of ⇡28mmHg. Interestingly,
this value is approximately halfway between the capillary (34.9mmHg) PO2 , and interstitial
(15.7mmHg) PO2 measured in studies.46 Assuming no large-scale O2 gradients (@ x ! 0), the
local capillary-tissue PO2 di↵erence given by Eq.2 is:

P = PB

PT = (1

)Rµ/(2K ↵T ),

which has the approximate evaluation of 1.16mmHg for our baseline parameters. Since ,
µ, and K do not vary spatially in our model, averaging

P over the computational domain

would yield the same value. However, if there were spatial variability (e.g., due to hematocrit variability which would a↵ect K), average P could vary substantially from the uniform
value above, and could be expected to be larger due to the e↵ect of more numerous interstitial regions having below-average PO2 . Although we cannot address this possibility using the
present homogeneous model, we believe it could be explored in future models possessing sufficient heterogeneity and considering both resting and exercising muscle (as studied in46 ). Our
model parameters and predicted tissue PO2 values are consistent with other recent modeling
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e↵orts.49,50

2.4.2

Near-Layer Thickness Tissue O2 Penetration Depths

Penetration depths using Eq.(2.3) were generated and assessed for dependence on CD and
tissue O2 consumption. The purpose of this investigation was to see when the O2 imposed at
the chamber would decay 90% to the PO2 at x = 1. Fundamentally, since at x ! 1 then
@ x ! 0, this profile can be seen to have a linear-z profile:
lim PT (x, z) = P1 (z) =⇡ P0 + c1 z

(2.6)

x!1

The slope of the PO2 profile, c1 can be found by inserting @ x = 0 into the governing PT equation
in Eq.(2.2), and isolating the resultant di↵erential equation for PT reveals the form:
lim @z PT =

x!1

(1
)µ
s̃ vB ↵T

This shows that the slope depends on the capillary volume fraction

(2.7)
as well as the tissue O2

consumption µ. For this reason, since P1 (z) varies, and PT (x, z) also varies, the penetration
depths were seen to depend on the arteriovenous (AV) coordinate, z. This is also reflected in
Fig.(2.3) where the penetration depth is greater as we move along z. Regardless, for the 50200% variations in µ and the 33-100% variations in , it was seen that the chamber O2 decayed
to 10% of the di↵erence with P1 (z) at a maximum of 120 µm deep into the tissue.
The utility of this observation is in justifying the thickness of the near layer, as well as
a two-layer model. The ’near’ layer in the model is assumed to have varying hemodynamic
parameters as compared to a ’far’ layer. In the model, PO2 in the near layer was assumed to
be determined by a balance between e↵ects of the chamber, capillary O2 supply dynamics, and
tissue metabolism. The far layer in contrast was assumed to have relatively fixed parameters.
Fig.(2.3) demonstrates that the chamber O2 only a↵ected the tissue and capillary O2 within
the near-layer, and thus the velocity homogenization constraints on the near-layer which were
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chosen were able to be imposed assuming the near-layer was the only layer responding hemodynamically to chamber O2 .

2.4.3

Tissue PO2 Assuming CD Variations

Various tissue PO2 distributions were generated to see the e↵ects of CD ( ) variations on the
overall O2 profiles at
ber PO2 (

= 15mmHg (Fig.2.4) and

= 60mmHg (Fig.2.5). For the low cham-

= 15mmHg) looking at a baseline CD (Fig.2.4a), there was a lower PO2 limit

indicated by the green contour of ⇡ 30mmHg which appeared at the outlet of the near-layer
region (upper-right region of tissue visualization below x = 0). Similarly, in low CD conditions (Fig.2.4c), the cyan tissue PO2 contour of ⇡ 30mmHg in the near-layer outlet (Fig.2.4a)
dropped to a lower tissue PO2 of 22mmHg (Fig.2.4c). Interestingly, the drop in CD did not
a↵ect the near-layer outlet O2 in the high chamber PO2 case of

= 60mmHg (Fig.2.5), but

resulted in a relatively varied far-layer PO2 since the CD was global across the entire skeletal
muscle segment.
The side-by-side linear plots averaging the O2 in the near and far layers for both tissue and
capillary PO2 highlighted that when the chamber PO2 is lower than the far-layer tissue PO2
(Fig.2.4b), the near-layer tissue PO2 is also lower than the far-layer PO2 ; the converse was also
seen to be true with higher chamber PO2 than far-layer PO2 (Fig.2.5b), and caused a higher
near-layer tissue and capillary PO2 . These e↵ects can be seen to be heightened with decreases
in CD (Fig.2.4d,2.5d). This di↵erential e↵ect of the chamber O2 on the near-layer tissue PO2
implies that any velocity regulation would need to be focused on the near-layer. Finally the
approximately constant 1-2mmHg di↵erence between the tissue and capillary O2 in both the
near and far layers can be seen to be explained by the governing equations. The tissue PO2 is
related to the capillary PO2 by the following relationship:
(1
)Rµ
PB =
+ 1
2K ↵T

(1

!
)RDT 2
@ x PT
2K

(2.8)
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Therefore, the linear o↵set between PT and PB is described by the first term, which when evaluated can take values from 1-2mmHg depending on the

and µ variation.

In general, since the color blue indicated the minimum, the prevalence of blue in Fig.(2.4)
and Fig.(2.5) indicated PO2 decreasing to very low values relative to the maximum. In both
cases, blue only appeared in the tissue region x

0 when CD decreases were imposed. There-

fore, it can be concluded that there was a strong sensitivity of tissue PO2 to CD variations. This
sensitivity of tissue PO2 is consistent with literature regarding the detriment of CD decreases
in microcirculatory systems.2,51 This is because the tissue exhibits a functional behavior that is
qualitatively consistent with low O2 transport in tissue. The model developed therefore yielded
a measure of skeletal muscle sensitivity to CD decreases. Namely, since PT (1) and PT (2) both
contain the parameter , an average may be taken over the domain by the following:
PT,avg(1)

1
=
T1 L

Z

T1
0

Z

0

L

PT (1) (x, z) dz dx , PT,avg(2)

1
=
T2 L

Z

T 1 +T 2

T1

Z

L

0

PT (2) (x, z) dz dx

Average tissue PO2 ’s can have their dimensionless sensitivity to CD {⇣˜CD,1 , ⇣˜CD,2 } by taking
the partial derivative with respect to the CD and normalizing by dividing with respect to the
average PO2 for the respective regions at
⇣˜CD,1 = ⇣

0

PT,avg(1)

1= 0

⌘

=

0:

@PT,avg(1)
0
, ⇣˜CD,2 = ⇣
@ 1
PT,avg(2)

2= 0

⌘

@PT,avg(2)
@ 2

(2.9)

This capability of regionally determining the sensitivity to decreases in CD is a feature unique
to the present model.

2.4.4

Tissue PO2 With Low CD and O2 Consumption

While CD drops decreased tissue and capillary PO2 in general throughout the region considered
in previous sections, it was seen in Sec.(2.3.2) that as indicated by Fig.(2.6), decreasing µ along
with CD produced similar PO2 levels to pre-decrease baseline CD and µ cases. Comparing the
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baseline CD and µ case in Fig.(2.4b) with the decreased CD and µ case in Fig.(2.6b), the near
tissue and capillary PO2 was altered moving along the AV coordinate z, while the far tissue
and capillary PO2 was almost identical to the pre-decrease PO2 levels. The similarity of tissue
and capillary levels far from the chamber with proportionately decreased CD and µ levels is
explainable using the linear theory developed above where @ x ! 0. It was stated that Eq.(2.7)
would arise in the case where flux vanishes far from the chamber. Here, the term of
case of

1

in the

<< 1 attains the asymptotic form of ⇡ 1/ . Thus it is seen that the slope of the tissue

PO2 far from the chamber will have the asymptotic term @z PT /
shows that if both µ and

µ/ , when

<< 1. This

are altered by similar amounts, the far tissue and capillary PO2 will

not change much. However, the near tissue and capillary levels are markedly di↵erent from the
baseline CD and µ PO2 levels. This is because altered levels of CD and µ changes the manner
in which the tissue responds to applied chamber PO2 .

2.4.5

Observations on the Tissue-Membrane Interface PO2

In Fig.(2.7) the interface PO2 was plotted against chamber PO2 for varying near-layer velocities
and membrane thicknesses. In Fig.(2.7a), the interface PO2 was proportional to both the nearlayer velocity and the chamber PO2 . The interface PO2 is defined as the PO2 at the surface
of the tissue; considering the physical processes, the tissue represents a source of O2 . The
higher the chamber PO2 , the higher O2 di↵uses through the O2 permeable-membrane, and thus
results in a higher interface O2 . It can be seen that from

2 [15, 60]mmHg, the interface PO2

ranges from P⇤(i) 2 [25, 50]mmHg. Since the tissue O2 has an inlet PO2 of around 47mmHg,
and typically contains PO2

30mmHg, it can be seen that the interface PO2 is roughly an

averaging e↵ect between the skeletal muscle, and the chamber PO2 .
In Fig.(2.7b) the interface PO2 was seen to be similarly proportional to the chamber PO2 ,
however the membrane thickness had a di↵erent e↵ect. In general, the decrease in membrane
thickness produced profiles with increasing slope. This is also intuitive; in the hypothetical
case where ⌧ p = 0, then observing Eq.(A.21) we can see that the linear-o↵set vanishes, and the
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slope argument in brackets simplifies to 1 in the limit where ⌧ p ! 0. Therefore, we can see
in the limit as ⌧ p ! 0, P⇤(i) =

. This also confirms the graphical e↵ect in Fig.(2.7b) where

the thinner the membrane is, the greater slope the line has, and approaches a fully proportional
relationship. Therefore, the membrane in general dampens the e↵ect from the O2 chamber.

2.4.6

Observations on the No-Flux Chamber PO2

In Fig.(2.8) the no-flux PO2 was plotted against the membrane thickness and the near-far (NF)
border for varying near and far-layer velocity. In Fig.(2.8a), it was seen that the no-flux PO2
was proportional to both the near and far-layer velocity. This is intuitive since with higher
velocities, there will be higher interface PO2 ’s, and thus a higher no-flux PO2 required to cause
no-flux through the di↵usion. The profiles are entirely horizontal implying that there is negligible dependence on the membrane thickness; if the chamber PO2 is chosen to cause no-flux
through the membrane, this should be identical regardless of the O2 membrane thickness.
In Fig.(2.8b) the no-flux PO2 was also plotted against the NF boundary. The case with
v1 = v2 = v0 (purple, dashed) is entirely horizontal like Fig.(2.8a), but when the velocity is
chosen to vary there is a dependence on the thickness of the near-layer. Once again, there is
both proportionality to the near and far layer velocity, which is also intuitive for the same reasons interface PO2 increases with the tissue velocities. Depending on the velocity within the
tissue, there are varying curvatures in the profiles.

2.4.7

Capillary PO2 Homogenizing Velocity with CD Variations

The homogenizing velocity curves in Fig.(2.9) indicated that a high capillary velocity v1(B) was
needed in the near-layer to equalize outlet tissue PO2 ’s in both the near-layer and far-layer at
low chamber PO2 at all CD values. Conversely a lower capillary velocity v1(B) was needed in
the near-layer to equalize outlet tissue PO2 ’s in both the near-layer and far-layer at high chamber PO2 for all CD values. This can be explained as an averaging e↵ect. If the far layer is
considered to be fixed since it is independent from the chamber PO2 seen in Fig.(2.3), then the
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near-layer velocity compensates such that when averaged with the chamber PO2 , it is roughly
equal to the far layer. In this interpretation, only a high near-layer PO2 (and thus high near-layer
velocity v1(B) ) can cancel a low chamber O2 to result in the far-layer fixed PO2 , and conversely
for high chamber O2 .
In the context of an averaging e↵ect, it was discussed in Sec.(2.3.5) that there were decreases in near-layer homogenizing velocity at all chamber O2 levels in low CD states, and
vice-versa for high CD states. The low CD result implies that a lower near-layer velocity can
homogenize the two tissue PO2 outlets. Using the averaging e↵ect interpretation, Fig.(2.9) can
be explained. Since the chamber PO2 does not vary with CD, with lower CD both the near
and far-layer exist at a lower O2 . In this case, a low chamber O2 does not require such a high
near-layer velocity to average to a lower far-layer tissue PO2 . Conversely at high chamber O2 ,
since the far-layer is at a lower tissue PO2 , an extremely low near-layer velocity is required to
average with the high chamber PO2 . These results suggest that in a low CD conditions, impaired regulatory capacity may be due to lower global O2 content in muscle.
It is worth mentioning that the averaging e↵ect required at a high chamber PO2 with low
CD states is sufficiently large that the near-layer velocity becomes zero at
is

(crit) .

= 50mmHg which

This novel phenomenological result of our two-layer model provides confirmation of

observations occurring from IVVM experiments. In such experiments, it has been documented
that certain high chamber PO2 ’s have the tendency to cause capillary RBC supply to go to zero
near to the O2 chamber.7,23,43

2.4.8

E↵ect of Consumption on Capillary PO2 Homogenizing Velocity

Finally, the consumption was altered to see how the velocity homogenization curves would be
altered in low CD states with varying tissue O2 consumption. It was seen in Fig.(2.11) that
at all points, a compensatory decrease in consumption increased the homogenization velocity.
This e↵ect using the averaging e↵ect interpretation can also be explained. For lower consumption value, the far-layer would have higher PO2 closer to the inlet PO2 of P0 = 47mmHg. This
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is since a lower consumption will decrease the deviation of the far layer from the inlet PO2 .
Thus if the far-layer is at higher PO2 , the averaging e↵ect interpretation indicates that at low
chamber O2 , the near-layer will need to be increased higher in order to average to the higher
far-layer PO2 . This justified the low chamber PO2 regime of Fig.(2.11). The averaging e↵ect
interpretation implies slightly more ambiguous di↵erences with baseline consumption at higher
chamber PO2 ’s. In particular,

(crit)

= 50mmHg with low CD is unchanged by di↵erences in

consumption.
In the context of the velocity homogenization curves,
regulatory capacity of the tissue (i.e. a higher

(crit)

(crit)

is indicative of the maximal

indicates a larger window of tissue adap-

tation), and it can be seen that this is likely altered in . Recalling the conclusion earlier that
low CD microcirculatory systems possessed a lower O2 value in both layers, physiological theories have been posited that tissue consumption O2 might compensate with CD decreases. As
per the results shown in Fig.(2.11), the invariance of

(crit)

to consumption decreases indicates

skeletal muscle compensatory mechanisms involving tissue O2 consumption are not e↵ective at
improving the homeostatic capability of skeletal muscle with low CD’s. This is one area where
the two-layer model contrasts with theories on microcirculatory regulation proposed in literature.3 This can form a possible further direction, since the presented model model which can
predict capillary RBC velocity alteration as per a capillary PO2 constraint could be compared
against IVVM investigations which would catalogue this velocity alteration against various CD
and tissue O2 consumption regions of the microcirculation.21,22 Pending validation, the model
could then be adapted and made to fit in within the larger context of an endothelial conduction
model of how capillaries signal upstream for increased capillary RBC velocity, as per local
O2 conditions.5,21 IVVM investigations documenting the critical chamber O2 in response to
varying tissue conditions would also assist in shedding light on this matter.
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Limitations

The two-layer model formulation has several limitations as noted in the formulation of the
model in the Appendix. Limitations in the two-layer model stem either from limitations in the
foundational one-layer model,36,45 or from assumptions made to model the two layers side-byside, detailed in A.1-A.4.
The one-layer model itself possesses limitations as discussed previously.36 Obtaining the
di↵usion-convection operator in A.1 involved several assumptions:
• Myoglobin in the tissue was disregarded since it has a small e↵ect for steady-state problems in the absence of hypoxia, and its inclusion would introduce non-linearity in PT .
• Di↵usion within the capillary space - that is, axial di↵usion within capillaries - is disregarded since it is generally a much smaller e↵ect than convection . This assumption
allowed the x-order of the PDE to be limited to 2nd order instead of 4th order.
• The Hill Equation was linearized to facilitate an analytic solution of PT and PB .
• Uniformly spaced capillaries are assumed, each receiving equal O2 supply, which is a
Krogh-like simplification of skeletal muscle geometry (see26 ) which may be relaxed in
the future.
• In addition, as was mentioned in the development of the model, a full 3D module arrangement with 3D di↵usion was not considered. An investigation considering 3D di↵usion
rather than being solved analytically, would be treated using finite-di↵erence if undertaken. And future-directions discussed below in Chapter 4 will examine extending this
to a larger capillary module arrangement.
As for the particular formulation of the two-layer model in this study, in accordance with the
one-layer model, it was assumed that O2 transport does not vary with time. This means the
chamber PO2 is fixed, inlet PO2 is fixed, and velocity and tissue O2 consumption in the skeletal
muscle are not changing in time. In addition, the matching conditions discussed in A.4 assumed
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that there would be a constant PO2 profile across the membrane-tissue boundary and a linearly
z-varying profile along the boundary between tissue layers. Including matching conditions
to minimize the resultant three arbitrary parameters was described over A.4. This presents a
limitation since any pre-assumed profiles between tissue layers, and at the membrane-tissue
boundary, will introduce error between the actual boundary O2 and the predicted O2 .
Finally, one other limitation to the two-layer model is its placement in the larger tissue
environment. The model assumes a rectilinear homogeneous tissue-capillary domain assuming
any upstream arteriole and downstream venules do not occupy the same geometric domain. The
model focuses exclusively on a two-layer region composed of two adjacent capillary modules,
and thus any upstream and downstream e↵ects are translated within the domain of interest
into variations with capillary blood velocity, tissue O2 consumption, and CD. It should be also
added that the regulation component of the 2-layer model has the limitation of assuming fixed
hematocrit (HT ), which can be regulated physiologically and would a↵ect the blood-tissue
mass transfer coefficient K as well as the capillary O2 supply.

2.5

Conclusion

In conclusion a two-layer microcirculatory O2 transport model was created which was able to
efficiently predict tissue PO2 distributions in two layers of capillary-perfused skeletal muscle.
The presence of the two layers (near and far) allowed for parameters such as capillary blood
velocity, density, and tissue O2 consumption to be either fixed or solved for in the near or
far-layer. Capillary density was varied indicating the sensitivity of the tissue O2 in the layers
to CD variations. A sensitivity parameter was proposed to quantify this CD dependence, and
one future direction could be to document this novel sensitivity parameter for varying system
parameters such as inlet PO2 , capillary velocity, and tissue O2 consumption.
In addition, the homogenizing near-layer capillary velocity was defined as the velocity in
the near-layer required to equalize outlet capillary PO2 for both layers at a particular chamber
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PO2 . This new parameter was investigated for varying capillary densities. Homogenization
curves were obtained by incrementally changing chamber PO2 ’s, and the ”critical chamber
PO2 ” (

(crit) )

at which the near-layer velocity was forced to zero under the homogenization

constraint was defined. It was seen

(crit)

varied from 75mmHg in high CD states to 50mmHg

in low CD states. An averaging e↵ect interpretation of the homogenization curves was proposed to explain this phenomenon for varying chamber PO2 ’s, capillary density, and tissue O2
consumption. This model’s ability to mathematically predict the near-layer velocity alteration
is a novel addition to approaches used which may be applied in the future to understanding
the variations seen in previous observations of near-layer velocity changes,22 and potentially
further predicting alterations under di↵erence circumstances
Finally, both the tissue-membrane interface PO2 and the no-flux chamber PO2 were defined. The interface PO2 was seen to intuitively be proportional to both the chamber PO2 and
near-layer velocity, while the membrane thickness increased the slope of the relationship between chamber PO2 and interface PO2 approaching a linear relationship. The no flux PO2 was
also seen to follow both near-layer and far-layer velocity variations (with higher sensitivity to
the near-layer velocity).
The connection between chamber O2 and near-layer velocity alterations can be explored as
another future direction. To this end, a feedback control technique could be utilized to study the
time-dependent evolution of the near-layer velocity as part of an endothelial feedback model5
in response to fixed chamber O2 ’s, potentially leading to a comprehensive O2 microcirculatory transport model. Fundamentally, as discussed in Sec.(2.4.9) the two-layer model was
investigated at steady-state and extending these results to time-varying chamber PO2 ’s and inlet velocities is a third future direction. Finally, given the success of the two-layer model, a
more general multi-element model could be considered for comparison with large-scale microcirculatory O2 distributions in-vivo. Ultimately, insights gained from the two-layer model
can help guide future in-vivo regulation experiments, as well as the further development of a
comprehensive multi-scale model of microvascular oxygen transport and flow regulation.
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[22] Richard J. Sové et al. “Localized Oxygen Exchange Platform for Intravital Video Microscopy Investigations of Microvascular Oxygen Regulation”. In: Frontiers in Physiology 12 (June 2021). doi: 10.3389/fphys.2021.654928. url: https://doi.org/
10.3389/fphys.2021.654928.
[23] Mary L. Ellsworth et al. “Erythrocytes: Oxygen Sensors and Modulators of Vascular
Tone”. In: Physiology 24.2 (Apr. 2009), pp. 107–116. doi: 10.1152/physiol.00038.
2008. url: https://doi.org/10.1152/physiol.00038.2008.
[24] Daniel Goldman. “A mathematical model of oxygen transport in intact muscle with
imposed surface oscillations”. In: Mathematical Biosciences 213.1 (2008), pp. 18–28.
url: https://doi.org/10.1016/j.mbs.2008.01.010.
[25] Nour W. Ghonaim et al. “Modeling steady state SO2-dependent changes in capillary
ATP concentration using novel O2 micro-delivery methods”. In: Frontiers in Physiology
4 (2013). doi: 10.3389/fphys.2013.00260. url: https://doi.org/10.3389/
fphys.2013.00260.
[26] Graham M. Fraser, Daniel Goldman, and Christopher G. Ellis. “Comparison of Generated Parallel Capillary Arrays to Three-Dimensional Reconstructed Capillary Networks
in Modeling Oxygen Transport in Discrete Microvascular Volumes”. In: Microcirculation (July 2013), n/a–n/a. doi: 10.1111/micc.12075. url: https://doi.org/10.
1111/micc.12075.
[27] Aleksander S. Golub and Roland N. Pittman. “PO2 measurements in the microcirculation using phosphorescence quenching microscopy at high magnification”. In: American
Journal of Physiology-Heart and Circulatory Physiology 294.6 (June 2008), H2905–

CHAPTER 2: BIBLIOGRAPHY

77

H2916. doi: 10.1152/ajpheart.01347.2007. url: https://doi.org/10.1152/
ajpheart.01347.2007.
[28] Aleksander S. Golub, Michael A. Tevald, and Roland N. Pittman. “Phosphorescence
quenching microrespirometry of skeletal muscle in situ”. In: American Journal of PhysiologyHeart and Circulatory Physiology 300.1 (Jan. 2011), H135–H143. doi: 10 . 1152 /
ajpheart . 00626 . 2010. url: https : / / doi . org / 10 . 1152 / ajpheart . 00626 .
2010.
[29] R. N. Pittman. “Oxygen gradients in the microcirculation”. In: Acta Physiologica 202.3
(Feb. 2011), pp. 311–322. doi: 10.1111/j.1748-1716.2010.02232.x. url: https:
//doi.org/10.1111/j.1748-1716.2010.02232.x.
[30] Bruce Klitzman, Aleksander S. Popel, and Brian R. Duling. “Oxygen transport in resting
and contracting hamster cremaster muscles: Experimental and theoretical microvascular
studies”. In: Microvascular Research 25.1 (Jan. 1983), pp. 108–131. doi: 10 . 1016 /
0026 - 2862(83 ) 90047 - x. url: https : / / doi . org / 10 . 1016 / 0026 - 2862(83 )
90047-x.
[31] Mary L. Ellsworth, Aleksander S. Popel, and Roland N. Pittman. “Assessment and
impact of heterogeneities of convective oxygen transport parameters in capillaries of
striated muscle: Experimental and theoretical”. In: Microvascular Research 35.3 (May
1988), pp. 341–362. doi: 10.1016/0026- 2862(88)90089- 1. url: https://doi.
org/10.1016/0026-2862(88)90089-1.
[32] Timothy W. Secomb et al. “Analysis of the E↵ects of Oxygen Supply and Demand on
Hypoxic Fraction in Tumors”. In: Acta Oncologica 34.3 (Jan. 1995), pp. 313–316. doi:
10.3109/02841869509093981. url: https://doi.org/10.3109/02841869509093981.
[33] Daniel Goldman, Ryon M. Bateman, and Christopher G. Ellis. “E↵ect of sepsis on
skeletal muscle oxygen consumption and tissue oxygenation: interpreting capillary oxygen transport data using a mathematical model”. In: American Journal of Physiology-

78

Chapter 2. Two-layer Continuously Distributed Capillary O2 Transport Model
Heart and Circulatory Physiology 287.6 (Dec. 2004), H2535–H2544. doi: 10.1152/
ajpheart . 00889 . 2003. url: https : / / doi . org / 10 . 1152 / ajpheart . 00889 .
2003.

[34] Christopher G. Ellis et al. “Defects in oxygen supply to skeletal muscle of prediabetic
ZDF rats”. In: American Journal of Physiology-Heart and Circulatory Physiology 298.6
(June 2010), H1661–H1670. doi: 10 . 1152 / ajpheart . 01239 . 2009. url: https :
//doi.org/10.1152/ajpheart.01239.2009.
[35] Thorbjorn Akerstrom et al. “Hyperinsulinemia does not cause de novo capillary recruitment in rat skeletal muscle”. In: Microcirculation 27.2 (Oct. 2019). doi: 10 . 1111 /
micc.12593. url: https://doi.org/10.1111/micc.12593.
[36] Keith Christian Afas, Raashi Vijay, and Daniel Goldman. “A two-compartment model
of oxygen transport in skeletal muscle using continuously distributed capillaries”. In:
Mathematical Biosciences (Jan. 2021), p. 108535. doi: 10.1016/j.mbs.2020.108535.
url: https://doi.org/10.1016/j.mbs.2020.108535.
[37] Daniel Goldman and Aleksander S. Popel. “A Computational Study of the E↵ect of
Capillary Network Anastomoses and Tortuosity on Oxygen Transport”. In: Journal of
Theoretical Biology 206 (2000), pp. 181–94. url: np.
[38] Daniel Goldman and Aleksander S. Popel. “A Computational Study of the E↵ect of
Vasomotion on Oxygen Transport from Capillary Networks”. In: Journal of Theoretical
Biology 209.2 (Mar. 2001), pp. 189–199. doi: 10.1006/jtbi.2000.2254. url: https:
//doi.org/10.1006/jtbi.2000.2254.
[39] T. B. Bentley, H. Meng, and R. N. Pittman. “Temperature dependence of oxygen di↵usion and consumption in mammalian striated muscle”. In: American Journal of PhysiologyHeart and Circulatory Physiology 264.6 (June 1993), H1825–H1830. doi: 10.1152/
ajpheart.1993.264.6.h1825. url: https://doi.org/10.1152/ajpheart.
1993.264.6.h1825.

CHAPTER 2: BIBLIOGRAPHY

79

[40] C.D. Eggleton et al. “Calculations of intracapillary oxygen tension distributions in muscle”. In: Mathematical Biosciences 167.2 (Oct. 2000), pp. 123–143. doi: 10 . 1016 /
s0025- 5564(00)00038- 9. url: https://doi.org/10.1016/s0025- 5564(00)
00038-9.
[41] Arjun Vadapalli, Daniel Goldman, and Aleksander S. Popel. “Calculations of Oxygen
Transport by Red Blood Cells and Hemoglobin Solutions in Capillaries”. In: Artificial
Cells, Blood Substitutes, and Biotechnology 30.3 (Jan. 2002), pp. 157–188. doi: 10 .
1081/bio-120004338. url: https://doi.org/10.1081/bio-120004338.
[42] J. David Hellums et al. “Simulation of intraluminal gas transport processes in the microcirculation”. In: Annals of Biomedical Engineering 24.S1 (Sept. 1995), pp. 1–24. doi:
10.1007/bf02770991. url: https://doi.org/10.1007/bf02770991.
[43] Timothy Hunter and Daniel Goldman. “A Model of Healthy Blood Flow Response to
Imposed Changes in Tissue Oxygen Partial Pressure”. en. In: (2020). doi: 10.13140/
RG.2.2.36172.64647. url: http://rgdoi.net/10.13140/RG.2.2.36172.
64647.
[44] Yuanliang Tang and Ying He. “Numerical modeling of fluid and oxygen exchanges
through microcirculation for the assessment of microcirculation alterations caused by
type 2 diabetes”. In: Microvascular Research 117 (May 2018), pp. 61–73. doi: 10 .
1016/j.mvr.2018.01.006. url: https://doi.org/10.1016/j.mvr.2018.01.
006.
[45] Keith Christian Afas and Daniel Goldman. “Studying Microcirculatory Flow Regulation in Skeletal Muscle Using a Novel Two-Layer Distributed Capillary O2 Transport
Model”. In: North American Vascular Biology Conference. Vol. 309459. 2020, p. 163.
[46] Daniel M. Hirai et al. “Skeletal muscle microvascular and interstitial PO2 from rest
to contractions”. In: The Journal of Physiology 596.5 (Jan. 2018), pp. 869–883. doi:
10.1113/jp275170. url: https://doi.org/10.1113/jp275170.

80

Chapter 2. Two-layer Continuously Distributed Capillary O2 Transport Model

[47] T. E. Gayeski and C. R. Honig. “O2 gradients from sarcolemma to cell interior in red
muscle at maximal VO2 ”. In: American Journal of Physiology-Heart and Circulatory
Physiology 251.4 (Oct. 1986), H789–H799. doi: 10.1152/ajpheart.1986.251.4.
h789. url: https://doi.org/10.1152/ajpheart.1986.251.4.h789.
[48] Lane M. Smith, Aleksander S. Golub, and Roland N. Pittman. “Interstitial PO2 Determination by Phosphorescence Quenching Microscopy”. In: Microcirculation 9.5 (Oct.
2002), pp. 389–395. doi: 10.1038/sj.mn.7800147. url: https://doi.org/10.
1038/sj.mn.7800147.
[49] Gang Liu, Feilim Mac Gabhann, and Aleksander S. Popel. “E↵ects of Fiber Type and
Size on the Heterogeneity of Oxygen Distribution in Exercising Skeletal Muscle”. In:
PLoS ONE 7.9 (Sept. 2012). Ed. by Timothy W. Secomb, e44375. doi: 10 . 1371 /
journal . pone . 0044375. url: https : / / doi . org / 10 . 1371 / journal . pone .
0044375.
[50] Jose T Celaya-Alcala et al. “Simulation of oxygen transport and estimation of tissue perfusion in extensive microvascular networks: Application to cerebral cortex”. In: Journal
of Cerebral Blood Flow & Metabolism 41.3 (June 2020), pp. 656–669. doi: 10.1177/
0271678x20927100. url: https://doi.org/10.1177/0271678x20927100.
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Chapter 3
A simplified control-systems model of
oxygen-dependent blood flow regulation to
capillary modules in skeletal muscle.
3.1

Introduction

The microcirculation in skeletal muscle is a system allowing for blood flow distribution, and
with the main purpose being for oxygen (O2 ) transport. The partial pressure of oxygen (PO2 ) in
tissue is a prime candidate to assess, as PO2 variations herald a functionality decline in skeletal
muscle. The lack of non-invasive experimental methods to accurately assess tissue PO2 profiles
within skeletal muscle, along with the difficulty of making 3D and time-dependent measurements at the capillary scale, implies analysis of microcirculatory O2 transport heavily relies on
biophysical models to simulate both tissue and capillary PO2 distributions.

Recently, a continuous-capillary microcirculatory O2 transport model which calculates
capillary and tissue PO2 in two layers of skeletal muscle adjacent to an external oxygen chamber, was developed1,2 from an earlier model for one layer of skeletal muscle.3 Both models are
81
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a novel extension of an earlier formulation developed by Eric P. Salathe in 1989,4 and account
for di↵usion, convection, and tissue O2 consumption using a linear-ansatz for capillary-tissue
O2 transfer, grounded in mass transport and previously validated.5 The model utilizes initial
and boundary conditions obtained through a collaborating intravital video microscopy (IVVM)
lab.6,7 These conditions may be used, along with analytic solutions obtained from the model, to
obtain capillary PO2 values, through both segments of skeletal muscle, provided PO2 inlets into
the muscle segments, and factoring in a chamber O2 level

which is involved in the IVVM

protocol.6 The results of the capillary PO2 calculations are shown below in Fig.(3.1):

(a) Baseline velocity, v1 = v2 = v0

(b) Diminished near-layer velocity, v1 = 0.1v0

Figure 3.1: Capillary PO2 output of the microcirculatory O2 model described in earlier publications1 simulating two-layers of skeletal muscle side-by-side, each with dimensions of
200µm⇥500µm. Here blood is flowing left to right z = (0 to L), where L = 500µm, with
a uniform tissue O2 consumption, and assuming inlet PO2 is P0 = 47mmHg, and chamber O2
is = 15mmHg. Color bars are included with both images separately as a formality, as color
scales are homogenized across both images.
Referring to the coordinate axes in Fig.(3.1), blood is flowing in the z oriented direction from
left to right (0 to 500µm), O2 is di↵using in the x oriented direction, the two layers are coupled
via di↵usive flux, and the chamber O2 is applied at x = 0 (top face). Due to the two-layer
nature of the model, an alteration in the capillary velocity within the upper layer (x = 0 to
200µm) may be done and the analytic solutions may be visualized for experimental conditions

3.1. Introduction
where the inlet PO2 is P0 = 47mmHg, and chamber O2 is
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= 15mmHg. Note that though

15mmHg is being applied to the segment, the tissue PO2 will be homogeneously equal to ,
but the capillary O2 may not have the same PO2 depending on the O2 flow near the surface.

Observed from Fig.(3.1), the experimental conditions the model is performed assuming,
greatly a↵ects the PO2 profiles within the capillaries throughout the skeletal muscle. As can
be expected, Fig.(3.1b) exhibits that the diminishing of the capillary velocity in the near-layer
causes a largely decreased O2 profile. The model for microcirculatory O2 transport may be
represented as a schematic block model by the following:

Figure 3.2: Block model of the two-layer microcirculatory system with two independent inlet
velocities {v1 , v2 }, two independent inlet PO2 ’s {P01 , P02 }, and integrating chamber oxygenation
{ } to obtain two outlet PO2 ’s {Pout,1 , Pout,2 }, which can be used to compute a di↵erence in
outlet PO2 as P(out) ( , v1 , v2 , P01 , P02 ).
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While the model can generate these O2 profiles rapidly, there remain some experimental observations that disagree with the results. More broadly, the model does not account for homoeostatic and regulatory phenomenon observed when O2 balance in skeletal muscle is perturbed.
In an IVVM experiment done recently, it was seen that for varying levels of , the capillary
velocity within skeletal muscle near to the external O2 chamber (near-layer, x = 0 to 200µm)
may be elevated or depressed as compared to the reference capillary velocity measured using
a glass cover-slip to implement a no-flux boundary condition (which should reflect behavior in
the tissue in the absence of or far away from the external O2 chamber).5,6 The dominant hypothesis of microcirculatory experimental literature regarding regulation, is that hemodynamic
parameters alter in response to perturbations; the aim of these alterations is such that capillary
O2 saturation on red blood cells (SO2 ) is maintained at a target value. Given the complexity
of microcirculatory networks and regulation mechanisms, such target values (if they exist) are
not always known, and depend on several variables, including physiological requirements of
the local muscle.

Nevertheless, focusing on the near-layer observed velocity changes in IVVM experiments,
the above SO2 -targeting hypothesis can be investigated by assuming that capillary endothelialsignalling is targeting the near-layer red blood cell velocity (v1 ) in order to ensure that the two
regions of tissue (near and far from the O2 chamber) are homogenizing their average capillary
SO2 , and therefore their capillary PO2 values against each other. Since the model developed1
allows for the velocity in the near layer to be defined relative to the layer far from the O2
chamber, this presents the opportunity for such a regulatory phenomenon to be explored on a
physical basis. This can be implemented by developing a control-systems model which evolves
the capillary PO2 leaving each respective layer, to have negligible di↵erence between layers.
This control-system would best implement the dominant hypothesis of microcirculatory regulation, in a manner which utilizes data provided in the model. To qualitatively confirm IVVM
experimental observations, a model which demonstrates the capillary red blood cell (RBC) ve-
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locity responding inversely to the chamber O2 (increase in chamber O2 decreases v1 ) would
confirm that experimentally observed changes of velocity near to the O2 chamber, are resulting
from skeletal muscle trying to maintain its capillary PO2 values.

3.1.1

Physiological Significance

As discussed, the predominant hypothesis which will be sought to be confirmed in this paper
(qualitatively), is that capillary blood velocity in the layer near exposed to an O2 chamber, will
change locally when exposed to varying chamber O2 levels. This perturbation in the context of
the developed O2 transport model, will be investigated to see if the target of velocity regulation
is to ensure that capillary PO2 outlets in both layers are homogenizing their O2 levels relative to
one another. This forms the starting point to use the continuous-capillary O2 transport model,
to investigate phenomenological observations hypothesized to derive from microcirculatory
regulation, in skeletal muscle. Microcirculatory regulation, while critical for ensuring skeletal muscle receives sufficient oxygen levels, could conceivably be altered (perhaps weakened),
and often is over the course of a pathological condition. A pathological condition where this
is seen in skeletal muscle, Diabetes Mellitus II (DMII), manifests tangibly on the microcirculatory scale by several alterations to baseline hemodynamic parameters. One such alteration is
the decrease in capillary density, speculated to be due to the accumulation of tryglycerides in
co-morbidities of DMII including obesity and metabolic syndrome.8 Since the capillary density is a parameter in the continuous-capillary O2 transport model developed,1,3 this can be
included as a case to observe a possibly noticeable di↵erence of velocity regulation in a state
of low capillary density. Any di↵erence in the microcirculatory regulatory response being
calculated, may provide insight to the pathogenesis of DMII. More generally the study may
provide parameters with which diseased skeletal muscle, and more generally skeletal muscle
with compromised capillary density, can be monitored (eg. experimentally or clinically). To
obtain a skeletal muscle state which accurately represents lowered capillary density, research
papers which have investigated disease often report average capillary density decreases as a
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proportion from baseline. With DMII being one such relevant microcirculatory disease, research papers have indicated varying observations of quantitative capillary density decreases.
One study which sampled a variety of skeletal muscle microcirculatory networks, reported a
44% decrease in capillary density (CD) in DMII,9 and so an approximate 50% decrease in capillary density will be taken as a suitable state with which to model low CD conditions through
this analysis of the microcirculatory feedback.

3.1.2

Study Objective

The objective of this study is to develop a control-system model with feedback, targeting capillary RBC velocity (v1 ) when skeletal muscle in the O2 transport model is perturbed by an
O2 chamber. As mentioned, the purpose of such a feedback model is two-fold: primarily, this
would analytically confirm the regulatory hypothesis of skeletal muscle PO2 -homogenization
with exposure to an O2 chamber. Second, it would a↵ord the opportunity to study the microcirculation’s altered regulatory capacity when gross microcirculatory parameters determining O2
transport such as capillary density are perturbed (whether in DMII, and other similar diseases
or states). Such a feedback model in essence is augmenting the existing two-layer microcirculatory O2 model previous developed1 by altering its schematic above in Fig.(3.2) to a block
diagram incorporating endothelial feedback as shown in Fig.(3.3).
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Figure 3.3: Block model of the two-layer microcirculatory system seen in Fig.(3.2) incorporating endothelial feedback. Here, the two outlet PO2 ’s {Pout,1 , Pout,2 } formed from the two
inlet velocities and PO2 ’s are processed into the outlet PO2 di↵erence P(out) ( , v1 , v2 , P01 , P02 ),
which is incorporated into the ”Endothelial Feedback” Block, which travels upstream and updates the inlet velocities {v1 , v2 }.

3.1.3

Microcirculatory Regulation: Upstream and Downstream

In 2008, a model was created by Arciero and colleagues,10 designed at providing a system of
equations to analyse the interconnection between an O2 gradient in skeletal muscle, and an
upstream alteration of arteriolar diameter. The hypothesized mechanism of this alteration (at
steady-state) was the following ordered set of steps:
1. Skeletal muscle consumption generating a capillary O2 saturation (SO2 ) gradient
2. SO2 gradients generating a local intra-capillary ATP release from red-blood cells
3. ATP releases generating an intra-capillary gradient of ATP
4. ATP gradient being convolved with a decay profile to simulate the decay of signal travelling over a length, which generates a consolidated upstream signal (via the binding of
ATP to receptors (e.g., P2Y11 ) on the microvascular endothelium)
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5. This signal being multiplied with a gain to translate it into vascular tone due to the e↵ect
of the endothelium on the surrounding vascular smooth muscle
6. Sigmoidal activation of the vascular smooth muscle cells (VSMs) in upstream arterioles,
targeting arteriolar vascular tone
7. VSM cells generating an increase or relaxation in tension, which can then alter the diameter of arterioles as needed.
8. Arteriolar diameter a↵ecting blood flow, and hence the downstream O2 supply and SO2
gradient
This approach of integrating a signal upstream acting on vascular tone was echoed in other
studies.12 At the capillary length scale concerned in Fig.(3.1), the Arciero model may be modified to describe how the upstream capillary velocity in the near-layer, referred to as v1 , may be
a↵ected.

3.2. Model & Methods
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Model & Methods

As outlined in App.(B.1), the flow-regulation model being considered for O2 -dependent endothelial feedback may be represented by (time-dependent) Eqs.(B.3,B.4,B.5,B.7):
P(out) = ↵
d⌃P
=
dt
(@t

p

⌘v1
P(out)
⌧⌃

⌃P

, ⌃P |t=0 = 0

vcond @z + )⌃A = 0, ⌃A |z=L = ⌃P (t)

dv1
=
dt

v ⌃A |z=0

⌧v

v1 + v1

, v1 |t=0 = v0 = 357µm/s

These steps may be visualized through a control system circuit which may be developed to
describe processes 1-4.

3.2.1

Control Systems Diagram

In general, a standard feedback control system is composed of an input (drawn incoming from
the left), an ampifier which modulates the input signal into its output, and a feed-back relay
which communicates the signal back to a mixer at the input.13

Figure 3.4: A standard feedback circuit with a mixer, amplifier, and feedback time-delay
(phase-shifter) port at the bottom. This model takes an input, amplifies it with a gain and
o↵set, phase shifts it, and then processes it with other inputs coming in to form the output on
the right. This can be represented using a first-order transfer di↵erential equation.
This feedback circuit may be modified to discuss endothelial feedback. For endothelial feed-
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back, the amplifier alters the input (capillary velocity) into output by a negative linear gain with
o↵set. Reflecting on Eq.(B.3), this can be seen to be a negative gain of ⌘( ) with o↵set of
↵( ). As stated, this linearized modulation is motivated by the linear regime within the velocity bandwidth concerned. This linearly modulated velocity is passed into the main feedback
relay, which is diverted into a separate feedback loop to generate a passive signal ⌃P . This
passive signal continues throughout the main feedback loop and is then conducted upstream to
arterioles which can a↵ect arteriolar radius. This conducted signal is referrred to as ⌃A (”A” for
”active”), and the interaction between the conducted acting signal and velocity is represented
as a mixer which then proceeds to the amplifier. It should be noted that since the secondary
feedback loop is undergoing signal generation on the spot (at the capillary outlet), then there is
essentially a negligible time-delay or phase-shift, indicated by

= 0.

Figure 3.5: The proposed second-order-control system model for Endothelial Feedback using
control systems conventions.13,14 Similar to Fig.(3.4), the near-layer velocity v1 is amplified
with an o↵set ( P(out) ) and amplified with a gain p to produce a signal at the capillary outlet.
This signal is then mixed with other velocity signals in a feedback loop, to produce a consolidated signal ⌃P where it then attains a phase shift at the bottom of the loop representing
the delay due to upstream-conduction to become the signal ⌃A felt at the capillary inlet. Then
the phase-delayed signal attains a gain, v and is mixed with other incoming velocity values
to modulate the capillary blood velocity to a level which homogenizes the capillary PO2 outlet
di↵erence P(out) = 0.
This control circuit shown in Fig.(3.5) is second-order due to using two feedback relays. The
outlined area in red in itself is a feedback relay to generate a passive signal, which may be
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relayed to the main feedback relay.13 This circuit model may be converted into a functional
block diagram in the Laplace domain:14
v1
s

+ v0 ⌧v

G(s)

+

⌘( )

+

↵( )
s

p H(s)

vG(s)

F(s)
Figure 3.6: A functional block diagram of the control system in Fig.(3.5), in the Laplace domain with generalized transfer functions F(s), G(s) and H(s)
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Here the gain parameters

p

and

v

seen in Fig.(3.5) re-appear, and several non-dimensional

transfer functions are illustrated in Fig.(3.6). These may be expanded on below:
Transfer Function

Expression

Circuit Relation

H(s)

1
s⌧⌃ +1

Feedback with relaxation time ⌧⌃

F(s)

e

G(s)

1
s⌧v +1

s

Phase shift by
Feedback with relaxation time ⌧v

Table 3.1: Chart explaning non-dimensional transfer functions illustrated in Fig.(3.6)
These non-dimensional transfer functions and their role in the master matrix in the Laplace
domain will be discussed further. The phase shift illustrated in the transfer function F(s) in
Table(3.1) represents a phase shift due to the conduction lag and will be expanded on below.

3.2.2

Implementation & Software

After simplifications outlined in App.(B.1.2), the set of ODEs provided above (Eq.B.3, B.4,
B.7, and B.8) were combined into two ODEs by substituting Eq.(B.3) into Eq.(B.4), and substituting Eq.(B.8) into Eq.(B.7) to form the following coupled time-delayed system of two
ODEs:

8
>
>
>
>
< (⌧⌃ @t + 1)⌃P = p (↵( ) ↵( )v1 ) , ⌃P |t=0 = 0
>
>
>
>
:(⌧v @t + 1)v1 = p ⌃P (t ⌧cond ) + v1 , v1 |t=0 = v0

(3.1)

These were solved via a built-in Fehlberg fourth-fifth order Runge-Kutta (rk45) numeric
solving algorithm in Maple 2022, and the resultant solutions for v1 (t) and ⌃P (t) were manipulated using Eq.(B.3) and Eq.(B.8) to obtain P(out) and ⌃A (t), respectively as outlined in
App.(C.2). These were plotted in Maple 2020 using the following constants:
These constants were obtained from the Arciero model,10 and where constants not utilized in
the Arciero model were used, design considerations of the model were utilized to specify value
of the constants. The PO2 -to-Signal Gain of 16.5mmHg
mal dimensionless signal produced was unity for

1

was chosen to ensure the maxi-

= 15mmHg, and the Signal-to-Velocity
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Description

Value

Units

p

PO2 -to-Signal Gain

16.5

mmHg

v

Signal-to-Velocity Gain

35.7

µm/s

⌧⌃

PO2 -to-Signal Time Constant

60

s

⌧v

Signal-to-Velocity Time Constant

1

s

L

Capillary Segment Length

500

µm

vcond

Endothelial Conduction Speed

700

µm/s

v0

Baseline Capilllary Blood Speed

357.3

µm/s

1

Table 3.2: List of constants used in the endothelial feedback model. Where possible, constants
are used from IVVM-informed baselines (ie. v0 & L). Since the end-point of the velocity adaptation is pre-specified as v1 calculated from the O2 transport model, gain and time constants
simply dictate the behavior of the adaptation profiles, but not their end-points. Thus for gain
and delay constants, where possible are sourced from literature, and where not, are calibrated
to produce reasonable time-profiles.

Gain was chosen arbitrarily to be 10% the baseline velocity since the value did not a↵ect the
steady state values of any of the parameters concerned. Time constants were extracted from the
Arciero model, and other hemodynamic parameters were obtained from the baseline parameters of the two-layer microcirculatory model.1,3

At baseline, it was assumed in accordance with previous developed models,3 that a capillary volume fraction of 3% was in the skeletal muscle segment. Other assumed parameters in
the models were: a tissue O2 consumption of µ0 = 1.5e-4mLO2 /mL/s, inlet PO2 ’s of 47mmHg
(corresponding to 65% O2 saturation), and baseline velocity of v0 = 357.3µm/s. To model
the approximate 50% reduction in capillary density in a low CD state, an alternative set of
linearization constants were utilized, obtained directly from the two-layer capillary-tissue O2
transport model assuming that the capillary volume fraction was 50% of 3%. These produced
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the following linearization constants:
P(out) ⇡ (q1 q2 ) (q3 q4 ) (v1 vmin )
8
>
>
>
>vmin = 200µm/s, q1 = 12.981mmHg, q2 = 0.265
<
>
>
>
>
:q3 = 3.257(10) 2 mmHg · s/µm, q4 = 3.443(10) 4 s/µm

⌃P & ⌃A , v1 and P(out) profiles were obtained for
and DMII linearization constants.

(3.2)

= {15, 30, 45, 60}mmHg, for both baseline
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Results
Graphical Results

Baseline Feedback Response
Assuming the linearization constants in Eq.(B.2), and all the constants shown in Table(3.2),
the results of the Feedback response for low chamber O2 (15mmHg and 30mmHg) are shown
below:

(a) Baseline simulation results

= 15mmHg

(b) Baseline simulation results

= 30mmHg

Figure 3.7: Output of the feedback model finite-di↵erence simulation in Maple 2022 for baseline conditions and low chamber O2 (15mmHg and 30mmHg). All 4 state variable profiles
(⌃P , ⌃A , v1 , P(out) ) are shown, and graphs have normalized y-axes across state-variable plot.
Signals can be seen to have lower maximums with increasing chamber O2 , lower steady-state
homogenizing velocities, and smaller di↵erences between the outlet PO2 ’s (Pout,1 & Pout,2 ). The
final outlet PO2 (around 41mmHg) is una↵ected.
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Firstly observable from Fig.(3.7a,3.7b, bottom panels), at low chamber O2 in baseline parameters, the near-layer has lower outlet PO2 that the far-layer. Consequentially, to homogenize this
PO2 di↵erence, the model indicates in Fig.(3.7a,3.7b, middle panels) that low chamber PO2 ’s
induce the near-layer velocity to increase which increases the near-layer outlet PO2 . As seen
in Fig.(3.7a,3.7b, upper panels), this is facilitated by a positive signal ⌃P which is normalized
to a value of 1. This signal is then convected upstream resulting in the time-delay between ⌃P
and ⌃A , after which the alterations to both the near-layer velocity, and consequentially average
outlet PO2 ’s happen. In addition, the simulation results may be shown for high chamber O2
values:

(a) Baseline simulation results

= 45mmHg

(b) Baseline simulation results

= 60mmHg

Figure 3.8: Output of the feedback model finite-di↵erence simulation in Maple 2020 for baseline conditions and high chamber O2 (45mmHg and 60mmHg). All 4 state variable profiles
(⌃P , ⌃A , v1 , P(out) ) are shown, and graphs have normalized y-axes across state-variable plot.
At 45mmHg, there is negligible signal magnitude, but negative as chamber O2 increases further to 60mmHg. The final outlet PO2 (around 41mmHg) is una↵ected.
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Here, in Fig.(3.8a), at increased chamber PO2 , it can be seen that the chamber PO2 of 45mmHg
is precisely the chamber PO2 which causes both average chamber PO2 ’s to be identical. Consequentially there is no di↵erence to induce a signal, and no velocity alteration induced. At high
chamber PO2 in Fig.(3.8b), the near-layer average PO2 outlet is higher than the far-layer outlet
PO2 . Therefore, there is a negative signal generated, which decreases the near-layer velocity to
79µm/s that homogenizes both outlet PO2 ’s at 40.4mmHg.

Pathological Feedback Response

To investigate a pathological condition mirroring the decreased capillary density in DMII,9 the
simulation may be repeated with the 50% decreased CD linearization constants in Eq.(3.2).
Using this, the results of the feedback response for low chamber O2 (15mmHg and 30mmHg)
are shown below:
Fig.(3.9) indicates that low chamber O2 in the low CD state also requires the velocity to increase in response, but there are several di↵erences from the baseline condition in Fig.(3.7).
Most notably, while the outlet PO2 ’s are indeed homogenized in both low CD and baseline
conditions, their final outlet PO2 is far lower in low CD conditions at 34.5mmHg compared to
the baseline homogenized outlet PO2 of 41mmHg. This is the same trend at 30mmHg chamber
PO2 . Next, the low CD state simulation results may be displayed for high chamber O2 values:
Here, comparing Fig.(3.10) against the baseline conditions, at 45mmHg, there was no response
in baseline conditions (Fig.3.8a, middle panel), while in low CD states, the velocity is required
to go further down. Most drastically, increasing the chamber PO2 to 60mmHg in Fig.(3.10b),
the di↵erence in outlet PO2 is so drastic that the velocity must be decreased towards zero. Still,
once the velocity in the near-layer shuts o↵, there is not homogenization of the outlet PO2 ’s,
noted by the two distinct outlet PO2 bands, and therefore, the signal remains persisting.
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(a) Pathological simulation results

= 15mmHg

(b) Pathological simulation results

= 30mmHg

Figure 3.9: Output of the feedback model finite-di↵erence simulation in Maple 2020 for pathological conditions and low chamber O2 (15mmHg and 30mmHg). All 4 state variable profiles
(⌃P , ⌃A , v1 , P(out) ) are shown, and graphs have normalized y-axes across state-variable plot.
Signals can be seen to have lower maximums with increasing chamber O2 , lower steady-state
homogenizing velocities, and smaller di↵erences between the outlet PO2 ’s (Pout,1 & Pout,2 ).
Signal magnitudes, steady state velocities, and final outlet PO2 are all lower than in baseline
conditions. The final outlet PO2 (around 34mmHg) is una↵ected with increasing chamber O2
but is lower than baseline conditions.

3.3.2

Analytical Results

The system as a coupled time-delayed set of ODEs admits some results in the Laplace domain
shown in App.(B.2) to explain trajectories throughout Figs.(3.7-3.10). In particular, it is shown
that an equilibrium velocity exists and that this value gives PO2 homogenization between the
two layers. These results are contained in details within the appendix, and will be further
explained in the Discussion.

3.4. Discussion

(a) Pathological simulation results
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= 45mmHg

(b) Pathological simulation results

= 60mmHg

Figure 3.10: Output of the feedback model finite-di↵erence simulation in Maple 2020 for
pathological conditions and high chamber O2 (45mmHg and 60mmHg). All 4 state variable
profiles (⌃P , ⌃A , v1 , P(out) ) are shown, and graphs have normalized y-axes across state-variable
plot. Here at both chamber O2 levels, signals become negative. At high chamber O2 of
60mmHg, outlet PO2 ’s are too high such that the steady-state velocity can decrease no further than 0µm/s. As a result, the outlet PO2 ’s remains non-homogenized, and the signals are
persistent.

3.4

Discussion

The purpose of the development of a feedback model was primarily to qualitatively confirm
the (simplified) regulatory hypothesis of skeletal muscle PO2 homogenization with exposure
to an O2 chamber. The feedback model was constructed with the schematic of Fig.(3.3) in
mind as per several constraints to agree with previously proposed approaches to modelling
microcirculatory feedback, and a set of four algebraic, ordinary di↵erential, and partial di↵erential equations were developed as detailed in App.(B.1), and implemented computationally
as detailed in App.(C.2). Diagrams of the constructed endothelial control feedback model are
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depicted in Sec.(3.2.1) both as a control diagram in Fig.(3.5), and as a functional block diagram
in Fig.(3.6), with compartmental transfer expressions outlined in Table.(3.1).

The construction of this model was done with the intention of a fixed-point feedback where
the system would evolve to a steady state where the di↵erence in PO2 would vanish, by the
near-layer velocity at t = 1 being dictated to evolve to v1 . In App.(B.2.1), transfer functions
were obtained, and steady-state Laplace analysis was utilized to confirm in Sec.(B.2.2) that
indeed the feedback evolved to the steady state velocity v1 = ↵/⌘ which caused P(out) = 0.
The plots of the profiles also yielded insightful results which will be discussed further for both
baseline CD conditions ( =

3.4.1

0 ),

as well as low CD conditions ( = 0.5 0 ).

Baseline Conditions

In Fig.(3.7) and Fig.(3.8), it was seen that for all levels of chamber O2 , the di↵erence in PO2
(bottom panel) vanished seen by both far and near-layer average outlet PO2 ’s approaching
each other in value. Depending on the surface O2 provided to the skeletal muscle, the nearlayer velocity evolved to di↵erent steady-state values, the signal generated possessed chamber
O2 -dependent peak values, and the average PO2 which both layers attained also depended on
the chamber PO2 , . In both Fig.(3.7) and Fig.(3.8), the accumulation of a signal at the outlet of the microcirculatory blocks illustrated in Fig.(3.1) drove the alteration of the near layer
velocity v1 to a steady state. In Figs.(3.7,3.8), it was seen that for low chamber O2 values, the
near-layer capillary velocity increased higher than its baseline of v0 = 357µm/s such that the
near-layer of skeletal muscle would increase its outlet PO2 above the surface O2 to homogenize its outlet PO2 with the deeper layer. Conversely, for Fig.(3.10), the maximum chamber O2
values caused the near-layer capillary velocity to decrease such that the near-layer of skeletal
muscle would decrease its outlet PO2 below the surface O2 to homogenize it with the deeper
layer.

3.4. Discussion

101

Some phenomenon were noteworthy to report. Fig.(3.7a, top panel) confirmed the design consideration which allowed the choice of

p.

In the Arciero model, the signal generated

had a slightly di↵erent physiological basis (ATP release, not considered in the current model),
and as such there was not a good yardstick to compare the conducted lumped signal considered for capillary velocity alteration. As a result in this study, conclusions were obtained on
the relative signal changes. Therefore, as a baseline signal calibration, for 15mmHg,

p

was

chosen to match the maximal signal in Fig.(3.7a,top panel) to unity |maxt ⌃P |= 1. All relative
signals were compared against this baseline value.

Another noteworthy point was that the magnitude of the velocity v1 alteration, was proportional to the signal generated, in sign and value. The higher the di↵erence between the inlet
velocity of v0 and the steady state velocity, v1 , the higher signal was generated. In cases of
high chamber O2 , a negative signal facilitated a negative v1 alteration. As expected, the relation between ⌃A and ⌃P was a uniform time-delay, which was predicted by the solution of the
conduction PDE. Thirdly, the simulation results displayed some minor oscillatory behavior for
the choice of the signal gain

v

= 10%v0 ; this indicates the strength of the feedback on the

velocity alteration. The choice of

v

did not a↵ect the final steady state value of v1 = ↵/⌘.

Therefore it was chosen arbitrarily to be 10% of v0 . Finally, an interesting phenomenon occurred for

= 45mmHg. This caused the signal to be almost zero, and the inlet velocity of

v0 = 357.3µm/s did not change. This was discussed in Sec.(B.2.4) where the equilibrium chamber O2 was defined for baseline conditions. Using the equation obtained by a quasi-Laplace
inversion for small t values in Sec.(B.2.3), this indicated that the equilibrium chamber O2 was
45.5mmHg, which was close to the chamber O2 in Fig.(3.8a) of 45mmHg.

3.4.2

Pathological Conditions (Low CD States)

As outlined in the Introduction, the secondary purpose of the study was to observe relative
alterations under pathological conditions, provided a feedback model could be obtained which
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qualitatively replicated experimental observations. Adapting the model to the low CD conditions observed in DMII, a 50% decrease in capillary density was considered which would
allow the model to address the manifestation of low CD conditions, and their e↵ect on microcirculatory regulation. Implementing this 50% capillary decrease, it was seen in Fig.(3.9)
and Fig.(3.10) that in homogenizing the capillary PO2 across both layers, all velocities were
significantly lower than their four counterparts with normal CD for similar chamber O2 values.
This indicates that operating on the hypothesis that microcirculatory regulation homogenizes
capillary PO2 outlets, lower capillary velocity values will be developed for any external PO2
level delivered to skeletal muscle in low CD conditions. In general, PO2 values were found to
be positively correlated with v1 in both layers; therefore, lower v1 values attained in DMII in
order to homogenize PO2 in capillaries across both layers, could conceivably result in hypoxia.
This may be related to hypoxic observations in peripheral skeletal muscle tissues observed in
advanced stages of DMII, which can lead to terminal outcomes such as peripheral limb necrosis.8

This possible prevalence for hypoxia was also reflected in the equilibrium chamber O2
value ˜ O2 ,(eq) in DMII obtained in App.(B.2.4). Using the linearization constants for P(out) ,
this equilibrium chamber O2 which caused no signal generation was found to be ˜ O2 ,(eq) =
37.5mmHg. This can be seen to be confirmed numerically from the plot trajectories, where the
switch from velocity increase/decrease in response to low/high chamber PO2 occurs between
30mmHg in Fig.(3.9b), and 45mmHg in Fig.(3.10a), unlike in baseline conditions where the
equilibrium chamber PO2 was seen to be exactly the 45mmHg case in Fig.(3.8a). Interpreting
the equilibrium chamber PO2 as a metric of the natural O2 state of the tissue, it can be seen that
skeletal muscle tends to attain greater equilibrium at a lower chamber O2 in low CD conditions,
if there are not compensating mechanisms.

Finally, the peculiar graphical result obtained in Fig.(3.10) will be discussed. Here, the

3.4. Discussion
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near-layer received such a high chamber O2 that the near-layer velocity decreased all the way to
zero. This can be explained since low CD condition requires a higher burden on each individual capillary to deliver O2 to the surrounding tissue. With impaired capillary O2 delivery, the
tissue seeks O2 from the O2 chamber purely through di↵usion. As observed, with such a high
chamber O2 , the capillaries are unable to decrease their velocities sufficiently, and therefore the
capillary modules are never homogenized sufficiently as seen in Fig.(3.10b, lower panel)

In summary, the model presented did qualitatively confirm the regulation hypothesis that
was formed on the basis of experiments. In particular, as found by Ghonaim and colleagues in
the EDL muscle in vivo,15 we found that altering muscle surface PO2 did lead to dynamic local
blood velocity changes which served to bring the a↵ected muscle segment closer to baseline
PO2 values. In addition, similar to results seen experimentally, we found surface PO2 values that would bring the local blood velocity to zero, as well as oscillatory behavior prior to
establishment of new steady-state blood flow and tissue PO2 values.

3.4.3

Limitations of the Model

There were several limitations to the model which may be identified:
1. Single modulated velocity: The model was constructed with the assumption that only
the near-layer velocity changed. The far-layer was set to be fixed assuming that it would
stay fixed, while the upper layer near to the O2 chamber would not change. Microcirculatory regulation is a comprehensive process which modulates all velocities within
capillary multi-segment modules to achieve O2 regulation. Therefore, several velocity
parameters in the tissue may be changing simultaneously, and further steps would be to
develop a model where both v1 and v2 are changing.
2. Fixed steady-state: Second, as mentioned in the discussion, the construction of this
model focused on the paradigm of a fixed-point feedback where the system would evolve
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to a pre-determined precise steady state such that the di↵erence in PO2 vanished, by the
near-layer velocity at t = 1 uniquely evolving to v1 , and where all signalling vanishes
identically. This is idealistic, but may not be representative of in-vivo microcirculatory
systems. More accurately, an in-vivo system may have a steady-state where signalling is
persistent, and velocity changes proceed to almost homogenize the system. This change
can be introduced by removing the v1 o↵set in the system of equations, and altering
and

p

v

to homogenize the system.

3. Simplified signalling model: Finally, as mentioned, the signal generated ⌃P was a general dimensionless construction from the control theory model, and did not have a physiological basis in microcirculatory signalling which depends on RBC shear stress, oxygenation, and ATP release. Further steps would be to develop a mechanistic scheme to
include both ATP and RBC dynamics into the model, so that absolute values in the signal
changes can be interpreted physiologically.

3.5

Conclusion

A set of algebraic, ordinary di↵erential, and partial di↵erential equations were formulated
to describe time-dependent endothelial feedback in microcirculatory segments representing
capillary-tissue modules of skeletal muscle. As mentioned earlier, this was assuming capillarytissue O2 transport could be approximated using a steady-state model with regulation, using a
time-dependent set of equations, making the model quasi-steady-state. The system was analyzed with traditional Laplace methods, and implemented into Maple 2022 using a combination
of code based on the analytic two-layer microcirculatory model previously developed, and code
which solved the system using numerical techniques. The set of ODEs qualitatively confirmed
the hypothesis that capillary velocity in a skeletal muscle layer exposed to an external O2 chamber will variate inversely with surface chamber O2 , in order to homogenize capillary outlet PO2 .

3.5. Conclusion
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This model was applied to investigate physiological consequences of low capillary density
states in disease, by decreasing the capillary density in the code by 50%. It was found that simulated microcirculatory segments with low capillary density do not have feedback responses
as e↵ective as baseline microcirculatory segments, and exhibit complete cut-o↵ of capillary
velocity in response to a high chamber O2 .

Limitations were identified in the model, which the author intends on extending by allowing the microcirculatory O2 transport model to be time-dependent, and also allow for both
near-layer and far-layer to alter in the model to allow the rescuing of the tissue, should it fall to
critically low O2 levels. The conclusions the model obtained in low CD states could allow for
the discovery of metrics which may lend to the therapeutic monitoring of O2 regulation in the
human microcirculation with further development and further accuracy of the model.
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Chapter 4
Final Summary
The microvasculature is a physiologically critical component of the cardiovascular system
comprising the smallest blood vessels in the body, capillaries, which are responsible for distributing oxygen from blood to the tissues they perfuse.1 Experimental techniques which are
interested in how the microvasculature within skeletal muscle regulates its local O2 concentration and blood flow through vessel networks amongst varied physiological demands, have been
successful at measuring several hemodynamic parameters with a variety of methods. IVVM in
particular, has been successful at quantifying blood flow and capillary O2 at the capillary muscle bundle level, and has been used to investigate heterogeneity in these parameters throughout
large regions of the microcirculation.2–4 Through IVVM, a variety of regulatory mechanisms
in the microcirculation have been able to be documented, showing capillary blood flow, fluctuating in response to externally applied O2 through oxygenation of skeletal muscle with a gas
chamber.5,6

The quantity of O2 which travels through capillaries and di↵uses into the surrounding
skeletal muscle tissue, referred to as tissue PO2 , remains a challenge to quantify through
IVVM.7 Physiological studies have speculated blood flow fluctuations observed occur to maintain the balance between capillary and tissue O2 at a homeostatic target. Without a method for
109
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IVVM to quantify tissue PO2 , quantifying the balance between tissue and capillary PO2 has
remained elusive, and therefore there is not a strong justification for the observed blood flow
fluctuations thought to be indicative of regulation.

While tissue PO2 has remained a difficulty for IVVM to quantify, the physical principles
of its travel including capillary convection, di↵usion, and mass balance have been known for
a century or longer in the physical sciences and mathematical modelling.8,9 This has presented
the unique opportunity for mathematical modelling to complement IVVM in order to calculate the tissue PO2 present in skeletal muscle surrounding the microvascular networks. Several
techniques have been used to model O2 within the circulation over the last few decades, before
and after the need to integrate modelling with IVVM. Most techniques approached microcirculatory O2 modelling representing capillaries as discrete cylindrical segments,10,11 allowing
for capillary blood flow to be included in models, that is a target for fluctuations in IVVM
experiments. As microvascular networks visualized through IVVM become more expansive,12
the question of whether it is always necessary to use such computationally demanding discrete
methods has arisen.

Recently, a model of microcirculatory O2 transport that follows in the same vein as previous discrete capillary methods has been developed;13 this model replaces discrete capillary
and tissue geometric regions, with a continuously defined tissue domain and incorporates capillary networks and capillary blood flow using continuous distributions. This model which has
been validated against discrete methods, is capable of modelling macroscale tissue O2 distributions amongst capillary modules, produces such distributions rapidly, and following the same
physiological rationale as discrete methods, explicitly accounts for capillary blood flow.13 This
presents a unique opportunity to use the continuous approach of modelling microvascular O2
transport to investigate blood flow variations in response to externally applied gas chamber O2 ,
as observed in IVVM experiments.

4.1. Summary of Results

4.1
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Summary of Results

The purpose of this thesis was to develop a model of microcirculatory O2 transport de-novo,
which can investigate and explain the phenomenon of near-layer blood flow perturbations
throughout skeletal muscle, in response to externally applied chamber O2 observed in IVVM.
As outlined in Sec.(1.3), this model was aimed to be achieved in two sub-models:
• Two-layer Continuously Distributed Capillary O2 Transport Model: The one-layer continuous microcirculatory O2 transport model was applied to two capillary modules which
were adjacently near and far to an external O2 chamber. The model was formulated, analytically solved, computationally implemented, behaved as per predictions, and qualitatively validated against microcirculatory IVVM data.14 An essentially inverse form of the
model, made possible by its linear nature, was able to accurately quantify steady-state
RBC velocity decreases in response to increasing chamber O2 . Novel tissue O2 metrics
including the homogenizing tissue velocity and equilibrium chamber O2 , were defined.
• Oxygen-Dependent Microcirculatory Blood Flow Regulation Model: Using the two-layer
capillary O2 transport model obtained in the previous chapter, a control-systems feedback
model was formulated to simulate regulation in microcirculatory networks through endothelial conduction. The model which was formulated as a control-systems circuit, was
translated into a set of ordinary di↵erential equations (ODEs), fully implemented computationally using numerical methods, and supported steady-state predictions from the
two-layer O2 transport model by showing how chamber O2 could dynamically alter the
near-layer velocity. Velocity completely turning o↵ in the near-layer as experimentally
observed with IVVM was concluded to be likely due to RBC velocity changing to homogenize tissue PO2 between the muscle surface, and deeper layers in muscle tissue.15,16
Previously in the field of microvascular research, a dominant hypothesis on regulation was
hemodynamic parameters alter in response to perturbations to maintain capillary O2 saturation at a target value.1,17,18 Using this comprehensive model developed over the thesis, it was
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quantitatively demonstrated that simulating local blood flow to variate in order to homogenize adjacent capillary modules, produced similar velocity fluctuation behavior as observed
in IVVM experiments.16 This lends credence to the microvascular hypothesis of regulation;
while the thesis solely demonstrated that capillary modules in IVVM experiments are likely
attempting to homogenize capillary PO2 gradients across adjacent boundaries, blood flow may
be provided to groups of multi-segment capillary modules to ensure their homogenized capillary PO2 is maintained at a target level. Further, in the linearized capillary-tissue transport
model, capillary PO2 is proportional to SO2 , hence homogenizing average capillary outflow
PO2 values in the two layers is equivalent to homogenizing capillary SO2 values. This could be
investigated further by incorporating the comprehensive model developed over this thesis as a
component of an even larger model of microvascular O2 and blood flow regulation accounting
for more regulatory mechanisms, and multiscale physiological and biochemical influences.

4.2

Future Directions

There are several areas for further development of the models in this thesis, with the aim of
making the O2 transport model (Ch. 2) achieving higher agreeance with IVVM, and incorporating more regulatory mechanisms into the endothelial regulation model (Ch.3) to account for
the physiology with higher accuracy.
• Macroscale Capillary Module Networks: The first model developed in this thesis was of
two capillary modules adjacent to an external O2 chamber; it was stated that the choice
of two capillary modules was the simplest method to analyse the binary characterization
of skeletal muscle (near/far) relative to the O2 chamber. Considerations has been made of
how to extend this model to larger arrangements of capillary modules to simulate bigger
fields of view for microcirculatory O2 transport. As was discussed in Chapter #2, for a 2⇥
1 column of capillary modules, there was 1 matching parameter at the O2 membrane-near
layer interface surface, and assuming a linear interface between the layers, 2 matching
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parameters at the near-far layer interface. In principle, dividing skeletal muscle adjacent
to the O2 chamber into an n ⇥ m grid of microcirculatory segments, would produce (m)
membrane-near layer interface matching parameters, (2(n

1) · m) inter-module-layer

coupling coefficients, and an additional coefficient at the arteriovenous interface between
modules (in the z direction), or (m

1) total arteriovenous module interface matching

parameters. In total summing all matching parameters, this would be (2mn 1) matching
parameters (3, in the case of a 2 ⇥ 1 column), leading to an (2mn 1) ⇥ (2mn 1) coupling
coefficient matrix. This could be inverted, and an analytic method could be provided
to obtain capillary and tissue PO2 with higher grid arrangements of capillary modules.
The purpose of this extension would be since velocity, capillary volume fraction, and
tissue O2 consumption could be specified at every individual module, multi-segment
module regulatory adaptation could be calculated and visualized. Provided macroscale
data as observed in modern microcirculatory IVVM experiments,19 large scale tissue PO2
levels could be calculated with higher speed than traditional numerical techniques used
in discrete models and finite-di↵erence implementations of continuous models.
• Time-Dependent O2 Challenges: In IVVM experiments the response of skeletal muscle to stationary chamber O2 values, communicates information regarding the regulatory capacity of the muscle-capillary system; as the steady-state response communicates
physiologically important information, so does the muscle’s time-dependent response to
Heaviside O2 steps, and oscillating O2 levels. The time-dependent response including the
speed of adaptation, and phase-lag of tissue PO2 oscillations relative to the chamber O2
phase, have been shown in IVVM experiments to communicate physiologically important information related to regulatory function of the capillary networks.19–21 With the
two-layer O2 transport regulatory model developed over this thesis, most investigation
has been at steady-state, and even the time-dependent response of the regulatory model
in this thesis has been acknowledged to be limited since the O2 transport it was integrated with was at steady-state. The original one-layer O2 transport model was initially
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conceived with time-dependence, but was simplified to steady-state O2 transport in the
interest of simplicity. This is because the two-layer model was solved using analytical
methods and including time-dependence would increase the complexity of analytic solutions vastly. Transitioning away from analytical techniques, and implementing a numerical method for calculating O2 transport distributions would allow for time-dependence to
be incorporated into the capillary O2 outlet di↵erence ( P(out) ) for the regulatory model.
This would allow the simulation of IVVM time-challenges to O2 levels to be observed
using the principles explored in this thesis, and would be highly motivated, provided
sufficient IVVM data for such time-challenges.

• RBC-ATP Signaling Mechanisms: As discussed in Chapter #3, the passive signal generated at the capillary outlet was chosen to be characterized by a first order transfer
equation, but a limitation was that the nature of the signal remained ambiguous. Physiologically, the signal generated throughout the length of capillaries recruiting higher
local blood flow has been demonstrated to be facilitated by endothelium as emphasized
by the regulation model in this thesis, but specifically precipitated by a release of ATP
from RBCs within the capillary lumen, which then binds to endothelial purinergic receptors.22 The role of RBCs is not passive in this process; RBCs release ATP in response to
their saturation levels which has been demonstrated in this thesis to be a delicate balance
with the O2 demands of the tissue surrounding. In addition, the release of ATP from
RBCs is facilitated by a signalling cascade within RBCs, and has been demonstrated
to be modulated by increasing shear stress on RBCs through the local speed of blood,
and by pharmacologically altering the deformability of RBCs. Since the ATP release is
dependent on blood flow, but ATP also recruits blood flow, RBCs themselves comprise
an essential feedback process within larger microcirculatory regulatory mechanisms.23,24
To model this process is a difficult endeavor since signalling cascade, and control-system
models discussed in this thesis can be represented by lumped parameter modelling, but
since RBC deformability is an integral component of this feedback, RBC geometry must
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be accounted for. RBC geometry, and in general cellular deformation has a long, but
sparse history of modelling, and usually requires techniques from soft condensed matter theory to accurately depict cellular biophysical response to shear, and other physical
influences.25–27 This would be a crucial process to investigate, and models characterizing the role of the RBC in this feedback response would be non-trivial. This makes the
RBC-ATP story a strong candidate for a further direction.
• Higher Complexity Endothelial Conduction: As was discussed in Chapter #3, conduction of the PO2 capillary outlet di↵erence, upstream through the endothelium was modelled by a simple conduction equation (@t

vcond @z + )⌃A = 0. This assumes that

the endothelium passively conducts the signal upstream with decay and constant conduction velocity. Physiologically this is a sufficient approximation for capillaries, since
their vessel wall is mostly composed of endothelium which are capable of signalling
upstream in a coordinated fashion. In principle however, upstream conduction has been
demonstrated to occur over large distances, on the order of millimetres (⇡ 103 µm). This
conduction distance passes the length scale of capillaries, and indicates that arterioles
are involved in endothelial feedback, an indication which has been supported by physiological experiments measuring changes in vascular tone of arterioles over the process of
endothelial feedback.28 Arterioles are composed of concentric rings of endothelium and
smooth muscle, which not only both are capable of upstream signalling, but communicate internally;29 research has shown blocking endothelial-smooth muscle communication adversely a↵ects upstream conduction.30 Therefore, to model upstream conduction
during endothelial feedback for the length involvement of arterioles, requires a model
with more complexity than the conduction equation used in this thesis. Using models
from cable theory typically used to model longitudinal conduction along neuronal axons has seen success in replicating conduction speed along the wall of arterioles,31,32 but
most models do not account for the inter-communication between endothelial cells and
smooth-muscle cells. Given the role of ATP in O2 -dependent regulatory mechanisms
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interacting with endothelial cells,22 the communication of endothelial cells with smooth
muscle cells is important to characterizing upstream conduction in the length scale of
arterioles. Therefore, a new model ultimately deriving from cable theory must be proposed that accounts for inter-cellular communication with smooth muscle, in order to
fully characterize endothelial upstream conduction.

4.3

Final Conclusions

In conclusion, the microcirculation has been demonstrated to be a system in the body with the
crucial and complex task of delivering blood flow and oxygen to tissue under a plethora of
physiological demands. Skeletal muscle being one of the tissues comprising the majority of
body-mass, critically depends on this regulation of blood flow and O2 delivery. Despite many
experimental techniques used to analyze this complex multiscale process in skeletal muscle,
IVVM has been a strong technique which has allowed for the visualization of this process at
the individual capillary and capillary-network level. Despite IVVM’s capacity to reliably measure capillary network geometry, O2 saturations, and blood flow in microcirculatory networks,
its lack of ability to (simultaneously) measure tissue PO2 has presented difficulty to fully understand how hemodynamic variations which are suspected to be homeostatic in nature, are
related to O2 balance within the surrounding skeletal muscle.

The one-layer model which was developed to be able to calculate tissue PO2 representing
capillaries as a continuous distribution, has seen much success in predicting tissue and capillary PO2 distributions at the capillary muscle bundle level. This study sought to extend this
model to be able to begin to explain regulatory phenomena observed in IVVM experiments
where blood flow markedly alters near to the surface of skeletal muscle and an external O2
chamber. Through the innovation of a model to characterize O2 transport in two capillary modules near and far to an external chamber, as well as a model to characterize how blood flow
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may change to equalize average capillary PO2 between layers, this phenomenon seen in IVVM
experiments was explored. It was demonstrated that using both models together, blood flow
near to the surface of the O2 chamber would inversely alter in response to chamber O2 levels
- a trend observed in IVVM experiments, but further elucidated using a novel model. This
response was seen to be altered in capillary modules with di↵erent capillary density, and tissue
O2 consumption rates, and the model predicted that blood flow could even vanish at sufficiently
high chamber O2 levels, a result exhibited in IVVM experiments.

What the thesis represents in its capability to complement IVVM experiments is only
overshadowed by its potential application to the field of cardiovascular physiology at large.
Being able to provide theoretical justification of a component of a microcirculatory regulatory mechanism, implies that extensions of this model will be able to account for phenomena
of higher complexity. As outlined in the future directions, several steps will be intended to
be taken to account for more physiology and larger scale microcirculatory networks. With a
model of sufficient complexity, diseased states can begin to be analyzed, and data from these
studies can be used to transition from academic investigations, to practical applications that
could monitor microcirculatory health in the clinical sphere.
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Appendix A
Chapter 1 Appendix
A.1

Governing Partial Di↵erential Equation

PDEs were obtained for the two layers and the O2 permeable membrane. Knowing that the
PDEs in Eqs.(2.1-2.2) applied to a single layer of skeletal muscle, it was assumed to apply
piecewise to several segments of skeletal muscle arranged adjacently.

A.1.1

PDE Formulation: Layer 1 and Layer 2

Analysis proceeded by noting that two separate PO2 profiles were needed in both the near layer
and far layer. Where in the one-layer model, the capillary PO2 PB (x, z) and tissue PO2 PT (x, z)
were indicated, here, independent PO2 profiles to describe the dynamics of each region with
their own parameters were introduced. Therefore, the PO2 fields {PT (1) (x, z), PB(1) (x, z)} and
{PT (2) (x, z), PB(2) (x, z)} refer to the PO2 in the two regions, with the subscript indicating which
layer each PO2 profile belonged to. In addition, subscripts for physical parameters indicate
regional belonging: {P01 , v1 , µ1 ,

1}

and {P02 , v2 , µ2 ,

2 }.

˜ T = 2Kµ/( sRvB DT ↵T ) described the nearThe PDE given in the one-layer model by ⇤P

layer of skeletal muscle microcirculation, and far-layer alike.1 All assumptions, including linearization of the Hill Equation due to a small regime of capillary SO2 variation were assumed,
and therefore the governing PDEs could be assumed to hold. Since the convection-di↵usion
˜ utilizes the capillary velocity and capillary volume fractions of each region, the opoperator ⇤
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erator required to be indexed, accounting for two sets of parameters. Indexing the operator by k
to indicate which region’s parameters are being used (1=near-layer, 2=far-layer), the following
operators in Eq.(A.1) were introduced:
(
˜ k = @z @2x + 2K @2x
⇤
s̃Rvk

2K
(1

k

k )RDT

@z , h̃k = 1

(1
k )RDT 2
@x
2K k ↵T

)

(A.1)

Using these, it was seen that the dynamics of the capillary and tissue PO2 ’s in both regions
could be formulated, along with their domains, according to the following:
˜ 1 PT (1) =
⇤
PB(1) =

˜ 2 PT (2) =
⇤

2Kµ1
s̃Rv1 DT ↵T

(1 1 )Rµ1
2K 1 ↵T

+ h̃1 PT (1)

n
o
(x, z) 2 R2 |0  x < T 1 , 0  z  L

n

PB(2) =

2Kµ2
s̃Rv2 DT ↵T

(1 2 )Rµ2
2K 2 ↵T

+ h̃2 PT (2)

(x, z) 2 R2 |T 1  x  T 1 + T 2 , 0  z  L

(A.2)
o

As in the one-layer model,1 parameters {µ, v, , R, K} refer to the O2 tissue consumption [mL
O2 /mL/s], capillary RBC velocity [cm/s], capillary volume fraction, capillary radius, and masstransfer coefficient [cm/s], respectively. In addition, flow-weighted hematocrit also referred to
as discharge hematocrit (HD ), is related to the model by the parameter
foundation1 by

defined in the model’s

= NHDCHb /(4↵T P50 ); here, HD is related to the standard defined volume-

averaged hematocrit also referred to as tube hematocrit (HT ) through an empirical formula.2
Parameters indexed by 1 or 2 indicate the near or far layer respectively, and T 1 and T 2 indicate
the thickness of the near and far segment respectively, which both have length L. In addition,
˜ k is 1st order in z and 2nd order in x, boundary conditions were formulated according to
Since ⇤
˜k
the necessities of ⇤

A.1.2

PDE Formulation: O2 Permeable Membrane

The O2 permeable-membrane as introduced in Sec.(2.1.2) was described as an experimental
inclusion from the IVVM protocol allowing for bu↵ering between the O2 chamber and skeletal
muscle tissue. It is constructed ideally to allow for a similar di↵usion constant DT throughout

A.2. Initial, Boundary, and Matching Conditions
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its length, and has a thickness of ⌧ p ⇡ 100µm. This is roughly half of the thickness of the
skeletal muscle segments considered which each have a baseline thickness of T 0 ⇡ 200µm,
reflective of the IVVM protocol.1,3
From Fig.(2.2), the domain for the membrane was be seen to be {(x, z) 2 R2 | ⌧ p  x <
0, 0  z  L}. The permeable-membrane is devoid of any vasculature or metabolism thus as a
result, only O2 di↵usion in the membrane is considered. Since there was no consumption, and
the permeable membrane is entirely homogeneous, it was assumed that the membrane obeys
Laplace’s Equation r2 PC = 0.
The profile which describes the PO2 distribution in the permeable membrane in the (x, z)
coordinate system was given by PC (x, z). Since the tissue in the near-layer is dependent on
x and z, at the membrane interface (x = 0) the tissue would have a hypothetical z dependent
profile given by PT (1) (0, z). Therefore, it would be natural to allow isotropic di↵usion in the z
and x directions within the membrane, resulting in the steady-state equation of (@2x + @2z )PC = 0.
However, as indicated in Fig.(2.1), the surface PO2 , which was theoretically dependent on z,
was assumed to be homogeneous. Therefore, the entire face of the membrane at (x = ⌧ p ) was
made to be oxygenated identically. E↵ectively, this meant the di↵usion within the membrane
could be assumed to be approximately entirely x-directed. Therefore, PO2 equation and the
domain of the membrane were given by:
@2x PC = 0 ,

A.2

n
o
(x, z) 2 R2 | ⌧ p  x < 0, 0  z  L

(A.3)

Initial, Boundary, and Matching Conditions

In order for the model to be fully defined, there were several boundary conditions imposed.
These were identified from Eqs.(A.2-A.3) by the region indicated in Fig.(2.2) that the boundary
conditions applied to.
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O2 Permeable Membrane

At the membrane, it was seen through Eq.(A.3), that two x-directed boundary conditions were
needed. One could be provided through the identification of the experimental oxygenation at
the surface:
PC | x=

⌧p =

(A.4)

In addition, since the di↵usion was assumed to be entirely x-directed, it was hypothesized that
at the membrane-tissue interface, there existed an interface PO2 level given by P⇤(i) . Therefore,
the other condition needed was given by:
PC | x=0 = P⇤(i) 2 R

A.2.2

(A.5)

Near Layer

˜ k , there are three total conditions required (1 z-directed, 2 x-directed). The
As indicated by ⇤
x-conditions were identified by ensuring C0 (R)-continuity (continuity of PO2 across the tissuemembrane interface), and the z-condition was identified by specifying the inlet PO2 , P01 on the
capillary PO2 . At the interface between the near-layer and far-layer (x = T 1 ), a general PO2
profile, P(1,2) (z) was assumed to be present at the inter-layer interface. Therefore, sharing the
boundary conditions with the membrane, the boundary conditions were as such:
{PT (1) | x=0 = P⇤(i) , PT (1) | x=T1 = P(1,2) (z) , PB(1) |z=0 = P01 }

A.2.3

(A.6)

Far Layer

Like the near-layer, there were a total of three conditions required (1 z-directed, 2 x-directed).
Inlet PO2 , was required to be specified as P02 on the capillary PO2 . As for the x-directed
conditions, at the inter-layer interface (x = T 1 ), C0 (R) continuity was imposed, and at the far
face located at x = T 1 + T 2 , flux was set to zero. Therefore, the boundary conditions were

A.2. Initial, Boundary, and Matching Conditions
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formulated as such:
{PT (2) | x=T1 = P(1,2) (z) , @ x PT (2) | x=T1 +T2 = 0 , PB(2) |z=0 = P02 }

A.2.4

(A.7)

Matching Conditions

The boundary conditions, while defining a complete solution, left two areas of ambiguities.
There remain two values which were undetermined: the interface PO2 given as P⇤(i) at x = 0, and
the inter-layer PO2 profile given as P(1,2) (z). These were treated by ensuring C1 (R) continuity
(continuity of flux). While there is almost no z-variation of the PO2 levels along the x = 0
face, there is a minimal amount of z-dependence of the x-directed flux across the boundary.
Therefore, in order to allow for a smooth transition from the membrane to the first layer, an
appropriate matching condition was to choose an interface PO2 P⇤(i) , such that along the z-axis,
the average x-directed flux was continuous across the membrane. Defining taking the average
RL
along the z-axis as the following operator h·iz : f (z) ! R, such that h f (z)iz = L1 0 f (z)dz, the
matching condition was chosen to be the following in Eq.(A.8):
⌦

@ x PC | x=0 PT (1) | x=0

↵

z

=0

(A.8)

In addition, while it was stated any profile may be specified for P(1,2) (z) at the inter-layer interface, the most straightforward option was to assume a linear ansatz, given by P(1,2) (z) =
⌘⇤

⇤

z/L and determine the two parameters (⌘⇤ ,

⇤

) using two justified matching conditions.

A linear ansatz is chosen since far from the chamber, it is known that x-di↵usion will be minimal, and thus with only z-convection, the profile ought to be linear in z. Therefore, to a first
order error, it is justifiable to assume a linear-z ansatz in between the near-layer and far-layer.
Here, ⌘⇤ indicates the PO2 at the inlet of the inter-layer interface at z = 0, while

⇤

indicates

the PO2 drop along the inter-layer profile from z = 0 to z = L, such that at z = L, the total
PO2 drop is ⌘⇤

⇤

. These parameters can be ’fitted’ by a variety of methods, but the method
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selected was to let the fluxes be identical across the inter-layer interface at the inlet z = 0, and
z = L. Understandably, this matching procedure involves parameters from both layers, and
may be formally stated as the following:
@ x PT (1) | x=T1 @ x PT (2) | x=T1

A.3

z=0

=0 ,

@ x PT (1) | x=T1 @ x PT (2) | x=T1

z=L

=0

(A.9)

Analytical Solution

The solution of this system was done by region, and matching was performed subsequently.

A.3.1

Membrane General Solution

For the membrane, the general solution was obtained by allowing a linear function PC (x) = c1 +
c2 x which satisfied @2x PC = 0, to satisfy the boundary conditions. Accordingly, the membrane
solution was obtained as Eq.(A.10):
PC (x) =

A.3.2

+

P⇤(i)
⌧p

!

(x + ⌧ p )

(A.10)

Near & Far Layer General Solution

Both near and far layers had their solution obtained using the same method as the one-layer
model.1 The tissue PO2 was decomposed into PT (n) = FT (n) +GT (n) , where the function GT (n) (x, z)
was chosen to satisfy the x-directed BCs for each layer. The chosen functions were given as:

GT (1) =

P⇤(i)

0 ⇤
BBB ⌘
+ BBB@

⇤z
L

T1

1
P⇤(i) CCC
CCC x , GT (2) = ⌘⇤
A

⇤

z
L

(A.11)

The functions GT (n) (x, z) were chosen to be the simplest solutions to homogenize the x-directed
BCs. Once the x-directed BCs were homogeneous, the PDE could be multiplicatively separated by variables, and in both cases, a sinusoidal function was selected with the appropriate
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eigenvalues in order to obey the homogenized boundary conditions. For both sections, the
eigenvalues were:
⇢

n1

T1
=
, {n 2 Z|n
⇡n

1}

(

,

2T 2
=
, {n 2 Z|n
⇡(2n + 1)

n2

0}

)

(A.12)

Using these two eigenvalues, a multivariable solution was constructed for both layers:
PT (1) = GT (1) (x, z) +

1
X

x

Bn1 (z) sin

n1

n=1

!

, PT (2) = GT (2) (x, z) +

1
X

x

Bn2 (z) cos

n2

n=0

!

(A.13)

By substitution into the x-directed BC’s, it was seen that both of these solutions satisfy the BCs.
˜ n PT (n) =
Then, substituting the solutions from Eq.(A.13) into the PDE ⇤

2Kµn
s̃Rvn DT ↵T

, all the terms,

including the non-homogeneous term on the RHS, and GT (n) could be Fourier decomposed
according to the layer’s respective eigenvalues. In this way, an ODE could be formulated to
determine Bn1 (z) and Bn2 (z), which are the z-dependent coefficients of each Fourier series in
Eq.(A.13). Solving the ODE in each equation resulted in one constant of integration (due
˜ n being 1st order in z). The solved form for PT (n) could be substituted into the relation,
to ⇤
PB(n) =

(1 n )Rµn
2K n ↵T

+ h̃n PT (n) , and imposing the BC at z = 0 which is PB(n) |z=0 = P0n , yielded

the sequence for the constant of integration. The full solution for the z-dependent coefficients
allowing for the definition of some auxiliary variables to provide brevity, was:

8
>
>
>
>
>
<
>
>
>
>
>
:

8
>
>
>
>
>
>
>
>
>
>
<
>
>
>
>
>
>
>
>
>
>
:

m1

Qm1 =

m2

=

=

T1
⇡m

⇣
Mm1 = ⇣1

(1 ( 1)m )µ1
s̃v1 ↵T

2T 2
⇡(2m+1)

Qm2 =

2K
s̃Rv1

, ⇠m1 =

+

⇤

(1

1(

⌘
P⇤(i) (1

, ⇠m2 =

2K
s̃Rv2

µ2
s̃v2 ↵T

⇤

(1

2

1)m
1 )L

2 )L

1

2K 2 1
m1
1+ RD (1
T
1)

(1

, ⇣1 = P01

1 )Rµ1

2K

1

⇣
⌘
( 1)m ) + ⌘⇤ P⇤(i) ( 1)m
⇣
⌘
, Bm1 (z) = 11 ⇠m11 Mm1 + Qm1 e ⇠m1 z
1

2K 2 2
m2
1+ RD (1
T
2)

, ⇣2 = P02

, Bm2 (z) =

⇣

2 )Rµ2

2K

2

⌘
M
+
Q
m2
m2 e
2

2 ⇠m2

1

(1

Qm1

, Mm2 = ⇣2
⇠m2 z

Qm2

(A.14)
⌘⇤
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Therefore, the tissue PO2 in both regions was obtained as Eq.(A.15):
⇣
PT (1) = P⇤(i) + ⌘⇤

PT (2) = ⌘

⇤z
L

⇤

⇤z

L

⌘
⇣
P
2 s̃v1 3m1
P⇤(i) Tx1 + 1
m=1 T 1 DT Bm1 (z) sin
⇣ ⌘
P
2 s̃v2 3m2
x T
+ 1
m=0 T 2 DT Bm2 (z) sin
m2

x
m1

⌘

(A.15)

Similarly, the capillary PO2 in both regions was obtained through substitution back into the
general PDE as Eq.(A.16):
PB(1) = P01

⇣
⇣1 + P⇤(i) + ⌘⇤

PB(2) = P02

⇣2 + ⌘⇤

⇤z

L

⇤z

L

⌘
⇣
P
2 m1 (1 1 )
P⇤(i) Tx1 + 1
B
(z)
sin
m1
m=1 T 1 ⇠m1
⇣x T ⌘
P1 2 m2 (1 2 )
+ m=0 T2 2 ⇠m2 Bm2 (z) sin m21

x
m1

⌘

(A.16)

It was verified via substitution that in the limit as infinite Fourier terms are taken, all boundary conditions are satisfied. These solutions could be matched with each other and with the
membrane solution, to determine the matching parameters given as the set {P⇤(i) , ⌘⇤ ,

A.4

⇤

}

Matching Process

At this point, the solutions in each region needed to be stitched together so that they are sufficiently smooth at their boundaries implemented by enforcing C1 continuity (continuity of PO2
flux). Since the boundary conditions and resultant form of the solutions ensured C0 continuity for any interface curves, imposing C1 continuity determined the form of all the matching
parameters {P⇤(i) , ⌘⇤ ,

⇤

}. The matching conditions given above in A.2 were therefore aimed at

matching fluxes (C1 (R) continuity). An analytical matching method which reduces the matching code to a floating point evaluation and matrix inversion, was developed. The analytical
matching process involved evaluating the solutions at points along the solutions’ respective domains to produce analytic linear relationships between {P⇤(i) , ⌘⇤ ,

⇤

}. These relationships were

governed by several coefficients dependent on parameters in all three regions, and were notated in Fourier series form, inputted into a matrix, and inverted to obtain the precise form of
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the matching parameters which were then substituted into the solution for numerical evaluation.
Recalling h·iz : b(z) ! R such that hb(z)iz =

R
1 L
L 0

b(z)dz, the matching conductions given

in A.2 were found to be linear with respect to the matching parameters and were allowed to be
collected into the following form:
2
666
666✏˜2
666
666✏˜
666 6
666
4✏˜
9

✏˜3
✏˜7
✏˜10

32 3 2 3
76 7 6 7
✏˜4 7777 6666P⇤(i) 7777 6666 ✏˜1 7777
777 666 777 666 777
76 7 6 7
0 77777 66666 ⌘⇤ 77777 = 66666 ✏˜5 77777
777 666 777 666 777
76 7 6 7
✏˜11 5 4 ⇤ 5 4 ✏˜8 5

(A.17)

These coupling coefficients were able to be grouped together and had the analytic form of:
✏˜1 =

⌧p

✏˜2 =

1
⌧p

+

✏˜3 =

1
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+

+
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+
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⇣

1

e
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m=1 (1 1 )T 1 LDT
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1
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1

1

e

+
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s̃v1 ↵T

⌘

⌘
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1 e L⇠m1
⇣
⌘
P
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1 1 L⇠
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(A.18)

All the parameters which do not correspond to the matching parameters have units [mmHg/µm]
{˜✏1 , ✏˜5 , ✏˜8 }, whereas the values which are coefficients on the matching parameters have units
[µm 1 ]. Assuming baseline parameters, the smallest coefficient value is ✏˜6 ⇡ 4.65(10) 5 µm

1

which corresponds to the coupling of the interface PO2 at the inlet of the inter-layer inter-
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face, while the largest coefficient value is ✏˜5 ⇡ 3.24mmHg/µm corresponding to the nonhomogeneous component of the coupling at the inlet of the inter-layer interface. These values
are dependent on the biophysical parameters at the membrane, near-layer, and far-layer. A
summary can be provided showing the respective values of all the ✏˜ coefficients for baseline
values in Fig.(A.1).

Figure A.1: Chart of the various ✏˜ coupling coefficient values, taken for 100 Fourier terms for
baseline parameters. Parameters of high value indicate a high dependency of the matching
condition from Sec.(A.2.4), represented in the corresponding row of the coupling coefficient
matrix (see Eq.A.17), on the respective matching parameter. For example, the first row of
the matrix corresponding to the continuity of flux across the membrane, involves coupling
parameters ✏˜2 , ✏˜3 and ✏˜4 (ignoring the RHS). Of these, it can be seen that ✏˜2 has the highest
value, indicating that the membrane-tissue interface PO2 (P(i) ) plays a larger role than the interlayer PO2 profile parameters {⌘⇤ , ⇤ } in homogenizing the PO2 flux across the membrane-tissue
interface, as expected.

The LHS in Eq.(A.17) could be efficiently grouped together and expressed by the matrix Ē,
and the right hand side could be expressed by the vector ~✏ , to produce the following solution
for the matching parameters:

2 3
666 ⇤ 777
6666P(i) 7777
666 777
666 ⌘⇤ 777 = Ē 1~✏
666 777
664 ⇤ 775

(A.19)
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Using this procedure, the full solutions outlined in Eq.(A.10), Eq.(A.15), and Eq.(A.16), were
able to be visualized for a unique surface chamber oxygenation
parameters {P0n , µn ,

A.5

, and for layer-dependent

n , vn }

Membrane-Tissue Interface PO2, and No-Flux Chamber PO2

Using the Matrix Equation Eq.(A.17), an analytic expression for the PO2 at the membranetissue interface as a result of the chamber PO2 , the membrane thickness, and the tissue O2
dynamics (metabolism, blood speed etc.) can be determined. In terms of the coupling coefficients, we can analytically invert the Matrix to see that:
P⇤(i) =

✏˜1 ✏˜7 ✏˜11
✏˜2 ✏˜7 ✏˜11

✏˜4 ✏˜5 ✏˜10 + ✏˜3 ✏˜5 ✏˜11 + ✏˜4 ✏˜7 ✏˜8
✏˜4 ✏˜7 ✏˜9 + ✏˜4 ✏˜6 ✏˜10 ✏˜3 ✏˜6 ✏˜11

(A.20)

Noting that the only coefficient which involves the chamber PO2 is ✏˜1 which can be re-stated
as ✏˜1 = ✏˜12 + /⌧ p , where ✏˜12 = ✏˜1
P⇤(i)

/⌧ p , this can be restated as a linear relationship with :

✏˜12 ✏˜7 ✏˜11 ✏˜4 ✏˜5 ✏˜10 + ✏˜3 ✏˜5 ✏˜11 + ✏˜4 ✏˜7 ✏˜8
=
+
✏˜2 ✏˜7 ✏˜11 ✏˜4 ✏˜7 ✏˜9 + ✏˜4 ✏˜6 ✏˜10 ✏˜3 ✏˜6 ✏˜11
✏˜2 ✏˜7 ✏˜11

✏˜7 ✏˜11 /⌧ p
✏˜4 ✏˜7 ✏˜9 + ✏˜4 ✏˜6 ✏˜10

✏˜3 ✏˜6 ✏˜11

!

(A.21)

An experimentally relevant parameter is the chamber PO2 , at which the membrane exhibits
no-flux; that is to say, the chamber PO2

satisfies

obtained using the coupling coefficients to state that

P(i)

=

= P⇤(i) . This can also be analytically
= P⇤(i) , at the no-flux chamber PO2 ,

✏˜4 ✏˜5 ✏˜10 ✏˜7 ✏˜11 ✏˜12 ✏˜3 ✏˜5 ✏˜11 ✏˜4 ✏˜7 ✏˜8
+ ✏˜4 ✏˜7 ✏˜9 ✏˜4 ✏˜6 ✏˜10 + ✏˜3 ✏˜6 ✏˜11 ✏˜2 ✏˜7 ✏˜11

✏˜7 ✏˜11
⌧p

P(i) :

(A.22)

134

Chapter A. Chapter 1 Appendix

Appendix A: Bibliography
[1] Keith Christian Afas, Raashi Vijay, and Daniel Goldman. “A two-compartment model
of oxygen transport in skeletal muscle using continuously distributed capillaries”. In:
Mathematical Biosciences (Jan. 2021), p. 108535. doi: 10.1016/j.mbs.2020.108535.
url: https://doi.org/10.1016/j.mbs.2020.108535.
[2] A R Pries et al. “Blood flow in microvascular networks. Experiments and simulation.”
In: Circulation Research 67.4 (Oct. 1990), pp. 826–834. doi: 10.1161/01.res.67.4.
826. url: https://doi.org/10.1161/01.res.67.4.826.
[3] Christopher G. Ellis, Stephanie Milkovich, and Daniel Goldman. “What is the Efficiency
of ATP Signaling from Erythrocytes to Regulate Distribution of O2 Supply Within the
Microvasculature?” In: Microcirculation 19.5 (July 2012), pp. 440–450. doi: 10.1111/
j . 1549 - 8719 . 2012 . 00196 . x. url: https : / / doi . org / 10 . 1111 / j . 1549 8719.2012.00196.x.

Appendix B
Chapter 2 Appendix
B.1

Control Model Formulation

Drawing inspiration from the Arciero model,1 the process described earlier may be summarized
in four steps:
1. Capillary Outlet SO2 Generation: The two-layer microcirculatory O2 model2 observed
in Fig.(3.1), can be used to relate capillary SO2 to PO2 , and compute the di↵erence
in outlet capillary PO2 ( P(out) ). In general, this is a non-linear function of near-layer
capillary velocity (v1 ).
2. Oxygen Signal Generation: Given sufficient basis to assume from Arciero’s model,1 a
general first-order transfer equation between P(out) and an intra-capillary signal generation (whether ATP, or some other general biochemical pathway agent) may be proposed.3
3. Oxygen Signal Upstream Conduction: A conduction partial di↵erential equation (PDE)
with decay may be used to model a signal conducting upstream along the capillary wall.4
The Arciero model indicates that the length for conduction to produce a signal decay (⇡15cm) is much longer than the considered length of skeletal muscle segment (500µm).1
Therefore, it will be assumed the generated signal will be only delayed, not decayed.
This will be as per a conduction speed, vcond .
4. Signal-Velocity First-Order Tranfer: Unlike the feedback considered in Arciero, in135
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stead of the signal undergoing a first-order transfer on diameter, since the model is being
developed within the length scale of capillaries which alter their velocity distributions
rather than radii, the upstream time-delayed conducted signal will act via a first-order
transfer on the near-layer velocity v1 .3

B.1.1

Set of Equations

Described earlier in Sec.(B.1), the four processes may be translated into a set of algebraic relations, coupled ordinary di↵erential equations (ODEs) and partial di↵erential equations (PDEs):
1. Capillary Outlet PO2 Generation: As described, the two-layer microcirculatory O2
transport model can create capillary PO2 distributions. These are described using PB(1) (x, z)
which describes the capillary PO2 [mmHg] in the near-region (X1 , 0  z  L), and
PB(2) (x, z) describing the capillary PO2 in the far-region (X2 ,0  z  L) both as a Fourier
Series, where X1 = {x 2 R| 0µm x  200µm}, and X2 = {x 2 R| 200µm x  400µm},
and L = 500µm. In order to obtain outlets PO2 ’s, the capillary PO2 distributions must
be averaged over a z region. Defining the space of PO2 distributions as P, and the

operator h·i(x)
X,z0 : P ! R which averages a multivariable function over the interval
R
1
X = {xi  x  x f } and evaluates at z = z0 given explicitly by h f i(x)
=
f |z=z0 dx,
X,z0
||X|| X

then the PO2 outlets may be computed. Average outlet PO2 ’s may be calculated and subtracted from eachother to generate the PO2 di↵erence parameter which we hypothesize
to generate the signal acting on the inlet near-layer velocity by the following
⌦
↵
P(out) = PB(2) (x)
X2 ,L

⌦

PB(1)

↵(x)

X1 ,L

(B.1)

By convention of how this parameter is defined, P(out) > 0 when the PO2 is lower in the
near-layer than the far-layer, and P(out) < 0 when the PO2 is higher in the near-layer. In
general, P(out) is a non-linear function of v1 and is computationally intensive to evaluate
to a floating-point. To simplify the study, a linearization may be considered within a
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domain of v1 which is suitable to this study. At baseline, the baseline velocity considered
in the model based on IVVM experiments is v0 ⇡ 357.3µm.5,6 Considering a reasonable
range of v1 given by V = {v1 2 R| v0

0.44v0  v1  v0 + 0.44v0 } 2 [200µm, 500µm],

it can be seen that P(out) may be linearized by a secant method. This consists of evaluating P(out) at the v1 limits in the range, and fitting a line at the boundaries of V, @V.
Performing this for baseline parameters utilized in previous studies with the two-layer
microcirculatory model, the secant linearized form of P(out) obtains the form:
P(out) ⇡ (q1 q2 ) (q3 q4 ) (v1 vmin )
8
>
>
>
>vmin = 200µm/s, q1 = 10.771mmHg, q2 = 0.194
<
>
>
>
>
:q3 = 2.567(10) 2 mmHg · s/µm, q4 = 2.923(10) 4 s/µm

For simplicity this will be abbreviated by defining the constants ↵( ) = q1
vmin (q3

q4 ), and ⌘( ) =

3

4

(B.2)

q2

+

. In this manner, the linearization process may be

expressed as:
P(out) = ↵

⌘v1

(B.3)

In general this linearization is quite well fitting and overestimates the PO2 di↵erence
slightly for all values within the interested range. Below is an illustration of the linearization process for

= 15mmHg:
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Figure B.1: Linearization of P(out) (v1 ) in the range v1 2 V with chamber O2

= 15mmHg.

As can be seen, Fig.(B.1) demonstrates that Eq.(B.2) is a good approximation for the
PO2 di↵erence. In general Fig.(B.1) show the convention defined. For

= 15mmHg,

Fig.(B.1) show that since P(out) > 0, then the far-layer will have higher capillary PO2 ,
which makes sense since the near-layer is exposed to a low O2 condition. As v1 increases,
then the PO2 outlet di↵erence will decrease since v1 increasing increases the PO2 in
the near-layer, and thus decreasing the di↵erence between the two layers. Note that
this linearized, steady-state description of O2 transport is one of the major simplifying
approximations used in the present model.

2. Oxygen Signal Generation: The O2 signal generation will be described via a first-order
transfer with a generalized gain constant

p

[1/mmHg], and a relaxation time constant

⌧⌃ . This will describe the generation of a passive signal (⌃P , dimensionless) at the outlet
of the blocks shown in Fig.(3.1).1,7 Due to physical considerations, it may be assumed as
an initial conditions that there is no signal present at time t = 0. This equation may be
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stated as the following:
d⌃P
=
dt

p

P(out)
⌧⌃

⌃P

, ⌃P |t=0 = 0

(B.4)

3. Oxygen Signal Upstream Conduction: This conduction process is described to convert
the passive signal generated at z = L = 500µm into an signal which may act on the
near-layer capillary velocity v1 . Hence this will be termed an active signal ⌃A and in
general may be defined by a convective PDE with decay
(@t

and conduction speed vcond ,

vcond @z + )⌃A = 0.4 The only initial condition which will be of utility will be to set

the active signal ⌃A evaluated at z = L = 500µm to the time dependent accumulation of
the passive signal ⌃P . Therefore the set of equations and boundary conditions is equal to
the following:
(@t

vcond @z + )⌃A = 0, ⌃A |z=L = ⌃P (t)

(B.5)

4. Signal-Velocity First-Order Tranfer: As mentioned, the purpose of the generation for
an active signal ⌃A is for it to act on the capillary near-layer velocity v1 . This may
be described via a first-order transfer with a generalized gain constant

v

[µm/s], and a

relaxation time constant ⌧v , along with an o↵set v1 . The purpose of v1 is to ensure that
the steady state of the velocity first-order transfer, is the particular velocity which will
cause the PO2 di↵erence to be null and ensures that the signal vanishes at t = 1, as will
be discussed later. Explicitly, the v1 may be provided by setting Eq.(B.2) to zero, and
solving for v1 given by:
v1 =

↵( )
⌘( )

(B.6)

As can be seen, v1 is dependent on the surface O2 . The first order transfer will utilize
the active signal evaluated at the inlet ⌃A |z=0 , and assume that at t = 0, the velocity is the
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baseline velocity v0 . Therefore, this equation may be stated as the following:
dv1
=
dt

B.1.2

v ⌃A |z=0

⌧v

v1 + v1

, v1 |t=0 = v0 = 357µm/s

(B.7)

Simplifying Analysis

Here, the PDE shown in Eq.(B.5) will be reduced down to an algebraic relation between ⌃A
and ⌃P analytically. In general, first-order spatiotemporal PDEs such as this one are solved via
compression using a coordinate transformation.8 Introducing the coordinate transformation:
8
>
>
>
>
< ⇠ = c1 t + c2 z
>
>
>
>
:⇣ = p(vcond t + z)

This coordinate transformation may cause the PDE to be re-expressed as a simple linear quasiODE:
⇣
(c1

vcond c2 ) @⇠ +

⌘

⌃A (⇠, ⇣) = 0

This may be solved by letting u be a 1-parameter map, with general solution expressed into the
original {t, z} coordinates of:
⌃A = u (p · (vcond t + z)) e

✓

c1 t+c2 z
c1 v
cond c2

◆

Implementing the initial condition of ⌃A |z=L = ⌃P (t) and simplifying, the final solution is seen
to be:
⌃A (t, z) = ⌃P

!
z L
t+
e
vcond

✓

v

z L

cond

◆

It was mentioned that the Arciero conduction length is much larger than the functional length of
the capillary modules considered L = 500µm,1 and so therefore, we can assume that L/vcond ⇡
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0. Therefore, evaluating at z = 0, it can be seen that the relation between ⌃A and ⌃P is:
⌃A |z=0 ⇡ ⌃P t

L
vcond

!

This indicates that the e↵ect that the conduction equation (@t

(B.8)
vcond @z + ) has on an initial

function a distance of L upstream/downstream in the direction of conduction, is a time shift
by a factor of ⌧cond = L/vcond . In the laplace domain, letting L denote the laplace transform,
⌦A = L{⌃A |z=0 }, and ⌦P = L{⌃P } the relation shown in Eq.(B.8) may be expressed as:
⌦A = ⌦P e
Therefore, the phase shift of
seen to be

B.2

s⌧cond

(B.9)

shown in Fig.(3.5) and expressed in F(s) in Fig.(3.6), can be

= ⌧cond .

Laplace Analysis

Here, the algebraic/ODE system developed over Eqs.(B.3,B.4,B.5,B.7) will be decomposed in
the Laplace Domain:
P(out) = ↵
d⌃P
=
dt
(@t

p

⌘v1
P(out)
⌧⌃

⌃P

, ⌃P |t=0 = 0

vcond @z + )⌃A = 0, ⌃A |z=L = ⌃P (t)

dv1
=
dt

v ⌃A |z=0

⌧v

v1 + v1

, v1 |t=0 = v0 = 357µm/s

Where the PDE in the 3rd line will be replaced by the analytic solution of the PDE in the
Laplace domain given in Eq.(B.9)
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B.2.1

Laplace Master Matrix

Here we can see the PO2 di↵erence shown in Eq.(B.3), along with the ODEs Eq.(B.4) and
Eq.(B.7), and along with Eq.(B.8) replacing the PDE, may all be expressed uniformly in the
Laplace Domain. These representations agree with Fig.(3.6) and utilize the generalized transfer
functions shown in Table(3.1). For conventions, L{ P(out) } = ˜⇢(s), and L{v1 } = U1 (s):
˜⇢ = ↵( )
s
p H(s)

⌦P =

⌘( )U1
˜⇢

⌦A = F(s)⌦P
U1 =

vG(s)⌦A

+ G(s)

✓v

1

s

+ v0 ⌧v

◆

This may be formulated as a Master Matrix:3
2
666
666⌘( )
666
666 0
666
666
666 0
666
666
4 1

1
p H(s)

0
0

Therefore, denoting L

1

0
1
F(s)
0

32 3
76 7
0 7777 6666 U1 7777
777 666 777
76 7
0 77777 66666 ˜⇢77777
777 666 777
76 7
1 77777 66666⌦P 77777
7777 6666 7777
G(s)5 4⌦ 5

v

A

2
3
666
777
↵( )
666
777
s
666
777
666
777
0
666
777
666
777 = 0
666
777
0
666
77
666
⇣v
⌘7777
4G(s) 1 + v ⌧ 5
0 v
s

(B.10)

as the inverse laplace transform, the final solution in abstract form for

this may be represented by the following:
2
666
666
666
666
666
666
666
666
666
4

3
7
v1 7777
777
7
P(out) 77777
777 = L
7
⌃P 77777
777
7
⌃ 5
A

82
>
>
666
>
>
>
666⌘( )
>
>
>
666
>
>
>
6
>
>
>666 0
1 <6
6666
>
>
>
666 0
>
>
>
666
>
>
>
666
>
>
>
4
>
>
: 1

1
p H(s)

0
0

0
1
F(s)
0

3
7
0 7777
777
7
0 77777
777
7
1 77777
777
7
G(s)5

v

1

2
39
>
666
777>
>
↵( )
>
666
777>
>
s
>
666
777>
>
>
>
666
7
7
>
777>
0
>
666
777=
666
>
777>
>
666
>
0
777>
>
666
>
>
7
666
7
>
⇣v
⌘77>
>
4G(s) 1 + v ⌧ 5>
>
>
0
v
;
s

(B.11)
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Final Value Theorem - Steady State

Using symbolic computational software (namely, Maple2020), it can be seen that the transfer
functions for these are given using the generalized transfer functions in Table(3.1) above as:

U1 =

G(s)

⇣

v p H(s)F(s)↵(

) + v0 ⌧v s + v1

⌘

( vG(s)⌘( ) p H(s)F(s) + 1)s
˜⇢ = ↵( ) ⌘( )(v0 ⌧v s + v1 )G(s)
( vG(s)⌘ p H(s)F(s) + 1)s
⌘( )(v0 ⌧v s + v1 )G(s))
p H(s) (↵( )
⌦P =
( vG(s)⌘ p H(s)F(s) + 1)s
⌘( )(v0 ⌧v s + v1 )G(s))
p H(s)F(s) (↵( )
⌦A =
( vG(s)⌘ p H(s)F(s) + 1)s

(B.12)
(B.13)
(B.14)
(B.15)

While these may not be inverted into the time-domain by conventional Laplace methods, the
Final Value Theorem (FVT) may be utilized. This states that the steady state of a function
{limt!1 f (t)}, if it exists, is equivalent to the limit {lim s!0 sL{ f (t)}}. This may be used to
obtain steady-state values from a transfer function. Indeed, it can be seen that substituting in
the transfer functions from Table(3.1), and taking the limits above, the following results are
obtained:
lim v1 = lim+ sU1 (s) = ↵/⌘

t!1

s!0

lim P(out) = lim+ s ˜⇢(s) = 0

t!1

s!0

lim ⌃P = lim+ s⌦P (s) = 0

t!1

s!0

lim ⌃A = lim+ s⌦A (s) = 0

t!1

s!0

Therefore, since it was defined that P(out) = 0 when v1 = ↵/⌘, it can be seen that out system
as well will progress to the steady-state desired in order to equalize the layer di↵erence.
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Quasi Laplace-Inversion: Small t Values

While Laplace Inversion of the transfer functions found in Eq.(B.12-B.15) is not feasible in
terms of elementary functions, the Final Value Theorem’s, the Initial Value Theorem (IVT)
may be utilized to find approximations of the functions for small and large t. It can be seen
that while the FVT points out that small-s-values correspond to the steady-state regime of
the function, the IVT states that s ! 1 tends to the initial value of a function. Therefore,
we can assume that for small t values, the regime of the function corresponding to large s
may be focused on, and so the non-linear component of the transfer function, namely F(s),
vanishes for large s. These inverted time-functions may be denoted by the subscript {close}
indicating that once the transfer function is inverted, this time-function is valid only for small
t values. Therefore, the two parameters of highest interest, the velocity v1 and ⌃A may be
inverted assuming F(s) vanishes, and all the other transfer functions are substituted:

v1,close =

↵ e
+
⌘

t
⌧v

p ⌧v (↵

⌃A,close =

(⌘v0
⌘

↵)

✓

⌘v0 ) e
⌧v

+

t ⌧

v

0
BBB
BBB1
p↵ B
@

cond
⌧v

e

t

⌧v e

t ⌧

cond
⌧v

⌧v

◆
⌧
cond

⌧⌃ e
⌧⌃

t ⌧

cond
⌧⌃

1
CCC
CCC Heaviside(t
CA

⌧cond )
(B.16)

⌧⌃

⌧⌃

Heaviside(t

⌧cond )

(B.17)

⌃A,close may be examined closer. It can be seen that the maximum signal is obtained in the
Quasi-Close Laplace Inversion at the time:

tmax =

⌧⌃ ⌧v ln
⌧v

⇣⌧ ⌘
v

⌧⌃

⌧⌃

time-delay

z}|{
L
+
vcond

(B.18)

At this time value, the maximal signal produced in the close regime function can be seen to be:

⌃A,close(max) = ⌃A,close |t=tmax =

p ⌧v (⌘v0

↵)

✓⇣ ⌘
⌧
v

⌧v
⌧v ⌧⌃

⌧⌃

⌧v

⇣⌧ ⌘
v

⌧⌃

⌧⌃

⌧⌃
⌧v ⌧⌃

◆

(B.19)
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Equilibrium Chamber O2

It can immediately be seen that ⌃A,close = 0 when ↵ = ⌘v0 . This can be used to obtain a
particular chamber O2 which causes no signal in the tissue to be produced from the PO2 di↵erence. This will be referred to as the equilibrium chamber O2 , and will be denoted by ˜ O2 ,(eq)
Expanding ↵ and ⌘, this can be seen to be given by:
˜ O2 ,(eq) =

3 (v0
4 (v0

vmin )
vmin )

1
2

(B.20)

Utilizing this, it can be seen that in Baseline conditions, { ˜ O2 ,(eq) = 45.5mmHg}, whereas in
DMII, { ˜ O2 ,(eq) = 37.5mmHg}
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Appendix C
Maple2022 Code Appendix
Here is contained various Maple2022 code, used to produce and floating-point evaluate the
Capillary PO2 Distributions, as well as perform the numerical solution of the Endothelial Feedback Model.

C.1

Tissue and Capillary PO2 Distribution Computation Code

This is a code which defines the two-layer tissue and capillary PO2 distributions:
• Here, the chamber O2 , denoted through the definition

= ⇢1 on line 3 , as well as 4

other floating parameters given as {⇢2 , ⇢3 , ⇢4 , ⇢5 } throughout lines 2 - 5 can modulate a
set of constants through the procedure defined on line 7 .
• The capillary and tissue PO2 distributions are given as spatial piecewise functions PT (x, z)
and PB (x, z) (on lines 23 & 24 , respectively) as a function of the space, and the number
of fourier terms to take through n f .
– These are entirely analytic, and are outlined through auxiliary procedures and functions from lines 8 - 22 . The final distributions involve the matching parameters
denoted in the code as {Pi , ⌘, }.
• Once the tissue and capillary PO2 distributions are defined, lines 25 - 39 define the ✏
coupling coefficients also as a function of the number of Fourier terms.
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– These are then analytically inverted o↵-screen using Laplace co-factor expansion
to calculate the matching coefficients as a function of the number of fourier terms
and are substituted in lines 40 - 45 .

• Finally, the set of coefficients defined at the beginning of the code is substituted into the
matching parameters, as well as the PO2 distributions to produce their final forms in lines
46 - 47
1

restart;

2

GeometricParams B seq([R = 3, T = 200, T = 200, L = 500, ⌧ p = 100]):

3

BiochemicalParams B seq([K = 157.3, g = 48.77 · ⇢5 , DT = 2410, s = 0.75,

4
5

Layer1Params B seq([P01 = 47, µ1 = 15.7 · 3.89 1 , v1 = ⇢2 ,

1

Layer2Params B seq([P02 = 47, µ2 = 15.7 · 3.89 1 , v2 = ⇢3 ,

2

= ⇢1 ]):

= 0.03 · ⇢4 ]):
= 0.03 · ⇢4 ]):

6

TotalConst B [GeometricParams, BiochemicalParams, Layer1Params, Layer2Params]:

7

const B (p1, p2, p3, p4, p5) ! {seq(subs({⇢1 = p1, ⇢2 = p2, ⇢3 = p3, ⇢4 = p4, ⇢5 = p5}, TotalConst))}:

8
9
10
11
12
13
14
15
16
17
18
19

1

B n ! T · (Pi · n) 1 :

2

B n ! 2 T · (Pi · (2n + 1)) 1 :
1

⇠1 B n ! 2K · (g · s · R · v1 )
⇠2 B n ! 2K · (g · s · R · v2 )
Z1 B P01

1

( 1) ) · µ1 · (g · s · v1 )

n

Q2 B µ2 · (g · s · v2 )
M1 B n ! (Z1

B2 B (n, z) ! (

1

Pi ) · (1

1
2

· (2K ·

·

2

· ((1

( 1)n ) + (⌘

· ⇠1 (n) · (1
· ⇠2 (n) · (1

GT1 B (x, z) ! Pi + (⌘
PC B x ! Pi

· (1 + 2K ·
1

1 ) · R · µ1

B1 B (n, z) ! (

· (1 + 2K ·
1)

(1

Q1 B n ! (1

1

·z·L

1)

1

2)

1

Pi ) · ⌧ p 1 · x:

(

1

1
2

·
·

2
1 (n)

2

2 (n)

: Z2 B P02

+

2) ·

· ((1
· ((1
(1
n

1 ) · R · DT)
2 ) · R · DT)

2 ) · R · µ2

1 · · ( 1) · ((1

Pi ) · ( 1)n : M2 B Z2

PB1 B proc(x, z, N) local n; (1

21

1..N)end proc:

22

PT2 B proc(x, z, N) local n; GT2 (x, z) + add(2 · g · s · v2 ·

1 ) · R · µ1 · (2K ·

1)

1

2)

1

:

1

⌘:

· M2 + Q2 ) · exp( ⇠2 (n) · z)
x
Pi ) · : GT2 B (x, z) ! ⌘
T

20

) 1:

· (2 · K ·

· M1 (n) + Q1 (n)) · exp( ⇠1 (n) · z)

1

) 1:

1

1 ) · L) :

L) 1 :

PT1 B proc(x, z, N) local n; GT1 (x, z) + add(2 · g · s · v1 ·

1

3
1 (n)

Q1 (n):

Q2 :
· z · L 1:

· (T · DT)

1

· B1 (n, z) · sin(x · ( 1 (n)) 1 ), n = 1..N)end proc:

+ GT1 (x, z) + add(2 · (1
3
2 (n)

· ( T · DT)

1

1 ) · 1 (n) · (T

· B2 (n, z) · sin((x

1 · ⇠1 (n))

·

PB2 B proc(x, z, N) local n; (1

24

0..N)end proc:

25

PT B (x, z, N) ! piecewise( ⌧ p  x < 0, PC (x), 0  x < T, PT1 (x, z, N), T  x  T + T, PT2 (x, z, N

26
27
28
29
30
31
32
33

+GT2 (x, z)+add(2·(1

PB B (x, z, N) ! piecewise(0  x < T, PB1 (x, z, N), T  x  T + T, PB2 (x, z, N

(T · DT · (1

1 ))

1

+ add(2 · g · s · v1 ·

· Z1 · (1

( 1)n ), n = 1..n f )end proc:

1

2 )· 2 (n)·(T · 2 ·⇠2 (n))

1

· B2 (n, z)·sin((x T )·( 2 (n)) 1 ), n =

1)):

1)):

1
1
· ( 1 · ⇠1 (n) · Z1 · (1
1 ) + µ1 · (g · s ·
⌧p
v1 ) 1 ) µ1 · (g · s · v1 ) 1 ) · (1 ( 1)n ), n = 1..n f )end proc:
1
1
1
✏2 B proc(n f ) local n; +
+ add(2 · g · s · v1 · 1 (n)2 · 1 · (T · DT · L · (1
· (1 exp( L · ⇠1 (n))), n = 1..n f )end proc:
1 ))
T ⌧p
1
1
✏3 B proc(n f ) local n; + add(2 · g · s · v1 · 1 (n)2 · 1 · ( 1)n · (T · DT · L · (1
· (1 exp( L · ⇠1 (n))), n = 1..n f )end proc:
1 ))
T
1
2
n
1
✏4 B proc(n f ) local n;
+add(2·g· s·v1 · 1 (n) · 1 ·( 1) ·(T ·DT ·L·(1 1 )) ·(1 (1 exp( L·⇠1 (n)))·(L·⇠1 (n)) 1 ), n = 1..n f )end proc:
2T
1
✏5 B proc(n f ) local n; add(2 · g · s · v2 · 2 (n)2 · 2 · ⇠2 (n) · ( T · DT · (1
· Z2 , n = 0..n f 1) + add(2 · g · s · v1 · 1 (n)2 · 1 · ⇠1 (n) ·
2 ))

✏1 B proc(n f ) local n;

2
1 (n) · (T · DT)

· B1 (n, z) · sin(x · ( 1 (n)) 1 ), n =

T ) · ( 2 (n)) 1 ), n = 0..N)end proc:

23

2 )·R·µ2 ·(2K · 2 )

1

· ((1

exp( L · ⇠1 (n))) · (L · ⇠1 (n))
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34
35
36
37

1
+ add(2 · g · s · v1 ·
T
1
✏7 B proc(n f ) local n; + add(2 · g · s · v2 ·
T
1
(T · DT · (1
1 )) , n = 1..n f )end proc:
✏6 B proc(n f ) local n;

✏8 B proc(n f ) local n; add(2·g· s·v2 ·

38

0..n f

39

add(2·g· s·v1 ·

40
41
42
43
44
45
46
47

1) +

2
1 (n)
2 (n)

2
2 (n) ·(

2

· ( 1)n ·
·

T ·DT)

2

1
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· ⇠1 (n) · (T · DT · (1

· ⇠2 (n) · ( T · DT · (1

1

·(

2 ·⇠2 (n)·Z2 ·(1

2 ))

2)

1

1 ))
1

1

, n = 1..n f )end proc:

, n = 0..n f

1) + add(2 · g · s · v1 ·

·exp( L ·⇠2 (n)) µ2 ·(g· s·v2 )

1

2
1 (n)

·

1

· ⇠1 (n) ·

·(1 exp( L ·⇠2 (n)))), n =

2
1
1 (n) ·(T ·DT) ·( 1 ·⇠1 (n)·Z1 ·(1

1
1
n
1 ) ·exp( L·⇠1 (n)) µ1 ·(g· s·v1 ) ·(1 exp( L·⇠1 (n))))·(1 ( 1) ), n = 1..n f )end proc:
1
1
✏9 B proc(n f ) local n; + add(2 · g · s · v1 · 1 (n)2 · 1 · ⇠1 (n) · ( 1)n · exp( L · ⇠1 (n)) · (T · DT · (1
1 )) , n = 1..n f )end proc:
T
1
1
✏10 B proc(n f ) local n; + add(2 · g · s · v2 · 2 (n)2 · 2 · ⇠2 (n) · exp( L · ⇠2 (n)) · ( T · DT · (1
1) + add(2 · g · s · v1 ·
2 )) , n = 0..n f
T
2
1
1 (n) · 1 · ⇠1 (n) · exp( L · ⇠1 (n)) · (T · DT · (1
1 )) , n = 1..n f )end proc:
1
1
✏11 B proc(n f ) local n; + add(2 · g · s · v2 · 2 (n)2 · 2 · (1 exp( L · ⇠2 (n))) · ( T · L · DT · (1
1) + add(2 · g · s · v1 ·
2 )) , n = 0..n f
T
2
1
1 (n) · 1 · (1 exp( L · ⇠1 (n))) · (T · L · DT · (1
1 )) , n = 1..n f )end proc:

✏12 B proc(n f ) local n; add(2 · g · s · v1 ·
1

v1 ) )

1

µ1 · (g · s · v1 ) ) · (1

n

2
1 (n)

· (T · DT)

( 1) ), n = 1..n f )end proc:

1

· ((1

exp( L · ⇠1 (n))) · (L · ⇠1 (n))

1

·(

1

· ⇠1 (n) · Z1 · (1

1)

1

+ µ1 · (g · s ·

Pival B (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) ! eval(subs(const(⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), (✏11 (n f )✏7 (n f )✏1 (n f ) ✏10 (n f )✏4 (n f )✏5 (n f )+✏11 (n f )✏3 (n f )✏5 (n f )+✏4 (n f )✏7 (n f )✏8 (n f ))·

(✏6 (n f )✏4 (n f )✏10 (n f ) + ✏2 (n f )✏11 (n f )✏7 (n f )

49

⌘val B (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) ! eval(subs(const(⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), (✏11 (n f )✏6 (n f )✏1 (n f )+✏11 (n f )✏2 (n f )✏5 (n f ) ✏4 (n f )✏5 (n f )✏9 (n f )+✏4 (n f )✏6 (n f )✏8 (n f ))·

50
51
52
53
54
55

(✏6 (n f )✏4 (n f )✏10 (n f ) + ✏2 (n f )✏11 (n f )✏7 (n f )
val

✏6 (n f )✏3 (n f )✏11 (n f )

✏9 (n f )✏4 (n f )✏7 (n f )) 1 )):

48

✏6 (n f )✏3 (n f )✏11 (n f )

✏9 (n f )✏4 (n f )✏7 (n f )) 1 )):

B (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) ! eval(subs(const(⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), (✏10 (n f )✏6 (n f )✏1 (n f ) ✏7 (n f )✏9 (n f )✏1 (n f )+✏10 (n f )✏2 (n f )✏5 (n f ) ✏2 (n f )✏7 (n f )✏8 (n f )

✏3 (n f )✏5 (n f )✏9 (n f ) + ✏3 (n f )✏6 (n f )✏8 (n f )) · (✏6 (n f )✏4 (n f )✏10 (n f ) + ✏2 (n f )✏11 (n f )✏7 (n f )
MatchParams B proc(n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) local i; {seq([Pi , ⌘, ][i] = [Pival , ⌘val ,

✏6 (n f )✏3 (n f )✏11 (n f )

✏9 (n f )✏4 (n f )✏7 (n f )) 1 )):

val ][i](n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), i

= 1..3)}end proc:

PTf B (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) ! subs(MatchParams(n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 )unionconst(⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), PT (x, z, n f )):

PBf B (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) ! subs(MatchParams(n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 )unionconst(⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), PB (x, z, n f )):

The outputs of this code, which is the final spatial (x, z) tissue and capillary PO2 distributions
{PTf (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), PBf (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 )} as a function of the number of Fourier terms
(n f ), chamber PO2 (⇢1 ), and 4 extra floating constant parameters (⇢2 , ⇢3 , ⇢4 , ⇢5 ), can then be
plotted in 3D as in Chapter 1, or further manipulated as in Chapter 2.

C.2

Endothelial Feedback System Solver Code

This is a code which numerically solves the Endothelial Feedback Model. Line numbering
starting at 56 is appropriate since in the worksheet where the model is numerically solved,
the previous 55 lines from the code in Sec.(C.1) is replicated:
• First, from the previous code in Sec.(C.1), the chamber O2 , denoted through the definition

= ⇢1 on line 3 , as well as 4 other floating parameters given as {⇢2 , ⇢3 , ⇢4 , ⇢5 }
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throughout lines 2 - 5 can modulate a set of constants through the procedure defined on
line 7 ; this dependency on floating parameters is passed on to the feedback system.

• Next, all relevant processes required from the O2 transport side of the feedback system
are computed:
– Capillary PO2 outlets are calculated from the previous capillary PO2 distribution
PBf (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) and averaged in lines 56 - 57 .
– Their di↵erence is calculated as P(out) in line 58 in accordance with the averaging
operator given in Eq.(B.1).
– The capillary outlet di↵erence function is secant linearized over the interval V as
outlined in Eq.(B.2) in line 59 - 60 , and an array of all the linearized functions
required for the chamber O2 values of [15,30,45,60], and CD values of [1.0,0.55]
is computed over lines 61 - 67 through the arrays Arr and Arr.
– In addition, the final steady-state velocity is numerically computed in line 68
• A list of constants is defined in line 69 , and the list of all the ODEs for all chamber O2
values considered and CD values considered is defined over line 70 - 76 , as well as the
initial conditions on line 77 . The system is numerically solved using Maple’s dsolve
functionality solved over lines 78 - 95
• Smaller processes including linearizing the outlet PO2 ’s per region for the 3rd panel of
the figures in Chapter 2 and finding the maximal signal to normalize all the ⌃P values are
done over lines 96 - 106
• Once the solution is obtained, the code follows by defining several functional processes
to perform plotting:
– Small font and general options are defined over lines 107 - 110

C.2. Endothelial Feedback System Solver Code

151

– Plotting both ⌃P and ⌃A normalized against the maximum value of ⌃P for a chamber
PO2 of 15mmHg and baseline CD are completely defined over lines 111 - 118 in
the process ⌃PlotFunc which uses m and p to cycle through

Arr and Arr arrays,

respectively.
– Plotting the near-layer velocity v1 , as well as its initial value v0 for reference are
completely defined over lines 119 - 129 in the process vPlotFunc which uses m and
p to cycle through Arr and Arr arrays, respectively.
– Plotting both Pout,1 and Pout,2 using the v1 values, as well as their homogenized PO2
value where their di↵erence vanishes defined as P f inal are completely defined over
lines 130 - 145 in the process

PPlotFunc which uses m and p to cycle through

Arr and Arr arrays, respectively.
• Finally, two important processes are defined to render the final images in Chapter two
– To create the 3-plot stack in each figure in Chapter 2’s Results section, the process
MergePanels() is defined over lines 146 - 158 . This process still depends on the
precise Arr and Arr array values.
– To render the 8 figures for the 8 cases (4 chamber PO2 cases, 2 CD cases), a loop is
defined as the process WriteFigs() over lines 159 - 167
• Finally, a small process to view all 8 figures at once is defined over lines 168 - 177
56
57

Pout1 B (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) ! evalf (subs(z = 500, int(PBf (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), x = 0..200) · 200 1 )):

Pout2 B (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) ! evalf (subs(z = 500, int(PBf (n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ), x = 200..400) · 200 1 )):

58

Pout B proc(n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ) return evalf ((Pout2

59

Pout,secan B proc(v, , ⇢4 , ⇢5 ) local j; return evalf ( Pout (2, , 200, 357.3, ⇢4 , ⇢5 ) + add(( 1) j · Pout (2, , [200, 500][ j], 357.3, ⇢4 , ⇢5 ), j =

60
61
62

1..2) · (v

200) · (500

200) 1 )end proc:

Pout,lin B Array(1..4, 1..2, (k, m) ! 0):

Arr B [15, 30, 45, 60]: Arr B [1, 0.5]: gval B 0.8:

63

f or k f rom 1 by 1 t o 4 do

64

f or m f rom 1 by 1 t o 2 do

65
66

Pout,lin [k, m] B Pout,secan (v, Arr[k], Arr[m], gval)
end do

Pout1 )(n f , ⇢1 , ⇢2 , ⇢3 , ⇢4 , ⇢5 ))end proc:
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67

end do:

68

v1 B Array(1..4, 1..2, (k, m) ! fsolve( Pout,lin [k, m], v)):

69
70

constset B {
t

P

= 16.5,

v

= 35.7, ⌧⌃ = 60, ⌧v = 1, L = 500, vcond = 700, v0 = 357.3}:

B proc(func) return Array(1..2, j ! [⌧⌃ , ⌧v ][ j] · di↵ (func, t) + func)end proc:

71

EqSet B proc() local i, Eq;

72

Eq B Array(1..2, 1..4, 1..2, (i, k, m) !

73
74

1
vcond
)][i] + [0, v0

+ (v1 [k, m]

t ([⌃P (t), v B (t)][i])[i]

v0 ) · Heaviside(t

L

=[

P , v ][i]

1
· vcond
)][i]):

· [subs(v = vB (t), Pout,lin [k, m]), Heaviside(t

end proc:

76

EqSets B EqSet():

77

BCs B {⌃P (0) = 0, vB (0) = 357.3}:

78

soln B Array(1..4, 1..2, proc(k, m) local i; dsolve({seq(EqSets[k, m][i], i = 1..2)}unionBCs, numeric)end proc):

79

⌃Pvec B Array(1..4, 1..2, 0..155, (mval, pval, ival) ! 0):
⌃Avec B Array(1..4, 1..2, 0..155, (mval, pval, ival) ! 0):

81

f or mval f rom 1 by 1 t o 4 do

82

f or pval f rom 1 by 1 t o 2 do

83

f or ival f rom 1 by 1 t o 151 do

84

i f rhs(soln[mval, pval]((ival

85

⌃Avec [mval, pval, ival] B rhs(soln[mval, pval](subs(x = (ival

1) · 5 1 )[3])

0 t hen
1

1) · 5

86

⌃Pvec [mval, pval, ival] B rhs(soln[mval, pval]((ival

87

⌃Pvec [mval, pval, ival + 1] B rhs(soln[mval, pval]((ival) · 5 1 )[2]);

88
89
90

⌃Pvec [mval, pval, ival + 3] B rhs(soln[mval, pval]((ival + 2) · 5 1 )[2]);
⌃Pvec [mval, pval, ival + 4] B rhs(soln[mval, pval]((ival + 3) · 5 1 )[2]);

92

⌃Avec [mval, pval, ival] B ⌃Avec [mval, pval, ival

93

⌃Pvec [mval, pval, ival + 4] B ⌃Pvec [mval, pval, ival + 3];

94

end i f ;

95

end do end do end do:

96

Poutfunc1 B Array(1..4, 1..2, (k, m) ! 0):
f or k f rom 1 by 1 t o 4 do

99

f or m f rom 1 by 1 t o 2 do

102
103

1];

Poutfunc2 B Array(1..4, 1..2, (k, m) ! 0):

98

101

5 · 7 1 , Heaviside(x) · x))[2]);

⌃Pvec [mval, pval, ival + 2] B rhs(soln[mval, pval]((ival + 1) · 5 1 )[2]);

else

100

1

1) · 5 )[2]);

91

97

L·

return subs(constset, Matrix(4, 2, (k, m) ! Vector(2, i ! Eq[i, k, m])))

75

80

1
L · vcond
) · ⌃P (t

Poutfunc1 [k, m] B Pout1 (2, Arr[k], 200, 357.3, Arr[m], 0.8) + add(( 1) j · Pout1 (2, Arr[k], [200, 500][ j], 357.3, Arr[m], 0.8), j = 1..2) · (v

200) · (500

200) 1 ;

200) · (500

200) 1 ;

Poutfunc2 [k, m] B Pout2 (2, Arr[k], 200, 357.3, Arr[m], 0.8) + add(( 1) j · Pout2 (2, Arr[k], [200, 500][ j], 357.3, Arr[m], 0.8), j = 1..2) · (v

104

end do

105

end do:

106

⌃maxval B max(seq(rhs(soln[1, 1]((i

107

fontopt B font = [“HELVETICA”, “roman”, 14]:

108

medfontopt B [“HELVETICA”, “roman”, 16]:

109

genopt B ylab ! seq([legendstyle = [location = right, font = medfontopt], fontopt, labels = [typeset(“Time Elapsed, ”, t, “ [s]”), ylab], labeldirections =

1) · 5 1 )[2]), i = 1..151)):

110

[“horizontal”, “vertical”], labelfont = medfontopt, titlefont = medfontopt, size = [700, 0.45], thickness = 3]):

111

⌃PlotFunc B proc(m, p) local i, k; display(seq(DynamicSystems[DiscretePlot](Vector(151, i ! rhs(soln[m, p]((i

1) · 5 1 )[1])), Vector(151,
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112

proc(i)

113

return [⌃Pvec , ⌃Avec ][k][m, p, i] · (⌃maxval )
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1

114

end proc),

115

linestyle = [solid, dash][k], color = Color(“HSV”, [1, 1, 1]), legend = typeset([⌃P (t), ⌃A (t)][k])), k = 1..2),

116

genopt(typeset(”Signal Generated[/]”)), view = [0..30, 1.2..1.2], axes = normal,

117

title = typeset(“Chamber Oxygen is ”,

118

“.\nMaximal Signal Magnitude is ”, |⌃P |, “ = ”, evalf [3](max(seq(abs(⌃Pvec [m, p, i] · (⌃maxval ) 1 ), i = 1..151)))))end proc:

119

= Arr[m], “mmHg. ”, [1], “ = ”, [2] = Arr[p] · [0], [“ (Baseline)”, “ (Low CD)”][p],

vPlotFunc B proc(m, p) local k; display(seq(DynamicSystems[DiscretePlot](Vector(151, i ! rhs(soln[m, p]((i

120

proc(i)

121

i f rhs(soln[m, p]((i

1) · 5 1 )[3])

1) · 5 1 )[1])), Vector(151,

0t hen
1

122

return [rhs(soln[m, p]((i

123

else return [0, subs(constset, v0 )][k]

124

end i f ;

125

end proc),

126

linestyle = [solid, dash][k], color = blue, legend = typeset([v1 (t), v0 ][k])), k = 1..2),

127

genopt(typeset(“Blood Vel. [um/s]”)), view = [0..30, 0..900], axes = normal,

128

title = typeset(“Chamber Oxygen is ”,

129

“.\nSteady-State Velocity is ”, v1 , “ = ”, round(eval(subs(x = evalf [3](rhs(soln[m, p](30)[3])), x · Heaviside(x)))), “um/s”))end proc:

130
131

1) · 5 )[3]), subs(constset, v0 )][k]

= Arr[m], “mmHg. ”, [1], “ = ”, [2] = Arr[p] · [0], [“ (Baseline)”, “ (Low CD)”][p],

PPlotFunc B proc(m, p) local TitleLabel, k;

i f m = 4 ^ p = 2 t hen TitleLabel B “not homogenized”

132

elseTitleLabel B seq([Pout,1 , “ = ”, Pout,2 = evalf [3](subs(v = rhs(soln[m, p](30)[3]), Poutfunc1 [m, p])), “mmHg”])

133

end i f :

134

display(seq(DynamicSystems[DiscretePlot](Vector(151, i ! rhs(soln[m, p]((i

1) · 5 1 )[1])), Vector(151,

135

proc(i)

136

i f rhs(soln[m, p]((i

137

return subs(v = rhs(soln[m, p]((i

138

else return subs(v = 0, [Poutfunc1 , Poutfunc2 ][k][m, p])

139

end i f ;

140

end proc),

141

linestyle = [solid, solid][p], color = [blue, red][k], legend = typeset([Pout,1 , Pout,2 ][k])), k = 1..2),

142

DynamicSystems[DiscretePlot](Vector(151, i ! rhs(soln[m, p]((i 1)·5 1 )[1])), Vector(151, i ! subs(v = rhs(soln[m, p](30)[3]), Poutfunc1 [m, p])), linestyle =

1) · 5 1 )[3])

0 t hen
1) · 5 1 )[3]), [Poutfunc1 , Poutfunc2 ][k][m, p])

143

dot, color = black, legend = typeset(Pfinal )),

144

genopt(typeset(“Outlet P”, O2 , “ [mmHg]”)), view = [0..30, 25..45], axes = normal,

145

title = typeset(“Chamber Oxygen is ”,

146

“.\nFinal Outlet P”, O2 , “ is ”, TitleLabel))end proc:

147

MergePanels B proc(m, p, fignum) local i, Tit1, A, B;

= Arr[m], “mmHg. ”, [1], “ = ”, [2] = Arr[p] · [0], [“ (Baseline)”, “ (Low CD)”][p],

148

i f Exists(cat(“Fig”, fignum, “.png”)) = true t hen

149

Remove(cat(“Fig”, fignum, “.png”));

150

end i f :

151

f or i f rom 1 by 1 t o 3 do

152

Tit1 B cat(“Fig”, fignum, “ ”, i, “.png”):

153

Export(Tit1, [⌃PlotFunc , vPlotFunc , PPlotFunc ][i](m, p), base = currentdir):

154

A[i] B Read(Tit1):

155

Remove(Tit1):

156

end do:

154
157

B B Stack([seq(A[i], i = 1..3)], vertical, halign = center):

158

return B;

159

end proc:

160

WriteFigs B proc() local m, p, tit, c

161

f or m f rom 1 by 1 t o 4 do

Chapter C. Maple2022 Code Appendix

162

f or p f rom 1 by 1 t o 2 do

163

tit B cat(m + 4, [“A”, “B”][p]):

164

c B MergePanels(m, p, tit):

165

Write(cat(“Fig”, tit, “.png”), c):

166

end do

167

end do:

168

end proc:

169

LargeStack B proc() local m, p, tempimg, LargeImg, FinalImg;

170

f or m f rom 1 by 1 t o 4 do

171

f or p f rom 1 by 1 t o 2 do

172

tempimg B Read(cat(“Fig”, m + 4, [“A”, “B”][p], “.png”)):

173

LargeImg[m, p] B tempimg:

174

end do

175

end do:

176

FinalImg B Stack([seq(Stack([seq(LargeImg[m, p], m = 1..4)], horizontal, valign = center), p = 1..2)], vertical, halign = center):

177

Write(“MergedPic.png”, FinalImg)

178

end proc:

This code is fully capable of rendering all 8 figures in the results section of Chapter 2.
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